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1. Abstracts 
1.1 Abstract 
GABAergic signalling plays a crucial role in the precise control of neuronal activity 
patterns. The early development of GABAergic neurons is regulated by intrinsic and 
extrinsic factors, including the thyroid hormone triiodothyronine (T3). Furthermore, 
GABAergic neurons develop in an intricate interrelationship with spontaneous network 
activity, which is a general feature of developing neuronal structures and plays a crucial 
role in the formation of neural networks by modulating survival and connectivity of 
neurons. The aim of this work was to study the impact of thyroid hormone T3 on early 
network development, especially on the development of GABAergic neurons and 
spontaneous network activity, in neuronal cultures prepared from embryonic rat cortex. 
The results show that T3 increases the overall density of glutamatergic and GABAergic 
synapses and enhances the frequency of early spontaneous network activity. In parallel, T3 
affects neuronal development in a population specific manner, especially promoting 
somatic and axonal growth of large GABAergic interneurons and the density of small late 
born GABAergic neurons. In the presence of T3 large GABAergic interneurons form 
numerous GABAergic boutons and conspicuous axonal arborizations around cell bodies of 
non-GABAergic neurons. Interestingly, blocking neuronal activity by TTX or glutamate 
receptor blockers reveals a thyroid hormone-mediated component on somatic growth, but 
optimal growth of large GABAergic neurons is both activity and hormone-dependent. 
Additionally, the characteristic axonal innervation pattern could be prevented by the 
tropomyosin-related kinase B (TrkB) receptor inhibitor K252a, suggesting the involvement 
of brain-derived neurotrophic factor (BDNF) signalling in T3-dependent axonal growth. 
Further, T3 enhanced the expression of the potassium-chloride cotransporter 2 (KCC2), 
and accelerated the developmental shift from depolarizing to hyperpolarizing GABAergic 
signalling in non-GABAergic neurons. Finally, recovery experiments indicate that T3-
deprivation during the first two weeks in vitro induced long-lasting deficits in the 
patterning of GABAergic axons, the density of small late born GABAergic neurons and the 
frequency of spontaneous network activity. This critical period parallels the phase of 
depolarizing GABAergic signalling as revealed by calcium imaging experiments. Taken 
together, the results indicate that T3 regulates the maturation of the cortical GABAergic 
system in a complex and subpopulation specific manner and thus contributes to the 
functional maturation of early cortical networks. 
Abstracts 
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1.2 Zusammenfassung 
Einleitung. GABAerge Interneurone sind ein wichtiger Bestandteil des cerebralen 
Cortex, da sie durch ihre hemmende Wirkung die Aktivität von erregenden Neuronen in 
präziser Weise kontrollieren können. Infolgedessen führen Störungen der Entwicklung und 
Funktion dieser GABAergen Neurone zu einer Reihe von neurologischen und 
psychiatrischen Störungen, wie z.B. Autismus, Epilepsie und Schizophrenie. Die 
Entwicklung von GABAergen Interneuronen wird sowohl durch intrinsische wie auch 
extrinsischen Faktoren beeinflusst. Ein wichtiger intrinsischer Faktor für die Ausbildung 
von neuronalen Netzwerken ist die sogenannte spontane Netzwerkaktivität, die während 
der frühen Netzwerkentwicklung das Überleben und die Verknüpfung von Neuronen 
steuert. Das Aufkommen spontaner Aktivität ist eine generelle Eigenschaft sich 
entwickelnder neuronaler Strukturen und ist gekennzeichnet durch synchrone Aktivität in 
einer großen Zahl von benachbarten Neuronen. Besonders interessant ist in diesem 
Zusammenhang, dass GABAerge Neurone und die Netzwerkaktivität sich während der 
Entwicklung gegenseitig beeinflussen, da die Reifung GABAerge Zellen einerseits 
aktivitäts-abhängig ist, andererseits GABAerge Transmission die Netzwerkaktivität durch 
eine vorübergehende erregende Wirkung auch fördert. Ein wichtiger extrinsischer Faktor 
für die Entwicklung GABAerger Interneurone ist das Schilddrüsenhormon Trijodthyronin 
(T3). Generell ist T3 ein wichtiger Entwicklungsfaktor für eine Vielzahl von Organen 
einschließlich des Gehirns. Dort steuert es die Migration und Differenzierung von 
Neuronen und deren Synaptogenese. Ein Mangel an T3 führt zu mentaler Retardierung und 
kann besonders während der späten embryonalen und frühen postnatalen Phase irreversible 
Schädigungen verursachen. 
Ziel und Methoden. Das Ziel der vorliegenden Arbeit war es, die Einflüsse von T3 
während der frühen Entwicklung von neuronalen Netzwerken zu untersuchen. Ein 
besonderes Augenmerk wurde dabei auf die voneinander abhängige Entwicklung von 
GABAergen Neuronen und spontaner Netzwerkaktivität gelegt. Die Ergebnisse sollen das 
grundlegende Verständnis der zugrunde liegenden Mechanismen verbessern, die zur 
Entwicklung von GABAergen Neuronen und damit der funktionellen Reifung des Cortexes 
beitragen. Die Versuche wurden an neuronalen Zellkulturen durchgeführt, die aus dem 
embryonalen Cortex von Ratten gewonnen wurden. Die Aktivität der Neurone wurde mit 
einem Calcium-sensitiven Farbstoff gemessen. Des Weiteren wurden die Zellkulturen 
immunzytochemisch gefärbt, um GABAerge Neurone sichtbar zu machen. 
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Ergebnisse. Die Ergebnisse zeigen, dass T3 sowohl die Frequenz der spontanen 
Netzwerkaktivität als auch die Zahl der glutamatergen und GABAergen Synapsen erhöht. 
Gleichzeitig beeinflusst T3 die Entwicklung von Neuronen in Zelltyp-spezifischer Weise, 
wobei die deutlichsten Veränderungen in der Zunahme in der Zellgröße und des 
Axonwachstums von sogenannten großen L-GABAergen Interneuronen und in der 
erhöhten Dichte von kleinen S-GABAergen Interneuronen gemessen wurde. Die L-
GABAergen Neurone bilden nach Stimulation mit T3 eine Vielzahl von GABAergen 
Boutons und weitverzweigte Axone um die Zellkörper von nicht-GABAergen Neuronen 
aus. Interessanterweise erhöhte T3 auch die Zellgrößen wenn die neuronale Aktivität 
blockiert wurde, was einen direkten Einfluss von T3 auf das Neuronwachstum vermuten 
lässt. Allerdings wuchsen die GABAergen Zellen nur dann optimal, wenn sowohl das 
Hormon als auch neuronale Aktivität vorhanden waren. Die Ausbildung der typische 
Axonstruktur mit vielen Boutons und feinen Verästelungen durch T3 konnte außerdem mit 
einem Inhibitor des Neurotrophinrezeptors TrkB verhindert werden, was vermuten lässt, 
dass das Neurotrophin BDNF eine Rolle bei der Ausprägung der von T3 induzierten 
Axonstruktur spielt. Darüber hinaus erhöhte T3 die Expression des Kalium-Chlorid-
Cotransporters KCC2, der für die hemmende Wirkung von GABA wichtig ist, und 
beschleunigte damit die für die Entwicklung typische Umkehrung von einer erregenden zu 
einer hemmenden Wirkung von GABAerger Transmission in nicht-GABAergen Neuronen. 
Abschließende Experimente haben gezeigt, dass die von T3-Mangel verursachten 
Entwicklungsstörungen nicht durch eine spätere Stimulation mit T3 nach der zweiten 
Kulturwoche korrigiert werden können, was darauf hinweist, dass T3-Mangel während der 
ersten zwei Kulturwochen dauerhafte oder zumindest lang anhaltende Defizite in der 
Axonausbildung L-GABAerger Neurone, der Dichte S-GABAerger Neurone und der 
Frequenz spontaner Netzwerkaktivität verursacht.  
Diskussion. Zusammenfassend zeigen die Ergebnisse, dass T3 die Reifung des 
kortikalen GABAergen Systems auf komplexe und in einer Zelltyp-spezifischen Weise 
moduliert und damit zur funktionalen Reifung von jungen kortikalen Netzwerken beträgt. 
Besonders die Veränderungen der L-GABAergen Neurone könnten eine wichtige Rolle bei 
der Entstehung pathologischer Störungen bei T3-Mangel spielen. Da T3 die 
Netzwerkaktivität erhöht und diese wiederum die Reifung junger Netzwerke beeinflusst, 
könnte T3 hierdurch weitere indirekte Effekte auf Entwicklung von Neuronen ausüben. 
Die lang andauernden Veränderungen der Netzwerkstruktur verdeutlichen zudem die 
wichtige Bedeutung von T3 während der frühen Gehirnentwicklung. 
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2. Introduction 
2.1 Network activity 
2.1.1 Development of neuronal circuits 
Proper function of the central nervous system (CNS) results from the establishment 
of specific neuronal networks with diverse neuronal phenotypes and precise synaptic 
connections between neurons during development. This network formation is achieved by 
a coordinated sequence of complex developmental events, which regulate neurogenesis, 
migration, differentiation and synaptogenesis (Zhang and Poo, 2001; Feller, 1999). The 
information for the organization of neural circuits relies on genetic programs and neuronal 
activity (Goodman and Shatz, 1993; Khazipov and Luhmann, 2006). Taking the presence 
and type of neuronal activity into account, roughly three phases can be distinguished in a 
simplified model of brain development: an early activity-independent phase, a phase 
characterized by the presence of spontaneous network activity and at least a phase of 
activity- and experience-dependent plasticity. 
Thus, the initial developmental of neurons and the establishment of crude 
connectivity of neuronal networks, which precedes predominantly during embryonic 
development, are determined by genetic programs and occur independent of neuronal 
activity (Goodman and Shatz, 1993). During this phase the generation of neurons, the 
development of distinct neuronal phenotypes, the migration of neurons to a distinct 
position within a network, and the establishment of an initial set of connections take place 
(Blankenship and Feller, 2010). During the later activity-dependent phase, neural activity 
is thought to drive refinement of the initial crude connectivity (Goodman and Shatz, 1993; 
Katz and Shatz, 1996; Feller, 1999). As neurons start to form synaptic connections, 
neuronal circuits develop highly synchronized spontaneous network activity. In rats, this 
type of activity patterns emerges around birth and is most prominent during the first 
postnatal week (Ben-Ari et al, 2007). It is suggested that this early spontaneous activity is 
important for the initial wiring of neuronal structures and disappears upon maturation of 
sensory systems (Katz and Shatz, 1996). During further postnatal development the network 
is then modified in an experience-dependent manner (Khazipov and Luhmann, 2006). This 
final refinement of connections is set by experience-dependent activity from sensory 
stimuli. Thus, in contrast to intrinsic spontaneous activity the refinement is a result of 
interactions between the nervous system and the outside world. 
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2.1.2 Emergence of spontaneous network activity  
Slow and synchronous spontaneous network activity is a characteristic feature of 
developing neuronal networks. It occurs transiently in many developing neural circuits, 
including the retina, the cochlea, the hypothalamus, the spinal cord, the cerebellum, the 
neocortex and the hippocampus, and is probably shared by all developing networks (Feller, 
1999; O’Donovan, 1999; Ben-Ari, 2001; Ben-Ari et al, 2007; Blankenship and Feller, 
2010). Interestingly, the patterns of spontaneous network activity and the mechanisms that 
generate it seem to be remarkably similar across various circuits (Blankenship and Feller, 
2010). Spontaneous network activity emerges across large groups of neighbouring cells as 
neurons start to form synaptic connections and functional circuits develop. Early network 
activity is driven by glutamatergic and depolarizing GABAergic transmission and can be 
abolished by the sodium channel blocker tetrodotoxin (TTX) or by antagonists of chemical 
synaptic transmission (O´Donovan, 1999). In general, network activity involves correlated 
firing of large populations of neurons and consists of recurrent bursts of action potentials 
and concomitant increases of intracellular calcium concentrations, which last for up to 
hundreds of milliseconds and are separated by intervals up to a few minutes (Corlew et al., 
2004; Moody and Bosma, 2005; Blankenship and Feller, 2010). Consequently, 
spontaneous activity can be examined by direct recording of the electrical activity or 
fluorescence imaging of the Ca
2+
 transients. As development proceeds, synchronous events 
with initially very low frequency develop to reach higher frequencies and maximal cellular 
participation, which includes nearly all neurons (Garaschuk et al., 2000; Opitz et al., 2002; 
Corlew et al., 2004).  
 
2.1.3 Functions of network activity 
Synchronous network activity plays an important role in the establishment of 
neuronal circuits and connections (Garaschuk et al., 2000; Voigt et al., 2005). As it 
emerges in a wide range of brain structures around birth, early network activity influences 
several developmental processes, which take place during early postnatal development, 
including neuronal migration and survival, differentiation, synaptogenesis, 
neurotransmitter specification and synaptic plasticity (Voigt et al., 1997; Voigt et al., 2005; 
Moody and Bosma, 2005; Khazipov and Luhmann, 2006). Especially the generation, 
migration and survival of GABAergic neurons might be affected by early network activity 
(de Lima et al., 2004, 2007, 2009). Electrical activity also induces changes in the global 
Introduction 
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properties of the neuron such as intrinsic excitability and patterns of gene expression and 
protein synthesis (Zhang and Poo, 2001) and thus network activity might also function as a 
synchronization factor during early development. 
Furthermore, it is suggested that early spontaneous activity patterns guide the 
refinement of neural structures (Katz and Shatz, 1996). According to the Hebbian rule 
“neurons that fire together wire together”, synchronous activity across large populations of 
cells is crucial for the proper wiring of developing neuronal networks (Cherubini et al., 
2011). This activity-dependent but experience-independent form of synaptic plasticity 
might enable gross map formation, whereas map refinement takes place during the 
subsequent experience-dependent phases, e.g. ‘critical periods’ (Katz and Shatz, 1996; 
Hensch, 2004). Indeed, it has been shown that the emergence of spontaneous network 
activity promotes and synchronizes the activation of AMPA receptors and the formation of 
synaptic contacts (Liao et al., 2001; Voigt et al., 2005), enhances the survival of 
participating neurons (Voigt et al., 1997), and regulates the establishment of long-range 
corticocortical connections (Voigt et al., 2005). It is suggested that early spontaneous 
activity disappears upon maturation of sensory systems, when experience-dependent 
mechanisms further refine network connectivity (Katz and Shatz, 1996; Hensch, 2004). 
  
2.1.4 Depolarizing GABA signalling during early development 
γ-aminobutyric butyric acid (GABA) released by GABAergic interneurons is the 
main inhibitory neurotransmitter in the adult central nervous system (CNS) and exerts its 
fast actions by the activation of GABA type A receptors (GABAAR). Because these 
receptors conduct Cl
-
 ions, the intracellular chloride concentration determines the strength 
and polarity of GABA-mediated neurotransmission (Ben-Ari et al., 2007; Kahle et al., 
2008). In the presence of a high intracellular chloride concentration GABAA receptor 
activation results in chloride efflux and a depolarization of the cell membrane. In contrast, 
a low intracellular chloride concentration results in chloride influx and cell membrane 
hyperpolarisation. The intracellular chloride concentration of neurons in turn is regulated 
by the two cation chloride cotransporters sodium-potassium-chloride cotransporter 1 
(NKCC1) and potassium-chloride cotransporter 2 (KCC2), which accumulate or extrude 
chloride respectively (Kahle et al., 2008; Blaesse et al., 2009). During early postnatal 
development a high expression of NKCC1 but low expression of KCC2 maintain a high 
intracellular chloride concentration and a depolarizing action of GABAergic signalling. 
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Later the developmental downregulation of NKCC1 and concomitant upregulation of 
KCC2 results in lower intracellular chloride concentration and a hyperpolarizing action of 
GABAA receptor opening (Fiumelli and Woodin, 2007). 
Thus, the cells that will become inhibitory interneurons in adulthood are a primary 
source of depolarization during development (Ben-Ari et al, 2007; Blaesse et al., 2009). As 
GABAergic synapses are functionally active before glutamatergic ones, GABA is even the 
principal excitatory transmitter during early development that induces depolarization in the 
neonatal brain (Ben-Ari. 2001). Consequently, depolarizing GABA is crucial for the 
generation of spontaneous synchronous network activity in developing neuronal structures, 
as initially described in the developing hippocampus, and referred to as Giant Depolarizing 
Potentials (GDPs) (Ben-Ari et al, 1989). The depolarizing action of GABA and its 
contribution to spontaneous network activity have been confirmed in many neuronal 
structures (Blankenship and Feller, 2010) including developing cultured neuronal networks 
prepared from embryonic rat cortex (Voigt et al., 2001, 2005; Opitz et al., 2002; Baltz et 
al., 2010).  
 
2.1.5 Network activity in cell culture 
As in the neonatal cerebral cortex in vivo (Khazipov et al., 2004; Adelsberger et al., 
2005) and acute slices (Garaschuk et al., 2000; Corlew et al., 2004; Allene et al, 2008), 
synchronized network activity also develops spontaneously in organotypic slice cultures 
(Gorba et al., 1999; McCabe et al., 2006; Johnson and Buanomano, 2007) and in networks 
formed by embryonic cortical neurons in culture (Muramoto et al., 1993; Opitz et al., 2002; 
Voigt et al., 2005). Interestingly, the mechanisms and the time course of activity 
development are quite similar to that observed in in vivo circuits.  
In cultures from embryonic rat cortex network activity characterized by 
simultaneous transients of [Ca
2+
]i involving many neurons first appeared at the end of the 
first week in vitro (Opitz et al., 2002). The slow rhythmic synchronous Ca
2+
 transients seen 
with imaging techniques reflect bursts of actions potentials recorded in single cells with the 
patch clamp technique (Opitz et al., 2002; Voigt et al., 2005). These spontaneous 
population events initially occur at a low frequency and are expressed only by a fraction of 
neurons. During the second week in culture the burst frequency increases and virtually all 
neurons become active and participate in synchronous network activity (Voigt et al., 1997; 
Opitz et al., 2002).  
Introduction 
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It has been shown that the synchronous calcium transients are dependent on 
depolarizing actions of GABAergic neurotransmission during the initial period of network 
activity between 8 and 12 DIV (Voigt et al., 2005). Consequently, the initiation of 
synchronous bursts can be blocked by GABA receptor antagonists until 12 DIV, but 
becomes independent from GABAergic signalling thereafter (Voigt et al., 2005; Klueva et 
al., 2008). During later development GABAergic signalling plays a modulatory role in the 
bursting patterns of neuronal networks, which starts with the depolarizing to 
hyperpolarizing switch in GABAergic signalling (Baltz et al., 2010). Electrical recordings 
on microelectrode arrays have shown that mature neuronal cultures exhibit temporally 
differentiated patterns of spontaneous network activity, which can be blocked by GABA 
receptor antagonists (Baltz et al., 2010). 
 
2.2 GABAergic interneurons 
2.2.1 Function of GABAergic neurons 
Neuronal structures, and so the cerebral cortex, consist of neurons, which are 
remarkably heterogeneously in their phenotype, morphology, network position and 
function. In general, the neurons of the cerebral cortex can be divided into two main 
populations, glutamatergic pyramidal neurons and GABAergic interneurons, which release 
the neurotransmitter γ-aminobutyric acid (GABA). GABA binds to two types of receptors, 
the GABAA and GABAB receptor. Whereas the GABAB receptor is a G-protein coupled 
metabotropic receptor, the GABAA receptor is a ligand-gated ion channel highly permeable 
to Cl
-
 and bicarbonate (Ben-Ari et al., 2007). The net effect of the channel opening 
depends on the electrochemical gradient of these anions (cf. chapter 2.1.4), but in general 
GABAA receptor activation generates a membrane hyperpolarisation that act to reduce 
neuronal excitability (Ben-Ari et al., 2007).  
Thus, GABA acting on Cl
-
 permeable GABAA receptors is the main inhibitory 
transmitter of the adult cortex and GABAergic signalling plays an important role in normal 
brain function by the precise control of neuronal activity (Markram et al., 2004; Buzsáki, 
2006). GABAergic interneurons are believed to play important roles in balancing 
excitation and inhibition, controlling the timing of pyramidal cell firing, synchronizing 
network activity, and the generation of cortical rhythms (Markram et al., 2004; Bartos et al, 
2007; Burkhalter, 2008). Interneurons regulate the spatio-temporal dynamics of neuronal 
network oscillations in a wide range of oscillation frequencies (Buzsáki, 2006), which are 
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thought to support brain function and are correlated to executive functions, learning and 
memory (Markram et al., 2004; Woo and Lu, 2006; Bartos et al, 2007). Thus it is not 
surprising that dysfunctions of GABAergic signalling are associated with pathological 
conditions, such as autism, mental retardation, epilepsies and schizophrenia (DeFelipe, 
1999; Levitt et al., 2004; Lewis et al., 2005; Wonders and Anderson, 2006; Ben-Ari et al., 
2007; Woo and Lu, 2006). 
 
2.2.2 Diversity of GABAergic interneurons of the adult cortex 
GABAergic interneurons make up 20 to 30 percent of the total neuronal population 
of neocortical areas and are remarkable heterogeneously in their form and functions 
(DeFelipe, 1997; Freund, 2003; Kawaguchi and Kubota, 1997; Somogyi and Klausberger, 
2005; Markram et al., 2004). Several approaches have been used to classify the different 
subtypes of interneurons by estimating their morphology, their neurochemical composition 
and their firing properties (DeFelipe, 1997; Kawaguchi and Kubota, 1997; Freund, 2003; 
Markram et al., 2004). It has been shown that subgroups of interneurons differ in the 
morphology of their dendrites and axons, target different subdomains of postsynaptic cells, 
express different calcium-binding proteins, e.g. parvalbumin, calretinin and calbindin 
(Kawaguchi and Kubota, 1997), and show different firing properties, like fast spiking, 
regular spiking or irregular spiking (Freund, 2003; Somogyi and Klausberger, 2005). By 
targeting specific domains of pyramidal neurons, interneurons are able to control 
spatiotemporal aspects of neuronal activity. For example, soma-targeting interneurons can 
tightly control the output and synchronization of pyramidal cells, whereas dendrite-
targeting interneurons are in an optimal position to modulate dendritic processing 
(Markram et al., 2004). 
Based on the expression of different neurochemical markers, three main groups of 
cortical interneurons have been proposed in a simplified classification (Gonchar and 
Burkhalter, 1997; Kawaguchi and Kubota, 1997; Rudy et al., 2011). In brief, a 
predominant group of interneurons is characterized by the expression of the calcium 
binding protein parvalbumin. This group includes fast spiking basket cells and chandelier 
cells. These neurons typically have multipolar morphology and target the soma and 
proximal dendrites or the axon initial segment of pyramidal cells, respectively (Kawaguchi 
and Kubota, 1997; Freund, 2003; Markram et al., 2004). The second group includes 
interneurons expressing somatostatin and is typically associated with Martinotti cells. 
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These interneurons have ascending axons that arborize in layer I and make synapses with 
the apical dendrites of pyramidal cells. The last group has recently been suggested to be 
characterized by the expression of ionotropic serotonin transporter 5HT3a (Lee et al., 
2010; Rudy et al., 2011). However, this group is more heterogeneous than the other groups 
and includes interneurons expressing the vasoactive intestinal peptide (VIP), neurons 
containing the calcium binding protein calretinin, reelin positive neurons of cortical layer I 
and also the so called neurogliaform cells (Kawaguchi and Kubota, 1997; Markram et al., 
2004; Lee et al., 2010). These cells, with exception of neurogliaform cells, often have 
bipolar or bitufted morphologies, are predominantly located to the upper layers in the 
cortex and innervate dendritic domains of pyramidal cells (Rudy et al., 2011). 
Neurogliaform cells are a relative unique subpopulation of interneurons having multipolar 
morphology and a round axonal plexus composed of fine branches and forming electrical 
synapses (Kawaguchi and Kubota, 1997).  
However, all these groups include several subtypes of interneurons that further 
differ in morphological and electrophysiological properties (DeFelipe, 1997; Kawaguchi 
and Kubota, 1997; Freund, 2003; Markram et al., 2004). The detailed classification of 
interneurons is still under investigation (Ascoli et al., 2008).  
 
2.2.3 Origin and development of cortical GABAergic interneurons 
The first GABAergic neurons of the mouse cerebral cortex are born as early as 
embryonic day 12 (Xu et al., 2004; Miyoshi et al., 2007; Batista-Brito and Fishell, 2009), 
but the period of GABAergic interneuron maturation extends towards late postnatal stages 
in rodents (Huang et al., 2007; Huang, 2009; Cossart, 2010). It is suggested that the 
maturation of GABAergic microcircuits results from the interplay between both intrinsic 
genetic programs and neuronal activity (Huang et al., 2007; Cossart, 2010). However, the 
exact factors and mechanisms regulating early interneuron development were unknown for 
long time, because the examination of GABAergic neurons is even more difficult during 
development than adulthood. As immature interneurons have not yet acquired their 
characteristic adult neurochemical and morpho-physiological features, it is difficult to 
identify and classify them (Cossart, 2010). Recently, the development of novel imaging 
techniques and genetic fate mapping strategies as well as the use of birth date studies and 
transplantation techniques opened new possibilities for the investigation of GABAergic 
neuron development.  
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Cortical interneurons are generated in the ventral telencephalon and migrate 
tangentially into the developing cortex (Wonders and Anderson, 2006). Recent studies 
have indicated that the morpho-physiological phenotype of interneurons is strongly 
predetermined by their embryonic origin (Butt et al., 2005). GABAergic interneurons of 
the cerebral cortex are generated predominantly in the medial ganglion eminence (MGE) 
and to a smaller degree in the caudal ganglion eminence (CGE) (Batista-Brito and Fishell, 
2009; Vitalis and Rossier, 2011). The subpopulations originating from these two sites do 
not only express different neuronal transcription factors, but also end up in several distinct 
interneuron groups. The MGE gives rise to the parvalbumin- and somatostatin-containing 
neocortical interneurons (Xu et al., 2004; Miyoshi et al., 2007), which typically target the 
somatic and proximal dendritic domains of other neurons, while the CGE gives rise to the 
dendrite targeting calretinin- and VIP-expressing interneurons (Xu et al., 2004; Batista-
Brito and Fishell, 2009; Vitalis and Rossier, 2011). 
 
2.2.4 Activity-dependent maturation of GABAergic interneurons 
The maturation of GABAergic neurons extends far into postnatal development. 
Thus, because of its early postnatal emergence, electrical activity is likely to modulate the 
late maturation of early-born interneurons as well as the development of late-born 
interneurons. Interneurons develop specific morphological phenotypes, with typical 
dendritic trees and axon targeting selected domains of postsynaptic neurons (Huang et al., 
2007). The occurrence of this characteristic morphological features seems to be 
intrinsically determined (Huang et al., 2007), as the generation of characteristic axonal 
arbors and prominent GABAergic boutons proceeds in vivo (Karube et al., 2004) as well as 
in organotypic culture (Di Cristo et al., 2004; Chattopadhyaya et al., 2004). In contrast the 
refinement of GABAergic axons and their synapses is dependent on neuronal activity. 
Blocking neuronal activity with TTX reduces the number of GABAergic boutons in 
organotypic cortical cultures (Chattopadhyaya et al., 2004). The other way around, 
increasing neuronal activity by blocking inhibitory GABA signalling by the GABA 
receptor antagonist bicuculline increased the number of GAD65 immunoreactive terminals 
and the density of inhibitory synapses (Marty et al., 2000). 
An important mediator of these activity-dependent effects is the neurotrophin brain-
derived neurotrophic factor (BDNF). The expression and secretion of BDNF by projection 
neurons in the cerebral cortex is regulated by neuronal activity (Zafra et al., 1990; 
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Lessmann et al., 2003). And of course, interneurons have been demonstrated to express 
various neurotrophin receptors, including the BDNF receptor tropomyosin-related kinase B 
(TrkB) (Cellerino et al., 1996; Gorba and Wahle, 1999). BDNF effects on interneurons are 
manifold and strongly promote interneuron growth (Marty et al., 1996, 1997; Palizvan et 
al, 2004), neurochemical maturation (Jones et al., 1994; Altar et al., 1997;  Huang et al., 
1999; Patz et al., 2003, 2004), dendritic elongation and branching (Vicario-Abejon et al., 
1998; Jin et al., 2003; Kohara et al., 2003) and synaptogenesis of GABAergic interneurons 
(Rutherford et al 1997; Seil and Drake-Baumann, 2000; Yamada et al., 2002; Palizvan et 
al, 2004). Furthermore, the strength and polarity of GABAergic signalling is dynamically 
modulated by neurotrophins through regulation of the postsynaptic KCC2 expression and 
thereby the reversal potential for chloride (Rivera et al., 2002; Aguado et al., 2003; Wardle 
and Poo, 2003).  
Thus, because GABAergic neuron maturation is activity-dependent and in turn 
GABAergic signalling promotes network activity due to the depolarizing actions of GABA 
during development (see chapter 2.1.4), GABAergic neurons develop in close 
interrelationship with spontaneous network activity. 
 
2.2.5 GABAergic neurons in cell culture 
The development of cortical interneurons in cultures from embryonic rat neocortex 
has been extensively studied before (de Lima and Voigt, 1997; Voigt et al., 2001; de Lima 
et al., 2004). As mentioned above, the identity of cortical interneurons is predetermined by 
genetic factors. Thus interneurons develop morphological and physiological properties 
comparable to the in vivo situation when grown in organotypic slice cultures or dissociated 
neuron cultures (de Lima and Voigt, 1997; Voigt et al., 2001; Chattopadhyaya et al., 2004; 
Karube et al., 2004). 
In neuronal cultures developing from dissociated embryonic rat cerebral cortices, 
two types of GABAergic neurons were described, named large L-GABAergic and small S-
GABAergic neurons (de Lima and Voigt, 1997). These two subpopulations differ in their 
time of birth and morpho-physiological properties. Thus these neurons are suggested to be 
in vitro correlates of early and late born cortical interneurons in vivo.  
Because immature GABAergic neurons do not express their typical adult 
phenotypes, the investigation of GABAergic neurons during early development is difficult. 
Therefore the subdivision of GABAergic neurons in two distinct groups that differ in their 
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time of birth and morphology provides a simplified but helpful approach to analyse the 
morphological and functional interneuron maturation in a population dependent manner, 
where these populations represent correlates of the distinct interneuron populations born in 
the medial and caudal ganglionic eminence. 
L-GABAergic neurons. The L-GABAergic neurons are a very prominent type of 
GABAergic interneuron. They are postmitotic by the time of plating, develop a large cell 
body with a stellate dendritic tree, and form a dense network of long-range connections 
with their thick axons (Voigt et al., 2001). Their dendrites are densely innervated by 
presynaptic terminals and their axons contact the soma and proximal dendrites of 
numerous postsynaptic cells. In mature cultures, L-GABAergic neurons show a fast-
spiking phenotype (Klueva et al., 2008), and express parvalbumin (de Lima et al., 2004; 
Klueva et al., 2008). Thus they show morphological and physiological properties similar to 
cortical parvalbumin neurons in situ (Voigt et al., 2001; de Lima et al., 2004; Klueva et al., 
2008). L-GABAergic neurons belong to the lineage of cortical interneurons, which 
originate in the subcortical medial ganglionic eminence (MGE) and develop to form 
diverse types of GABAergic neurons, including parvalbumin-positive basket interneurons 
(Wonders and Anderson, 2006; Batista-Brito and Fishell, 2009). During network formation 
L-GABAergic neurons play an important role in the generation of early synchronous 
network activity (Voigt et al., 2001). Because of their high connectivity and the 
depolarizing actions of GABA during early development, these neurons are able to drive 
network oscillations even in the absence of glutamatergic neurotransmission (Voigt et al., 
2001).  
S-GABAergic neurons. S-GABAergic neurons are a second and numerically larger 
subpopulation of GABAergic neurons. These neurons are born later then the L-GABAergic 
neurons and are generated in vitro from precursors that do not produce GABA during the 
first few days in vitro (de Lima and Voigt, 1997). S-GABAergic neurons increase in their 
number at least until 12 DIV and are differentiated at around 14DIV. Then these neurons 
typically have small bipolar or multipolar cell bodies and very thin axons (de Lima and 
Voigt, 1997; de Lima et al., 2004). Because S-GABAergic neurons are double-labelled 
with calretinin (de Lima et al., 2004) they are thought to be correlates of calretinin/VIP 
interneurons that mainly populate the upper cortical layers in vivo (Kawaguchi and 
Kubota, 1997; Markram et al., 2004). In contrast to the population of parvalbumin-positive 
neurons this heterogeneous group of interneurons, including the calretinin-expressing 
neurons, is thought to originate from the caudal ganglionic eminence (Batista-Brito and 
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Fishell, 2009; Cossart, 2010). In culture these neurons strongly depend on glutamatergic 
activity during a critical time window, otherwise they are irreversibly eliminated from the 
network (de Lima et al., 2004). 
 
2.3 Thyroid hormones 
The thyroid hormones thyroxine (T4) and triiodothyronine (T3) are tyrosine-based 
hormones, which are primarily produced by the thyroid gland. Specific thyroid hormones 
receptors are abundantly expressed in all tissues, and thus thyroid hormones act on nearly 
every cell in the body (Hulbert, 2000). In general, thyroid hormones are responsible for 
regulation of cell metabolism and are essential for proper development and differentiation 
of nearly all cells. Thyroid hormones furthermore play a determining role in the early 
growth and development of most organs. Especially the brain of humans and other 
mammals has been identified as an important target of thyroid hormone actions for many 
years (Legrand, 1984; Dussault and Ruel, 1987). Thyroid hormones play an important role 
in the establishment of the cortical microarchitecture. Consequently, thyroid hormone 
deficiency in developing mammals, including humans, may lead to severe morphological 
and functional alterations of the CNS (Yen, 2001; Morreale de Escobar et al., 2004; Wallis 
et al., 2008).  
 
2.3.1 Consequences of thyroid hormone deficiency 
Defects in thyroid hormone signalling can be caused by impaired thyroid function, 
mutations in thyroid hormone receptors and transporters, and iodine deficiency, as iodine is 
an important compound in thyroid hormone synthesis (Bernal, 2009). The resulting 
hypothyroxinemia can occur at any stage of life and induces morphological and functional 
alterations of the CNS. However, the most devastating consequences of thyroid hormone 
deficiency take place during fetal and early postnatal development with poor growth and 
severe cognitive impairment (de Benoist et al., 2008). These deficits can be prevented by 
thyroid hormone replacement shortly after birth (Dussault and Ruel, 1987; Anderson, 
2001). If not treated adequately, neonates exhibit general features of hypothyroidism as 
growth and mental retardation, tremor, spasticity and speech and language deficits 
(Morrela de Escobar et al., 2004; Williams, 2008). The most damaging disorders induced 
by thyroid hormone deficiency are irreversible mental retardation and cretinism (Delange, 
2000; World Health Organization, 2004). 
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Also iodine deficiency caused by a low dietary supply of iodine causes thyroid 
hormone deficiency. The resulting damage increases with the extent of the deficiency, but 
also mild iodine deficiency causes subtle degrees of mental impairment that lead to poor 
school performance, reduced intellectual ability, and impaired work capacity (World 
Health Organization, 2004). It has been suggested that iodine deficiency is responsible for 
a mean intellectual quotient (IQ) loss of 10-15 points at the population level (Delange, 
2000; de Benoist et al., 2008). Therefore iodine deficiency is a major public health 
problem for populations throughout the world, particularly for pregnant women and young 
children. Still, 266 million children and 2 billion people worldwide are at risk for iodine 
deficiency (de Benoist et al., 2008). Thus, iodine deficiency is the world’s greatest single 
cause of preventable brain damage (World Health Organization, 2004). 
Besides modulation of cognition and brain performance thyroid hormones have also 
been implicates in regulation of mood and behavior:  
Depression. Thyroid hormone dysregulation has been linked to depression and 
thyroid hormone testing is a routine in psychiatric admission for depressive patients 
(Kirkegaard and Faber, 1998). Additionally, thyroid hormone application is a commonly 
used strategy to accelerate or augment a standard antidepressant therapy (Carvalho et al., 
2009), although the mechanisms behind this effect are not clear. Recent evidence comes 
from animal studies showing that mice harbouring a mutant thyroid hormone receptor 
alpha 1 (TRalpha1) (Tinnikov et al., 2002) show depression-like behavior (Pilhatsch et al., 
2010). 
Anxiety. Mice with a point mutation in the TRalpha1 gene (Tinnikov et al., 2002) 
furthermore showed an  anxious phenotype with reduced exploratory behavior and 
memory deficiencies, which could be improved following T3 administration (Venero et al., 
2005, Wallis et al., 2008). 
ADHD. Attention deficit and hyperactivity disorder has been diagnosed in the 
offspring of mothers exposed to mild-moderate iodine deficiency (Vermiglio et al., 2004). 
Accordingly, transgenic mice bearing a human mutant thyroid hormone receptor beta1 
gene, a condition that also occurs in human resistance to thyroid hormones (RTH) (Weiss 
and Refetoff, 2000), display stereotypic behavioral features, hyperactivity and learning 
deficits (McDonald et al., 1998; Siesser et al., 2006). 
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2.3.2 Physiology 
The thyroid hormones T4 and T3 are products of the thyroid gland. Whereas T4 is 
derived exclusively from synthesis and secretion by the thyroid gland, T3 is largely 
produced in peripheral tissues by enzymatic removal of an outer ring iodine atom from T4 
(Hulbert, 2000; Patel et al., 2011). To fulfil its function in the brain, T4 first have to cross 
the blood-brain barrier by a specific transporter. After having entered the brain, T4 is taken 
up by astrocytes, where it is converted to T3 (Williams, 2008; Patel et al., 2011). This 
activation of T3 and also the inactivation of both thyroid hormones are done by specific 
enzymes, the iodothyronine deiodinases (Gereben et al., 2008). The type 2 deiodinase (D2) 
is expressed predominantly in astrocytes (Guadano-Ferraz et al., 1997) and catalyses the 
removal of an outer ring iodine atom from the ‘prohormone’ T4 to generate the more 
active product T3 (Hulbert, 2000; Patel et al., 2011). In contrast, the type 3 deiodinase 
(D3), which is located in neurons, inactivates T3 or prevents T4 being activated by 
catalysing removal of an inner ring iodine to generate the biological inactive 
diiodothyronine (T2) or reverse triiodothyronine (reverse T3, rT3) respectively (Hulbert, 
2000; Williams, 2008; Patel et al., 2011). The generated T3 is released by astrocytes and 
taken up by neurons, presumably by active uptake via the specific transporter MCT8 
(Williams, 2008; Patel et al., 2011). T3 then exerts its major actions directly in neurons and 
is finally degraded by D3 in neurons (Williams, 2008). Thus the control of local T3 levels 
in brain tissue takes place in functional units of astrocytes and neurons. 
 
2.3.3 Signalling pathways 
The mechanisms by which thyroid hormones exert their influence are complex and 
still not completely defined. In the classical view, thyroid hormones act via nuclear thyroid 
hormone receptors (TRs). There are two receptor types, TRalpha and TRbeta, both 
expressed in several isoforms (Forrest et al., 1990; Bradley et al., 1992). These thyroid 
hormones receptors are abundantly expressed in all tissues of the body (Hulbert, 2000). In 
the brain, TRalpha has been estimated to account for 70-80% of total TR expression and is 
widely expressed, whereas TRbeta shows more restricted expression patterns (Bradley et 
al., 1992). Because the physiological ligand of TRs is T3, it is considered to be the active 
form of thyroid hormones, whereas T4 might function as a prohormone (Williams, 2008).  
Nuclear thyroid hormone receptors are ligand-modulated transcription factors that 
bind directly to the DNA at thyroid hormone response elements (TREs) located in gene 
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regulatory regions (Yen, 2001; Bernal, 2007; Bernal, 2009). Unlike most other nuclear 
receptor types, unliganded thyroid hormone receptors bind corepressor complexes with 
histone deacetylase activity (Yen, 2001; Bernal, 2007). Thereby they maintain a 
nonpermissive chromatin structure and inhibit gene transcription. By binding T3 these 
repressors are released and coactivator complexes are recruited to the DNA. These 
complexes induce chromatin opening by intrinsic histone acetyl transferase activity and 
enhance transcriptional activity (Yen, 2001; Bernal, 2007). 
The repressing action of unliganded TRs exerts important physiological roles 
during the development but can also exhibit harmful activity (Hashimoto et al., 2001; 
Bernal et al., 2003; Bernal, 2007). In contrast to hypothyroid animals with unliganded 
receptors, mutant mice lacking all TRs do not display obvious signs of developmental 
abnormalities (Morte et al., 2002). Thus, the absence of the receptor is not equivalent to the 
absence of the hormone. This can be explained by the hypothesis that abnormal regulation 
of transcription by the unliganded receptor is responsible for the effects of profound 
hypothyroidism, rather than the direct missing of hormone (Bernal et al., 2003; Bernal, 
2007). This hypothesis is supported by the observations that the expression of a dominant-
negative point mutation in the TRalpha1 gene lead to the typical alterations of severe 
hypothyroidism (Tinnikov et al., 2002; Venero et al., 2005; Wallis et al., 2008; Bernal, 
2009). 
In addition to genomic actions, also extragenomic pathways of thyroid hormone 
action have been described (Davis et al., 2005; Cheng et al., 2010). Recently, it has been 
suggested that thyroid hormone receptors might also be located in the cytoplasma (Storey 
et al., 2006). There the TRs can interact with the regulatory p85 subunit of the 
phosphoinositide 3-kinase (PI3K) and regulate downstream targets such as mammalian 
target of rapamycin (mTOR) or Rac (Cao et al., 2005; Storey et al., 2006). Furthermore, it 
has been shown that T4 and, to a lesser extent, T3 bind to a membrane receptor formed by 
the integrin alphaVbeta3, which then activates the mitogen-activated protein kinase 
(MAPK) signalling cascade (Davis et al., 2005; Cheng et al., 2010). Finally, thyroid 
hormones have been suggested to regulate the kinetics of glutamatergic and GABAergic 
signalling potentially by direct non-genomic modulation of neurotransmitter receptors 
(Losi, et al., 2008; Puia and Losi, 2011). Additionally, thyroid hormones rapidly modulate 
protein phosphorylation (Sarkar et al., 2006) and cytoskeletal proteins (Zamoner et al., 
2006). However, the mechanisms of non-genomic actions and their contribution to the 
physiological actions of thyroid hormones in vivo are still largely unknown. 
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2.3.4 Influence on brain development 
It is suggested that thyroid hormones have no influence on very early 
developmental events, such as neurulation, neural fate induction and establishment of 
polarity, but regulate later processes, especially those related to early postnatal 
development, including myelination, differentiation, dendrite proliferation and synapse 
formation (Zoeller and Rovet, 2004; Bernal et al., 2003; Williams, 2008). Consequently, 
cellular correlates following T3 deprivation are damages in myelination, migration defects, 
altered cortical layering, and reduction of axonal or dendritic outgrowth, as it has been 
reported for neocortex, hippocampus and cerebellum (Bernal and Nunez, 1995; Anderson, 
2001; Yen, 2001; Koibuchi et al., 2001; Morrelae de Escobar et al., 2004). Numerous 
studies pointed out the importance of thyroid hormones in the expression of presynaptic 
proteins involved in neurotransmitter release, including Synapsin (Hosoda et al., 2003), 
SNAP-25 (Zhang et al., 2008), Synaptophysin (Gong et al., 2010) and Synaptotagmin-1 
(Wang et al., 2011). Accordingly, thyroid hormones have been shown to regulate the 
distribution of axonal projections (Li et al., 1995; Lucio et al., 1997), the number of 
dendritic spines (Ruiz-Marcos et al., 1980, 1982; Nimchinsky et al., 2002), and the 
differentiation of dendrites (Ipiña et al., 1987; Sala-Roca et al., 2008). 
Recently it has been shown that disturbance of T3 signalling during early 
development led to profound defects in the maturation of the GABAergic system. 
Especially interneurons positive for the calcium binding protein parvalbumin are 
modulated by thyroid hormone signalling (Berbel et al., 1996; Venero et al., 2005; Gilbert 
et al., 2007; Wallis et al., 2008). It has been shown that hypothyroidism reduces the density 
of parvalbumin-positive neurons both in neocortex and hippocampus (Gilbert et al., 2007), 
as well as the density of parvalbumin-positive terminals and processes (Berbel et al., 
1996). Additionally, reduced numbers of parvalbumin-immunoreactive interneurons have 
been reported in mice expressing a dominant-negative point mutation in the TRalpha1 gene 
without alteration of the total number of GABAergic neurons (Venero et al., 2005; Wallis 
et al., 2008). 
 
2.3.5 Temoral aspects 
The developmental timing is thought to be an important factor in thyroid hormone 
actions. In a simplified model, three stages of thyroid hormone dependent brain 
development can be distinguished (Williams, 2008): The first stage spans the time before 
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the onset of fetal thyroid hormone synthesis, which occurs at 16-20 weeks postconception 
in humans or by embryonic day E17.5-18 in the rat. During this period, thyroid hormone 
influences proliferation and migration of neurons in the cerebral cortex, hippocampus and 
medial ganglionic eminence. The second stage covers the perinatal and early postnatal 
period, when thyroid hormones modulate neurogenesis, neuron migration, axonal 
outgrowth, dendritic branching, synaptogenesis, and the initiation of glial cell 
differentiation and myelination. The third stage occurs in the later postnatal period, when 
thyroid hormones are critical for continuing maturation and plasticity. 
Most of the thyroid hormone responsive genes identified so far are expressed and 
regulated by thyroid hormone during the early postnatal period (Oppenheimer and 
Schwartz, 1997; Bernal et al., 2003). Therefore, thyroid hormones have been suggested to 
accelerate and synchronize early neuronal maturation (Bernal et al., 2003). Based on the 
temporal patterns of thyroid hormone-dependent gene expression in the brain even a 
critical period of thyroid hormone sensitivity spanning the first 2-3 postnatal weeks in the 
rat has been suggested (Bernal et al., 2003).  
Additionally, the developmental timing has also influence on the impact and 
reversibility of malformations induced by hypothyroidism (Anderson, 2001; Bernal et al., 
2003). Deficiency of thyroid hormones during critical periods of development leads to 
profound and potentially irreversible defects of brain maturation. In both prenatal and early 
postnatal brain development a deficit of thyroid hormones causes severe neuronal damage 
leading to irreversible mental retardation and motor deficits (Yen, 2001; Morreale de 
Escobar et al., 2004; Bernal, 2009). In contrast, disorders following adult onset 
hypothyroidism are usually reversible with proper treatment (Bernal, 2009). 
Interestingly, the critical period of thyroid hormone signalling largely parallels the 
time of early synchronous network activity. However, only rare evidence is available about 
the influence of thyroid hormone signalling on spontaneous neuronal activity. Sporadic 
reports suggest that thyroid hormones T4 and T3 enhance the frequency of spontaneous 
activity in neuronal cultures (Romijn et al., 1981; Hosoda et al., 2003). Thus it is feasible 
that thyroid hormones might regulate developmental processes, at least partly, by the 
modulation of spontaneous network activity.  
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2.4 Aims of the study 
The main aim of the presented project was to study the effects of thyroid hormone 
T3 on the early development of cortical networks with an emphasis on GABAergic 
neurons. The emergence of spontaneous network activity is a general feature of developing 
neuronal structures and previous studies suggest that especially GABAergic neurons 
develop in a close interrelationship with the functional development of the network (Voigt 
et al., 2001; de Lima et al., 2004, 2007). As thyroid hormones have been shown to regulate 
the maturation of GABAergic neurons (see chapter 2.3.4) and as they have also been 
implicated in the regulation of neuronal activity (see chapter 2.3.5), it is feasible that they 
modulate the intricate development of GABAergic neurons and network activity.   
 
The investigation of the thyroid hormone-mediated modulation of cortical network 
development involved the following steps: 
 First, to study the influence of T3 on the development of spontaneous network 
activity. 
 Second, to identify T3-mediated changes in the development of different neuronal 
subpopulations. Because GABAergic interneurons develop in a close 
interrelationship with the network activity, special attention was given to the 
morphological development of GABAergic interneurons. 
 Third, to address the mechanisms and the direction of T3-mediated effects to 
identify which effects are directly mediated by T3 and whether T3-induced cellular 
alterations are activity-dependent. 
 Fourth, to investigate the influence of T3 on the functional maturation of 
GABAergic signalling, e.g. the expression of the chloride transporters KCC2 and 
NKCC1. 
 Fifth, as thyroid hormone actions might be restricted to limited periods, the 
sensitivity of GABAergic neurons and the network activity to T3 stimulation was 
addressed during different culture periods.  
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3. Materials and Methods 
3.1 Animals 
In the present work, Sprague Dawley rats (Rattus norvegicus) were used to prepare 
neuronal cultures. The rats were bred at the Institute of Physiology, Magdeburg. Handling 
with the animals was according to the rules of the Otto-von-Guericke University and the 
federal state Saxony-Anhalt. 
 
3.2 Materials 
The chemicals, solutions, antibodies, lab equipment and software used in this study 
are listed in the appendix (see chapter 7). 
 
3.3 Cell culture 
Neuronal cultures were prepared from embryonic rat cortex and cultured for 7-21 
days in serum-free N2 medium in the presence of a surrounding glial feeding layer as 
described previously (de Lima and Voigt, 1997). All experimental procedures were 
approved by local government authorities.  
 
3.3.1 Preparation of petri dishes 
Cortical neurons were cultivated in the presence of a surrounding glia-feeding 
layer. This procedure required a special set-up of culture dishes, where neurons could grow 
in the central region separated from glia cells in the outer portion of the Petri dish. Each 
acid-cleaned glass cover slip was fitted to a 20-mm hole in the bottom of a 60-mm Petri 
dish and treated overnight with poly-D-lysine (0.1 mg/ml in borate buffer, pH 8.5, 36°C). 
Dishes were air dried, washed with sterile water and replenished with Dulbecco’s modified 
Eagle medium (DMEM; Invitrogen, Carlsbad, CA, USA) containing 10% fetal calf serum 
(FCS, Invitrogen) until cell plating. To prevent the glial cells from spreading onto the 
cover slip, the central region was temporarily isolated by a plexiglas ring glued with silicon 
grease around the hole. The plastic ring was removed after neuron attachment to allow a 
free interchange of culture media between centrally cultured neurons and peripherally 
cultured feeder glia. 
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3.3.2 Astroglial cell cultures 
Astroglial cultures were prepared from cerebral hemispheres of newborn Sprague-
Dawley rats (postnatal day 0-3) as reported in detail (de Lima and Voigt, 1999). Briefly, 
hemispheres were dissected under sterile conditions, and meninges were carefully 
removed. The tissue was minced in Hank’s medium (HBSS, Ca2+ and Mg2+ free, 
Invitrogen; 20mM HEPES, pH 7.4) and dissociated by trituration through G21 and G25 
syringe needles. Cells were seeded at low densities in DMEM containing 10% FCS in 
tissue culture flasks (175 cm
2
). The cells were maintained in a humidified 5%C02/95% air 
atmosphere at 36°C. Medium was replaced twice a week. Nonastroglial cells were 
removed from confluent 2-week-old cultures by shaking flasks overnight on a rotatory 
platform at 180 rpm (rotations per minute). Confluent astroglial cultures were used as 
feeder layers for pure neuronal cultures or for conditioning of freshly prepared serum-free 
medium. Purified astroglial cells were plated at a density of 300 cells/mm
2
 in the outer 
portion of the Petri dish bottom five days before the neurons. 
 
3.3.3 Neocortical neuron cultures 
Neuronal cultures were prepared from cerebral cortices of embryonic Sprague-
Dawley rats at embryonic day 16 (E16; day after insemination = E1). Rat embryos were 
removed by caesarean section from the anesthetized mother (4% chloral hydrate, 1 ml/100 
g body weight). The mother was killed immediately after the removal of the embryos by an 
overdose of the anesthetic (10% chloral hydrate, 3 ml). The embryonic neocortical 
hemispheres were dissected under sterile conditions and rinsed in Hank’s medium. Cells 
were taken from the dorsolateral parts of the telencephalic vesicles (excluding 
hippocampal and basal telencephalic anlagen). Meninges were removed, and cortical tissue 
was minced, rinsed in Hank’s medium, and dissociated with a solution of 0.5% 
trypsin/EDTA (Boehringer, Mannheim, Germany) in Hank’s medium for 25min at 36°C. 
Trypsin solution was then removed, and protease activity was blocked by trypsin inhibitor-
DNAse solution (0.52 mg/ml soybean trypsin inhibitor, 0.04 mg/ml DNAase I, 3 mg/ml 
bovine serum albumin in DMEM). The suspension was repeatedly passed through G21 and 
G25 syringe needles (3 times each). After centrifugation (10min, 1200rpm) cells were 
rinsed with Hank’s medium, and the percentage of viable cells was determined by using 
propidium iodide.  
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Cells were seeded onto poly-D-lysine coated glass cover slips at a density of 300-
500 cells/mm² in N2 medium (75% DMEM, 25% Ham’s F12 and N2 supplements from 
Invitrogen). Cultures were treated at 6 DIV (days in vitro) with cytosine arabinoside (Ara-
C) at a final concentration of 5 µM and a third of the medium volume was then changed 
after 24 hours. All cultures were maintained in a humidified 5% CO2/95% air atmosphere 
at 36°C. One third of the culture medium was refreshed once a week. To support neuronal 
survival in cultures that grew older then 14DIV purified astroglial cells were added at 
9DIV to the neurons at a density of 300 cells/mm
2
. The additional astroglia yielded a better 
cell survival and more consistent results in morphometric analysis during the third week in 
vitro.  
 
3.3.4 Hormone application 
Neurons were cultured for 14 days in serum-free N2 medium either in the presence 
or absence of triiodothyronine (T3, Sigma-Aldrich, St. Louis, MO). T3 was applied in our 
experiments at 0DIV (15nM) and a third of medium volume was refreshed at 7 DIV. This 
concentration range is in line with other in vitro studies showing physiological effects of 
T3 at concentrations between 5 and 30nM (Romijn et al., 1981; Potthoff and Dietzel, 1997; 
Hosoda et al., 2003; Hoffmann and Dietzel, 2004; Morte et al., 2010). Dose-response 
curves were obtained from experiments with T3 concentrations between 10
-13
 and 10
-6
 M 
(Fig. 6). Significant effects were already observed at concentrations as low as 12
-12
 M. 
Since higher T3 concentrations yielded more consistent results without noticeable side 
effects T3 was used in a concentration of 15nM throughout this study.  
For reversal experiments all cultures were washed twice with prewarmed DMEM at 
14DIV and the medium was replaced by fresh medium that was conditioned in astroglial 
flasks cultures for at least 24 hours and was either supplemented with T3 (15nM) or 
without T3 resulting in four experimental groups: a) chronically deprived cultures (T3
−
), b) 
chronically T3-supplemented cultures (T3
+
), c) cultures supplemented with T3 only during 
the third week in vitro (T3
−/+
), d) and cultures supplemented during the first two weeks 
(T3
+/−
). 
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3.3.5 Drugs application 
In the initial experiments (sections 4.1.1-4.2.1, 4.2.5, 4.2.6), corticosterone 
(0.1μg/ml, Sigma) was added to the culture medium alone or in combination with T3 
following the original protocol by Romijn et al (1981).  
In the experimental groups the following drugs were added to the medium at 
various time points (see result section) and cultures were maintained until fixation time, 
with an additional drug application after 5 days (except BDNF and K252a): glutamate 
receptor (GluR) antagonists CNQX (6-cyano-7-nitroquinoxaline-2,3-dione disodium, 10 
µM; Tocris Cookson, Ellisville, MO) and APV (D-2-amino-5-phosphonopentanoic acid, 
50 µM; Tocris), sodium channel blocker TTX (Tetrodotoxin, 1 µM, Alomone Labs, 
Jerusalem, Israel), recombinant human brain-derived neurotrophic factor (BDNF; 50 
ng/mL; Pepro Tech, Rocky Hill, NJ), protein kinase inhibitor K252a (100 nM; Calbiochem 
by Merck KGaA, Darmstadt, Germany), KCC2 inhibitor VU0240551 (4 µM; Cat. sc-
253834; Santa Cruz Biotechnology Inc., Santa Cruz, CA), GABAA receptor antagonists (-
)-bicuculline methiodide (BMI; 20 µM; Sigma-Aldrich) and Picrotoxin (PTX; 10 µM; 
Tocris Cookson, Ellisville, MO).  
In one series of experiments the thyroid hormone receptor antagonist 1-850 (Merck 
KGaA Darmstadt, Germany) (Schapira et al., 2003; Sui et al., 2008) was added at a 
concentration of 1µM to the culture medium at plating (0 DIV). For hormonal stimulation 
T3 (10ng/ml) was added 24h later. Drug application was repeated on 7 DIV and cultures 
were grown until 14 DIV. 
 
3.4 Calcium-Imaging 
3.4.1 Detection of calcium transients 
Changes in neuronal intracellular calcium concentration ([Ca
2+
]i) were recorded as 
reported previously (Voigt et al., 2001; Opitz et al., 2002). Briefly, cell cultures were dye-
loaded for 1 h in regular culture medium by adding fluo-3 pentacetoxy-methylester 
(Molecular Probes; purchased from MoBiTec, Goettingen, Germany) to a final 
concentration of 5 µM. Cultures were washed with Hepes-buffered artificial cerebrospinal 
fluid (aCSF; in mM: 140 NaCl, 5 KCl, 1.5 CaCl2, 0.75 MgCl2, 1.25 NaH2PO4, 20 D-
glucose, 15 Hepes/NaOH, pH 7.4) and allowed to equilibrate for 30 min. Recordings were 
performed  at room temperature on an inverted microscope (Axiovert S100 TV, Zeiss, 
Oberkochen, Germany) equipped with a cooled charge-coupled device camera (CoolSNAP 
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ES; Roper Scientific, Ottobrunn, Germany). Sequences of fluorescence images were 
recorded for at least 120 seconds at 1 or 2 Hz from at least five randomly chosen fields per 
culture. A differential interference contrast (DIC) image of each field was acquired for 
later cell identification and in some experiments fields were marked with a diamond tool 
for identification of GABAergic neurons after post hoc GABA immunocytochemistry (see 
below). 
 
3.4.2 Burst analysis 
Images were processed with MetaMorph software (vers. 7.0, Molecular Devices, 
Sunnyvale, CA) as described in detail (Opitz et al., 2002). In each dish we recorded 
fluorescence images from five fields and determined the total number of neurons as well as 
the number of active neurons in each field. Total number of neurons in the field was 
assessed by examination of DIC images. Each cell was visually identified and marked as a 
region of interest (ROI). Additional ROIs were set above cell free area to determine the 
background noise. All ROIs were later superimposed on the fluorescence-images taken 
each second for 4 minutes to determine the fluorescence intensity over time. A change in 
[Ca
2+
]i was considered significant when the absolute difference of gray values exceeded 5 
times the standard deviation of background noise measured in cell free areas (Voigt et al., 
2001; Opitz et al., 2002). Because 7.5% of cells can simultaneously be active when 
synaptic transmission was completely blocked (Opitz et al., 2002), synchronous bursts are 
defined as events in which at least 10% of all cells participate. Frequency of synchronous 
‘bursts’ was calculated off-line with custom-made software written in MATLAB (vs. 7.5, 
MathWorks, Natick, MA) and Excel (Microsoft Corp., Richmond, WA). 
 
3.4.3 Kinetic analysis 
Kinetics of spontaneous calcium transients were analysed using Excel (Microsoft 
Corp., Richmond, WA) and the MiniAnalysis software (version 6.0.3, Synaptosoft, 
Decatur, GA). The fluorescence trace (F) of each individual cell was background corrected 
and normalized (dF/F0) according to the minimal fluorescence level during the sequence 
(F0). All single cell transients of the same field were averaged and considered as the 
averaged network activity (Cohen et al., 2008; Allene et al 2008; see also Fig. 26 B). The 
duration of averaged calcium transients (time between the event onset and the recovery to 
baseline level) was calculated semi-automatically using the MiniAnalysis software 
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(Synaptosoft). Because kinetics of calcium transients in the same field were rather 
homogeneous during the imaging session, the mean burst duration per field was also 
calculated and statistics were made on this data. 
 
3.4.4 GABA shift experiments 
To investigate the developmental changes in GABAA receptor mediated synaptic 
transmission the exposure to locally applied potassium and GABA agonist muscimol 
during calcium imaging was used (Owens et al., 1996; Ganguly et al., 2001; Baltz et al., 
2010). Cultures were continuously perfused with an aCSF containing the glutamate 
receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX; 2.5 µM; 
Tocris) and D-(-)-2-amino-5-phosphonopentanoic acid (D-AP5; 12.5 µM; Tocris) to 
suppress spontaneous network activity. At defined time points during each recording 
session cells were locally perfused with short pulses of an aCSF containing either high 
potassium (KCl, 60 mM; Merck) to identify living neurons or the GABAA receptor agonist 
muscimol (200 μM; Sigma-Aldrich) using a multibarreled perfusion system (Baltz et al., 
2010). The local application lasted 2 seconds resembling prolonged neuronal activation 
during population burst activity. 
 
3.4.5 Analysis of stimulation induced calcium transients 
Images were processed off-line using MetaMorph software (Molecular Devices) 
and fluorescence data were processed with Excel (Microsoft Corp.). For each cell we 
calculated the background-corrected baseline fluorescence and the standard deviation of 
baseline fluctuations during a 5-s-period before local stimulant application. To detect 
stimulation induced changes in intracellular calcium concentration the maximal emitted 
fluorescence in response to local stimulation was detected. A cell was considered 
responsive to muscimol or KCl when the change in fluorescence exceeds five times the 
standard deviation of baseline fluctuations. The fraction of muscimol responsive cells was 
calculated per field as percentage of KCl responsive cells. 
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3.5 Morphometric analysis 
3.5.1 GABA-Immunocytochemistry 
GABA-immunocytochemistry was used for identification and morphometric 
analysis of the neuronal populations. GABA-containing neurons were labelled with a 
monoclonal mouse anti-GABA antibody (Szabat et al., 1992) as described previously (de 
Lima and Voigt, 1997; Voigt et al., 2001; de Lima et al., 2007). Cultures were fixed 30 
min at 36°C by adding 70% glutaraldehyde to the culture medium to make a final 
concentration of 3.5%. Cultures were then thoroughly washed in Tris/metabisulfite 
solution (0.85% sodium metabisulfite in 0.05M Tris buffer; pH 7.5). To reduce aldehyde-
induced autofluorescence and unspecific antibody binding cultures were treated with 
ethanolamine (1M in Tris/metabisulfite solution) for 20 min at RT, and preincubated for 3 
hours at room temperature (3% bovine serum albumin, 10% normal goat serum, 0.6% 
Triton X-100 in Tris/metabisulfite solution). After washing, cultures were incubated with 
monoclonal mouse anti-GABA antibody (1:200; clone 5A9; Chemicon, Temecula, CA) in 
Tris/Metabisulfite solution containing 3% bovine serum albumin, 10% normal goat serum, 
0.6% Triton X-100 overnight at room temperature. After the primary antibody incubation 
all washes were made with phosphate buffered saline (0.1M, pH 7.4). Primary antibodies 
were labelled with secondary goat anti-mouse antibody (1:200; Convance Inc, Princenton, 
NJ) and mouse peroxidase-anti-peroxidase (1:200, Sternberger, Baltimore, MD) in PBS 
containing 10% normal goat serum, 2% bovine serum albumine, 5% Sucrose and 0.3% 
Triton X-100 for 2 hours at room temperature. Antibody-peroxidase complexes were made 
visible by 0.01% 3, 3' diaminobenzidine tetrahydrochloride, 0.004% H2O2, 1% Nickel 
ammonium sulfate, 50mM Imidazole in 50mM Tris-HCl saline buffer. After the final PBS 
wash, coverslips were dehydrated in an ethanol series, cleared in two changes of xylene, 
and mounted over clean slides with Fluoromount (Serva, Heidelberg, Germany). 
 
3.5.2 Population analysis 
Analysis was focused on the following neuronal subpopulations: 1) large 
GABAergic interneurons (L-GABA), 2) late-born small mainly fusiform GABAergic 
interneurons (S-GABA) and 3) non-GABAergic neurons. In each experiment the cell 
density and the cell body size of GABAergic and non-GABAergic neurons were quantified 
in sets of treated cultures compared with a set of age-matched control cultures. Cell counts 
were made in 10 fields per coverslip with the aid of a grid in the microscope eye piece. 
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Fields were chosen at regularly spaced points over the coverslip surface and countings 
were made using different magnifications depending on the cell density (Field size range: 
125 µm x 125 µm to 625 µm x 625 µm).  
 
3.5.3 Single cell morphometry 
The quantification of soma area was based on high magnification individual 
drawings of the cell bodies (40x objective for L-GABAergic neurons and 100x objective 
for S-GABAergic and non-GABAergic neurons; no more than 5 cells were drawn in each 
of randomly chosen fields). Drawings of cell bodies and dendrites were made with an 
upright microscope (Zeiss, Standard WL) equipped with a Camera lucida. Drawings of cell 
body profiles were scanned and a digitalized version was analysed with MetaMorph 
software. Similarly, drawings of dendritic profiles were made for L-GABAergic cells using 
a 40x objective followed by digitalization and analysis with MetaMorph software. 
 
3.5.4 GABA bouton density 
To quantify the local GABAergic synaptic innervation in low density cultures, 
micrographs of fields containing small groups of non-GABAergic neurons were taken with 
a CCD camera (Spot slider, Diagnostic Instruments, Sterling Heights, MI) with a 100x oil 
immersion lens (Axiophot, Zeiss, Oberkochen, Germany). In each field (120 µm x 90 µm) 
the total number of neurons and the total number boutons formed by GABAergic axons 
was counted and expressed as fraction of boutons per neuron. Counts were made in 20 
fields per cover slip. 
 
3.5.5 Morphology of GABAergic axons 
To quantify the number of GABAergic boutons and the local axonal ramifications 
formed by GABAergic axons, micrographs of randomly chosen fields were taken with a 
charge-coupled device camera (Spot slider, Diagnostic Instruments, Sterling Heights, MI) 
with a 40x objective on an upright microscope (Axiophot; Zeiss). In each image a central 
region of interest (120 µm x 90 µm) was selected and the total number of neurons, the total 
number of GABAergic boutons and the total number of branches formed by GABAergic 
axons was counted. Additionally the total length of GABAergic axons was measured in 
each field using MetaMorph software (Molecular Devices). Counts and measurements 
were made in 10 fields per cover slip. 
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3.6 Analysis of synaptic densities 
3.6.1 Synapse immunocytochemistry 
For immunocytochemical synaptic staining cell cultures were fixed for 30 min at 
36°C in 4% paraformaldehyde in phosphate buffer (0.1M, pH 7.4) containing 0.12M 
glucose, followed by chilled methanol (-20°C) for 10 min at 4°C. After washing in 
phosphate-buffered saline (PBS, 0.01M, pH 7.4), cultures were incubated in 0.25% Triton 
X-100, 10% goat serum, 5% sucrose, 2% BSA in PBS for 10 min at room temperature. 
Cell cultures were stained for presynaptic marker synapsin and one of the postsynaptic 
proteins PanShank or GluR2 to detect glutamatergic synapses and for synapsin and 
gephyrin to detect GABAergic synapses. The double staining was performed sequentially 
by first incubating with polyclonal rabbit anti-Synapsin1/2 (1:500, Cat.No. 106 002, 
Synaptic Systems, Göttingen, Germany) overnight at 4°C followed by goat anti-mouse 
Cy2 (1:400, Dianova, Hamburg, Germany) for 2 h at room temperature. After a short 
fixation (30 min, 4% paraformaldehyde, 36°C) cultures were incubated with monoclonal 
mouse anti-PanShank (1:100, clone N23B/49, NeuroMab, Davis, CA), monoclonal mouse 
anti-GluR2 (1:100, clone L21/32, NeuroMab) or monoclonal mouse anti-gephyrin (1:1000, 
Cat. No. 147 011, Synaptic Systems, Göttingen, Germany) overnight at 4°C followed by 
goat anti-rabbit Cy3 (1:400, Dianova, Hamburg, Germany) for 2 h at room temperature. 
Cell cultures were rinsed thoroughly with PBS between every incubation step. After a final 
wash in PBS, coverslips were dehydrated in an ethanol series, cleared in two changes of 
xylene, and mounted on clean slides with Fluoromount (Serva, Heidelberg, Germany). 
 
3.6.2 Analysis of synaptic stainings 
For quantitative evaluation of the synaptic staining at least two coverslips were 
analysanalysed per experimental condition in each of at least two experiments. Two 
consecutive micrographs for the two antibody labels were taken at five randomly chosen 
fields per culture dish with a CCD camera (Spot slider, Diagnostic instruments, Sterling 
Heights, MI) and a 100x oil immersion lens (Axiophot, Zeiss, Oberkochen, Germany). The 
bandwidth of filter sets used to visualize Cy3 and Cy2 did not overlap. The pairs of 
micrographs were brought into register using the MetaMorph software (vers. 6.0, Universal 
Imaging Corp., West Chester, PA) and five randomly chosen fields measuring 10 μm x 10 
μm were selected in each pair of photographs. In each field the amount of all 
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synapsin/GluR2, synapsin/PanShank or synapsin/gephyrin co-localized clusters was 
determined and expressed as percentage of all synapsin positive clusters.  
 
3.7 Western blotting 
3.7.1 Specificity of antibodies used in western blots 
For recognition of NKCC1 we used the well characterized and commonly used 
monoclonal antibody T4 (Lytle et al., 1995). The hybridoma culture supernatant containing 
the monoclonal mouse T4 antibody, developed by Dr. Christian Lytle and Dr. Bliss 
Forbush III, was obtained from the Developmental Studies Hybridoma Bank developed 
under the auspices of the National Institute of Child Health and Human Development and 
maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 
52242. The antibody specificity for NKCC detection has been characterized extensively 
(Lytle et al., 1995, Zhang et al., 2006). The T4 antibody was developed against the last 310 
residues of the carboxy terminus of the human colonic NKCC1, but is not NKCC-isoform 
specific and recognizes both NKCC1 and NKCC2. However, in neocortical neurons the T4 
antibody is suggested to exclusively recognize NKCC1 (Sun and Murali, 1999) since the 
expression of NKCC2 is not detected in the brain (Payne and Forbush, 1994; Payne et al., 
2003). Following the manufacturer’s instructions the T4 antibody was used at a 
concentration of 330ng/ml (1:100) for Western blots. The T4 antibody gave two bands, one 
averaged ~145 kDa and a possible dimer at ~250 kDA. In all blots the T4 antibody 
recognized several nonspecific bands at lower molecular weights as reported elsewhere 
(Zhang et al., 2006). 
For analysis of KCC2 expression we used an affinity purified IgG polyclonal rabbit 
anti-KCC2 (4 µg/ml; Cat. KCC21-A; Alpha Diagnostic International Inc, San Antonio, 
TX) directed against an 18 amino acid peptide of rat KCC2 located on the cytoplasmic N-
terminus (Nakanishi et al., 2007). Specificity of the antibody has been tested elsewhere by 
eliminating staining in Western blots by preabsorbtion with the immunizing peptide for 
KCC2 (Chee et al., 2006). We tested the expression of KCC2 also exemplary with 
monoclonal mouse anti-KCC2 antibody (1-10 µg/ml; Clone N1/12; UC Davis/NIH 
NeuroMab Facility, Davis, CA). This antibody is directed against amino acid residues 932-
1043 of the intracellular carboxyl terminus of KCC2 and recognition of this sequence has 
been established elsewhere (Williams et al., 1999; Gulyas et al., 2001; Munoz et al., 2007). 
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In our experiments both antibodies give rise to identical staining pattern of KCC2 protein 
on Western blots. 
Expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was detected 
with monoclonal mouse anti-GAPDH (1:1000; clone 1D4; Covance, Princeton, NJ) and 
has been used as a loading control for western blotting experiments.  
 
3.7.2 Blotting procedure 
Neuronal cultures were rinsed in phosphate-buffered saline (PBS), and 
homogenized in ice-cold RIPA lysis buffer (150 mM NaCl; 1% Igepal; 0.5% Sodium 
deoxycholate (Doc); 0.1% sodium dodecyl sulfate (SDS); in 50 mM TrisHCl, pH 8.0) 
supplemented with 4%  commercial protease inhibitor mixture (Complete; Roche 
diagnostics GmbH, Mannheim, Germany) and 0,5% phenylmethanesulfonyl fluoride 
(PMSF; Sigma-Aldrich). Samples of at least five sister cultures were pooled per age and 
experimental group. Debris was pelleted by centrifugation at 13000rpm for 30 min. 
Supernatant was denaturated at 95°C for 5min, and the protein concentration of the 
supernatant was determined using BCA Protein Assay Kit (Pierce by Thermo Fischer 
Scientific Inc., Waltham, MA, USA). Equal amounts of proteins (20µg) were seperated by 
8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Mini-
Protean Tetra Cell; Bio-Rad Laboratories Inc., Hercules, CA) and transferred onto 
nitrocellulose membrane (Optitran BA-S 83; Whatman, Maidstone, United Kingdom, 
distributed by Whatman, Dassel, Germany) using semi-dry method (EBU-4000; C.B.S. 
Scientific, Del Mar, CA, USA). Membranes were incubated in blocking solution (5% milk 
in 0.1M PBS, 1% GNS, 0.1% Tween) for at least 30min at room temperature, washed one 
time in 0.1M PBS + 0.1% Tween (PBST) and then probed overnight at 4°C with primary 
antibodies at dilutions indicated above (in 1% milk, 1% GNS, 0.1% Tween in 0.1M PBS). 
Membranes were washed thoroughly with PBST, incubated for 2 hours at room 
temperature with horseradish peroxidase linked secondary antibodies polyclonal goat anti-
mouse immunoglobulins/HRP (1:10000; Cat. P0447; Dako, Glostrup, Denmark) or 
polyclonal goat anti-rabbit immunoglobulins/HRP (1:2000; Cat. P0448; Dako) in 0.1M 
PBS, 1% milk, 1% GNS, 0.1% Tween, and washed again extensively with PBST. 
Molecular weight markers (PageRuler Unstained Protein Ladder; Fermentas by Thermo 
Fischer Scientific Inc.) linked to Precision Protein StrepTactin-HRP conjugate (1:10000; 
Cat. 161-0380; Bio-Rad Laboratories Inc., Hercules, CA) were used to identify molecular 
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weight of stained protein bands. Detection using enhanced chemiluminescence (ECL) 
substrate SuperSignal West Dura (Pierce) was carried out with GeneGnome5 (Syngene by 
Synoptics Ldt, Cambridge, UK), and the intensity of the bands was quantified using 
Quantity One software (Bio-Rad Laboratories Inc., Hercules, CA). Intensity values were 
corrected by corresponding GAPDH levels and normalized to the mean intensity of T3
−
 
samples of 7DIV old cultures. 
 
3.8 Statistics 
All statistical tests were performed with SigmaStat software (version 2.03, SPSS 
Inc., Chicago, IL). Differences between T3-treated and T3-deprived cultures were tested 
using unpaired Student’s t-test or Mann-Whitney Rank Sum Test (MW-RST). For 
comparison of multiple culturing conditions differences were initially tested with one-way 
ANOVA or Kruskal-Wallis one-way ANOVA on ranks followed by ad hoc pair wise tests 
using t-test or Mann-Whitney Rank Sum Test. The proportions of double-labelled synapses 
in different conditions were compared with the Chi-square test. Cause and effect 
relationship of axonal parameters was tested using linear regression (LR). The local cell 
density was set as the independent variable and axonal parameters as dependent variables 
and the p-value and the coefficient of determination (r²) were calculated. Data are 
presented as means ± standard error of the mean (SEM). A p-value of <0.05 was 
considered to be statistically significant and alpha value was set to 0.05. Asterisks in 
graphs show the level of statistical significance (*, p <0.05; **, p <0.01; ***, p <0.001; 
n.s., not significant). 
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4. Results 
4.1 Thyroid hormone modulation of network activity and neuronal populations 
In general, embryonic neurons grown in dissociated culture start to develop 
neuronal processes quickly after plating and form first synapses after 3-4 days in vitro (de 
Lima et al., 1997). With increasing connectivity cultured cortical networks spontaneously 
develop synchronized rhythmic activity (Muramoto et al., 1993; de Lima et al., 1997; 
Voigt et al., 2005). This recurrent activity characterized by simultaneous transients of 
[Ca
2+
]i emerges normally at the beginning of the second week in culture (Opitz et al., 
2002). During further development the frequency of these spontaneous bursts of activity 
increases and virtually all neurons become synchronously active (Voigt et al., 1997; Opitz 
et al., 2002; Baltz et al., 2010). Whereas young cultures show almost large and stereotypic 
bursts, mature cultures develop highly diverse burst patterns containing network events 
with variable neuronal participation, spike numbers and durations (Baltz et al., 2010).  
 
4.1.1 T3 modulation of spontaneous network activity 
To evaluate the effects of the T3-supplemented medium, sets of two weeks old 
neocortical cultures (13-14DIV) were examined with Fluo-3 calcium imaging (Fig. 1). The 
chronic addition of triiodothyronine (T3) to the growth medium, beginning with the time of 
plating, dramatically increased the frequency of spontaneous bursts of activity (Fig 1 B, D, 
E; 1.63 ± 0.16 bursts/min in T3-deprived cultures [mean ± SEM, n = 20 fields from 4 
cultures/3 preparations] vs. 5.97 ± 0.68 bursts/min in T3-treated cultures [mean ± SEM, n 
= 15 fields from 3 cultures/3 preparations], p < 0.001, MW-RST). The 14-day-old T3-
treated cultures also showed a more irregular burst pattern than T3-deprived cultures (Fig. 
1 A-D). Additionally to large bursts, in which most cells were synchronously active, 
hormone-treated cultures showed an excess of smaller bursts, in which only 20 to 40% of 
all neurons participate (Median = 26.303, n = 390 events). In contrast, in hormone-
deprived cultures larger bursts containing 80 to 100% active cells were more frequent 
(Median = 91.045, n = 73 events, 4 cultures from 4 preparations, p < 0.001, MW-RST). 
Total active cells and maximal attendance per synchronous event were not altered by T3 
treatment. Thus, T3-treated cultures show both an increase in events and a more mature 
pattern of synchronous activity. 
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Figure 1: T3 increases frequency of in spontaneous synchronous network activity. 
A-B. Traces show the intracellular calcium signal of individual neurons in representative fields 
from 14DIV old cultures grown either in the absence (A) or presence (B) of triiodothyronine. C-D. 
Activity histograms of neurons from the same fields as shown in A and B, respectively. E. Number 
of synchronous bursts is dramatically enhanced in two-week-old cultures (13-14DIV) treated with 
T3. Besides changes in burst frequency, T3-stimulated cultures also offered a more irregular burst 
pattern than T3-deprived cultures. T3-treated cultures show more bursts with 20-40% 
participation than T3-deprived cultures, which show more larger bursts containing 80-100% 
participating neurons (A-D). 
 
4.1.2 T3 modulation of GABAergic and glutamatergic synapses 
The development of spontaneous network activity in neuronal cell cultures is 
usually paralleled by a rapid increase in the number of synaptic contacts and the activation 
of AMPA receptors in the synaptic network (Muramoto et al., 1993; Voigt et al., 2005). 
Therefore it was tested whether the T3 mediated increase in spontaneous network activity 
in this experimental setup is also correlated to changes in synaptic density. The relative 
numbers of functional glutamatergic and GABAergic synapses were quantified by double 
labelling pre- and postsynaptic components (Fig. 2). Glutamatergic synapses were 
identified by co-localization of Synapsin/PanShank or Synapsin/GluR2 and GABAergic 
synapses were identified by co-localization of Synapsin/Gephyrin (Gundelfinger and tom 
Dieck, 2000; Yu et al., 2007).  
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Figure 2: T3 increases the density of glutamatergic and GABAergic synapses. 
A-C. Fluorescence images of 14-day-old cultures show Synapsin/PanShank double-labeled 
glutamatergic boutons. D-F. Images of 14-day-old cultures show synapsin/gephyrin double 
labeled GABAergic synapses. G. T3 treatment increased the percentage of Synapsin/GluR2, 
Synapsin/PanShank and Synapsin/Gephyrin double labeled clusters in 14-day-old cultures 
(Glutamatergic synapses: data from 6-7 cultures, 2-3 preparations; GABAergic synapses: data 
from 6 cultures, 2 preparations). 
 
Colocalized pre- and postsynaptic markers in cortical cell cultures showed an even 
distribution of synaptic contacts (Fig. 2 A-F; see also Voigt et al., 2005). The percentage of 
double-labelled clusters compared with the total number of synapsin dots was used to 
quantify synaptic connectivity (Fig. 2 G). Hormone addition to the culture medium 
increased the percentage of Synapsin/GluR2 (49.73 ± 1.33 % in T3
+
 vs. 45.06 ± 1.25 % in 
T3
–
; mean ± SEM,  N = 150 fields, P <0.01, Chi-square test), Synapsin/PanShank (53.46 ± 
1.46 % in T3
+
 vs. 46.25 ± 1.54 % in T3
–
; mean ± SEM,  N = 175 fields, P <0.001, Chi-
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square test) and Synapsin/Gephyrin (48.74 ± 1.29 % in T3
+
 vs. 42.87 ± 1.41 % in T3
–
; 
mean ± SEM,  N = 150 fields,  P <0.001, Chi-square test) double-labelled clusters in 14 
day-old cultures. These results suggest an increased growth of glutamatergic and 
GABAergic synapses in T3-treated cultures. 
 
4.1.3 Impact of T3 enrichment on neuronal morphology 
The next question was if the functional changes in network activity are correlated to 
morphological alterations of neurons. Especially evaluating the maturation of GABAergic 
interneurons is of special interest, because they develop in a close interrelationship with the 
spontaneous network activity (Voigt et al., 2001; de Lima et al., 2004, 2007). In neuronal 
networks developing from dissociated embryonic rat cerebral cortices, two types of 
GABAergic neurons were described (chapter 2.2.5; see also de Lima and Voigt, 1997; 
Voigt et al., 2001; de Lima et al., 2004). A prominent type of GABAergic neuron, the L-
GABAergic neuron, develops a large cell body, stellate dendritic tree and form long range 
connections with thick axons (Fig. 3 A, B, arrow). S-GABAergic neurons, a second and 
numerically larger subpopulation of GABAergic neurons, are later born, have smaller 
fusiform to bipolar or multipolar cell bodies and very thin axons (Fig. 3 A, B, arrow 
heads).  
 
 
Figure 3: Identification of neuronal subpopulations in neuronal cultures. 
A-B. Images show GABA immunostained 14-day-old cultures grown in the absence (A) or presence 
(B) of T3. Each image shows a large (L-)GABAergic neuron (arrow) among smaller (S-)GABAergic 
neurons (arrowheads) and unstained non-GABAergic neurons. Note that large L-GABAergic 
neurons are hypertrophic in the T3-enriched cultures compared with T3-deprived cultures. Scale 
bar = 50 μm.  
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To evaluate the impact of T3 supplement on their morphological maturation, the 
density and the soma sizes of L-GABAergic interneurons, S-GABAergic interneurons and, 
for complementation, non-GABAergic neurons were assessed in 14-day-old GABA-
immunostained cultures (Fig. 4).  
The relative proportion of all GABAergic neurons is increased in T3-treated 
cultures (Fig. 4 G; 13.1 ± 0.81 % in T3
+
 compared with 7.99 ± 0.60 % in T3
–
; p < 0.001, 
MW-RST). The relative increase is due to a simultaneous decrease of the non-GABAergic 
population (Fig. 4 C; 674.83 ± 26.68 cells/mm² in T3
+
 compared with 1059.03 ± 43.45 
cells/mm² in T3
–
; n = 100 and n = 110 fields respectively, p < 0.001, MW-RST). The 
density of L-GABAergic neurons remained constant between T3-treated and T3-deprived 
cultures (Fig. 4 A; 5.30 ± 0.44 cells/mm² in T3
+
 compared with 5.60 ± 0.39 cells/mm² in 
T3
–
, n = 100 and n = 110 fields respectively, p = 0.386, MW-RST), but S-GABAergic 
neurons’ density increased significantly (Fig. 4 B; 86.18 ± 5.28 cells/mm² in T3+ compared 
with 68.52 ± 4.46 cells/mm² in T3
–
; n = 100 and n = 110 fields, respectively, p = 0.01, 
MW-RST; data in figure 4 were obtained from 10 T3-deprived and 11 T3-treated cultures 
from five preparations). 
The sizes of neuronal somata in GABAergic and non-GABAergic subpopulations 
provide an additional measure of the overall growth and differentiation of these neurons in 
culture (Fig. 4 D-F, H). The comparison of T3-treated cultures with T3-deprived cultures 
showed a large increase in the soma size of L-GABAergic cells (Fig. 4 D; 311.51 ± 7.53 
μm² in T3+ vs. 207.78 ± 6.03 μm² in T3–; n = 210 neurons for each set, p <0.001, MW-
RST). In contrast, S-GABAergic cells showed a slight decrease in cell size (Fig. 4 E; 46.31 
± 0.51 μm² in T3+ vs. 47.83 ± 0.56 μm² in T3–; n = 244 and n = 273 neurons respectively, p 
= 0.028, MW-RST). Also an increase but to a much lesser extent was measured in case of 
non-GABAergic neurons (Fig. 4 F; 119.14 ± 3.02 μm² in T3+ vs. 108.45 ± 2.46 μm² in T3–; 
n = 335 and n = 404 neurons respectively, p = 0.001, MW-RST). Note that the density of 
L-GABA was not changed (Fig. 4 A) suggesting that the soma size increase is due to cell 
growth and not caused by elimination of smaller cells. However, soma size alterations of 
subpopulations of S-GABAergic neurons and non-GABAergic neurons could be 
consequence of alterations of population density, i.e., the elimination of smaller non-
GABAergic neurons (Fig. 4 C) or the preservation of more immature and smaller S-
GABAergic neurons (Fig. 4 B). 
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Figure 4: Influence of T3 on the density and morphology of neuronal subpopulations. 
A-B. The quantification of neuronal density shows no significant change of L-GABAergic neurons 
density (A) and a small increase in S-GABAergic neurons density (B) in T3-treated cultures. In 
contrast, the density of non-GABAergic neurons decreased in T3-treated cultures (C). D-F. The 
soma size of L-GABAergic neurons increased significantly in T3-treated cultures (D). The other 
subpopulations showed smaller relative changes of soma size (H): The size of S-GABAergic somata 
decreased slightly (E), and non-GABAergic neurons’ size showed a small increase (F). G. As a 
consequence of T3 treatment, the relative proportion of the total GABAergic neurons increased 
significantly. A-H. Data from 2-3 cultures per experimental set from each of five preparations. n 
=160, 7DIV; n = 170, 14DIV; 2-3 cultures from each of three preparations. 
 
Thus, T3 modulation specifically alters the density of the neuronal subpopulations, 
resulting in an increase of the relative density of GABAergic neurons. Moreover, notable 
growth of L-GABAergic neurons occurs in the presence of T3 modulation. As shown 
before, these cellular alterations are paralleled by an increase in the frequency of 
  Results 
 
39 
 
spontaneous network activity and the overall density of functional glutamatergic and 
GABAergic synapses. 
 
 
4.2 Mechanisms of T3-mediated effects 
4.2.1 Triiodothyronine actions on GABAergic neurons and network activity 
Since in the original publication by Romijn et al.(1981) the culture medium of the 
experiments above contained in addition to the thyroid hormone T3 also corticosterone. 
Because corticosterone was suggested to affect growth and spontaneous activity in cultures 
(Romijn et al., 1981) and alter cortical circuits’ development (Stone et al., 2001; Leret et 
al., 2007; Lupien et al., 2009), a control experiment was performed to look for the effects 
of this hormone separately, and for possible synergistic actions with T3. Hormones were 
added to the culture medium, each alone or in combination, during the second week in 
vitro and synchronous network activity and soma sizes of L-GABAergic neurons were 
measured (Table 1, Fig. 5). The addition of T3 to the culture medium, alone or in 
combination with corticosterone, significantly increased the burst frequency and soma area 
of L-GABAergic cells (Fig. 5 C-F). Cultures treated with corticosterone alone neither 
showed significant increase in burst frequency nor soma enlargement of L-GABAergic 
cells (Fig. 5 B, E, F). No synergistic effects were apparent, when corticosterone was 
applied together with T3 (Fig. 5 D, E, F). Thus the results from this set of experiments 
suggest that hormone-mediated increases in burst frequency and growth of L-GABAergic 
neurons were mediated by T3. This result concurs with previous studies showing that T3 
influence neuronal electrical activity in cortical cultures (Romijn et al., 1981; Hosoda et 
al., 2003). Whereas corticosterone can rapidly modulate excitatory (Karst and Joels, 2005; 
Olijslagers et al., 2008) and inhibitory postsynaptic currents (Maggio and Segal, 2009), no 
changes were observed in the slow early network activity after chronic corticosterone 
treatment in 14DIV old cultures. This does not exclude, however, that corticosterone has 
other, more transient effects, either in other aspects or in later stages of network 
development not considered here. 
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Figure 5: T3, but not corticosterone, modulates burst frequency and neuron size. 
A-D. Time histograms show the network activity profiles of neurons from representative 14-day-
old cultures either without hormones (A), in the presence of corticosterone (B), T3 (C) or both 
hormones (D). E. Increase in spontaneous network activity could be observed after culturing 
neurons in triiodothyronine alone or in combination with corticosterone. In contrast, treatment 
with corticosterone alone does not affect burst frequency. F. T3 treatment alone increased the 
soma area of L-GABAergic neurons. Graphs in E and F show normalized burst frequency and soma 
size relative to the mean of hormone-deprived cultures (see also Table 1).  
 
Table 1: T3 and corticosterone effects on network burst frequency and soma size of L-GABAergic 
neurons. 
 Burst frequency (bursts/min)  L-GABA size (µm²) 
 Mean±SEM N# P  Mean±SEM N§ P 
Deprived 0.45±0.07 10   164±3 120  
T3 1.69±0.42 9 0.002  200±5 100 <0.001 
Cort 0.30±0.07 11 0.154  172±4 120 0.141 
T3 + Cort 0.90±0.09 10 <0.001  219±4 120 <0.001 
N*, number of recorded fields from 2 cultures, 2 preparations; N°, number of neurons from 5-6 
cultures, 2 preparations respectively. P indicates result of t-test (burst frequencies) or MW-RST 
(soma sizes) compared with hormone-deprived cultures. Cort, corticosterone. 
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4.2.2 Thyroid hormone concentrations under experimental conditions 
In line with other in vitro studies showing physiological effects of T3 at 
concentrations between 5 and 30nM (Romijn et al., 1981; Potthoff and Dietzel, 1997; 
Hosoda et al., 2003; Hoffmann and Dietzel, 2004; Morte et al., 2010), the concentration of 
T3 applied in the experiments described so far was 15nM. Compared with the plasma 
concentration of T3 in vivo, and disregarding any degradation during the culture time, the 
dose used in the cultures is apparently in a supraphysiological level. In young rats, total T3 
serum concentrations of ~1 nM and free T3 of 1 to 6 pM have been reported (Hulbert, 
2000). However, the cerebral cortex derives most of its T3 from local deiodination of T4 
(total plasma concentration 60 nM in young rodents). Moreover cells can regulate their T3 
content by means of active transport (Hulbert, 2000). Thus, defining the exact 
concentration of active T3 acting locally on cortical neurons is difficult. Although cell 
cultures mimic the intact cerebral cortex with respect to the metabolism of thyroid 
hormones and the regulatory mechanisms that control T3 levels, the more vigorous 
metabolism in vitro can rapidly degrade T3, dramatically reducing the initial dose after 24 
hours (Leonard and Larsen, 1985).  
The aim of the next experiment was to test if the observed alterations in both soma 
sizes of GABAergic neurons and frequency of spontaneous network activity by T3 are 
dose-dependent and if they are detectable at concentrations of T3 comparable to the 
physiological plasma concentration. Cultures were treated with different concentrations of 
T3 (range 10
-13
 to 10
-8
 M) for 14DIV (Table 2 A). Compared with T3-deprived cultures, 
the network activity (Fig. 6 A) and the soma area (Fig. 6 B) significantly increased in 
cultures with T3 concentrations above 10
-12
M, and statistical significance increased with 
increasing concentrations. In one additional set of experiments, the effects of T3 from 10
-12
 
up to 10
-6
 M were tested. As before, with T3 concentrations above 10
-10 
M no further 
increase or decrease in burst frequency and soma area of L-GABAergic cells was observed 
(Table 2 B). These results show that concentrations of T3 comparable with free plasma T3 
concentration (10
-12
 M) are sufficient to elicit changes in early network activity and 
GABAergic neurons growth. Maximal changes were seen with concentrations >10
-10
 M. 
Since higher T3 concentrations yielded more consistent results without noticeable side 
effects T3 was also used in the following experiments in the initial concentration of 15nM. 
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Figure 6: Dose-response curve of T3 actions on burst frequency and GABAergic neurons size.  
A, B. Cultures were treated with different concentrations of T3 for 14 days (0-14DIV). A significant 
increase in burst frequency (A) and soma area of L-GABAergic neurons (B) was evident already at 
a concentration as low as 10-12 M T3. Graphs show normalized burst frequency and soma size 
relative to the mean of hormone-deprived cultures. 
 
Table 2: Dose response curve of T3-mediated effects. 
 Normalized burst frequency  Normalized L-GABA size 
 Mean ± SEM N# P  Mean ± SEM N§ P 
A        
0 M 100±3 15   100±2 120  
10-13 M 177±30 15 0.051  100±2 120 0.939 
10-12 M 186±28 15 0.004  108±2 119 0.002 
10-11 M 172±19 15 <0.001  109±2 124 0.006 
10-10 M 200±21 15 <0.001  116±3 122 <0.001 
15x10-9 M 166±9 15 <0.001  115±3 80 <0.001 
B        
0 M 100±11 17   100±2 92  
10-12 M 301±52 17 <0.001  108±3 90 0.028 
10-9 M 388±99 17 <0.001  118±3 90 <0.001 
3x10-8 M 402±44 17 <0.001  117±4 87 <0.001 
10-6 M 375±66 17 <0.001  114±3 89 <0.001 
N#, number of recorded fields from (A) 3 cultures, 2 preparations and (B) 2 cultures, 1 
preparation; N§, number of neurons from (A) 2-6 cultures, 2 preparations and (B) 3 cultures, 1 
preparation. P indicates comparison against T3-deprived cultures (0M, MW-RST).  
 
4.2.3 No acute effects of T3 on network activity  
Beside its role in gene regulation, T3 shows fast non-genomic actions and is 
hypothesized to interact with transmitter receptors (Farwell et al., 2006; Zamoner et al., 
2006; Losi et al., 2008). Therefore it was probed whether T3 changes spontaneous network 
activity when applied acutely (Fig. 7 A). The acute effect of T3 on burst activity was tested 
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in cultures grown in either hormone-free medium (Fig. 7 B, white bars) or hormone-
supplemented medium for 14-21 days (Fig. 7 B, grey bars; 20 fields, 5 fields from each of 
4 cultures, 2 preparations). Before the addition of T3 five fields were imaged in hormone-
free ringer solution (Fig. 7 B, open bars). These recordings showed the already described 
significant increase in burst frequency after long time treatment with T3 compared with 
T3-deprived cultures. No significant change in burst frequency was observed after acute 
addition of T3 (10 ng/ml; Fig. 7 B, dashed bars; T3-deprived cultures in T3-free ringer 
solution: 4.5 ± 0.41 burst/min, in the presence of acute T3: 4.04 ± 0.35 bursts /min, p = 
0.395, t-test; T3-treated culture in T3-free ringer solution: 14.31 ± 1.69 bursts /min, in the 
presence of T3: 11.54 ± 1.4 bursts /min, p = 0.208, MW-RST, mean ± SEM). This set of 
experiments demonstrate that T3 significantly increases burst frequency when applied over 
a period of days, but has no effect when applied for minutes. 
 
 
Figure 7: No acute burst frequency modulation after T3 stimulation. 
A. Time histogram showing the mean burst frequency of recorded fields before and during the 
application of T3 to the recording solution. B. Burst frequency was not altered by acute presence 
of T3 in the imaging solution. White bars (left side): cultures were grown in T3-free medium; grey 
bars (right side): cultures were grown in T3-supplemented medium. Imaging was done in T3-free 
ringer solution (open bars) and repeated after the addition of T3 to the recording solution 
(dashed bars). Recordings were made in 14 to 21-day-old cultures; n = 20 fields from 4 cultures, 2 
preparations. 
 
4.2.4 Blockade of nuclear receptor signalling by TR antagonist 1-850  
The lack of short-term effects of T3 concurs with the idea of a slow, nuclear 
receptor mediated action. To test this, cultures were treated chronically with the thyroid 
hormone receptor (TR) antagonist 1-850 (1µM) in the absence or presence of T3 (Fig. 8). 
As expected, T3 significantly increased the burst frequency (Fig. 8 A, T3
–
: 2.22 ± 0.20 
bursts/min; T3
+
: 7.86 ± 0.67 bursts/min, mean ± SEM, n = 20 fields, 4 cultures, 2 
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preparations,  p < 0.001, MW-RST) and the soma size of L-GABAergic interneurons (Fig. 
8 B, T3
–: 325.56 ± 6.16 μm2, T3+: 386.70 ± 7.15 μm2, mean ± SEM,  n = 120 neurons, 6 
cultures, 2 preparations, p < 0.001, t-test). Addition of T3 receptor antagonist 1-850 
significantly diminished the T3-mediated increase in burst frequency (Fig. 8 A, T3
+
/1-850: 
3.24 ± 0.32 bursts/min, p = 0.01, t-test, compared with T3
–
) and prevented the increase in 
soma size of L-GABAergic neurons (Fig. 8 B, T3
+
/1-850: 332.84 ± 6.38 μm2, p = 0.413, t-
test, compared with T3
–
). In hormone-deprived cultures T3 receptor antagonist 1-850 only 
slightly decreased both network activity and soma size (Fig. 8 A, T3
–
/1-850: 1.75 ± 0.11 
bursts/min, p < 0.041, t-test, compared with T3
–
; Fig. 8 B, T3
–
/1-850: 294.04 ± 5.33 μm2, p 
< 0.001, t-test, compared with T3
–
). These results corroborate that T3-induced alterations 
in burst frequency and neuron morphology are, at least in part, mediated by nuclear thyroid 
hormone receptors. 
 
 
Figure 8: Modulation of T3-mediated actions by thyroid hormone receptor antagonist 1-850. 
A, B. Chronic treatment with the thyroid hormone receptor antagonist 1-850 significantly 
diminished the T3-mediated increase in burst frequency (A) and prevented the increase in L-
GABAergic soma size (B). 
 
4.2.5 Sequence of T3-mediated soma enlargement and burst frequency increase 
The initial experiments have shown that synchronous network activity enhancement 
parallels the increased growth of L-GABAergic neurons by thyroid hormone at 14DIV 
(chapters 4.1.1, 4.1.3). The next question was if hormonal modulation of L-GABAergic 
interneurons’ growth occurs before spontaneous network activity develops. This is relevant 
because L-GABAergic interneurons play a role in the emergence of spontaneous network 
activity (Voigt et al., 2001). On the other hand, the maturation of GABAergic neurons is 
activity-dependent (Patz et al., 2004; Jin et al., 2003; Chattopadhyaya et al., 2004; de Lima 
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et al., 2004). So it is also possible that GABAergic maturation is not the cause but rather 
the effect of activity enhancement by T3 stimulation. 
Hormone treatment during the first week did not result in an increase of 
spontaneous activity, suggesting that the regulation of activity was mainly due to the 
presence of T3 during the second week (Fig. 9 A; T3
–
 at 7DIV: 0.86 ± 0.23 bursts/min, 
mean ± SEM, n = 14 fields; T3
+
 at 7DIV: 0.93 ± 0.20 burst/min, n = 19 fields, p < 0.804, t-
test; T3
–
 at 14DIV: 1.93 ± 0.19 bursts/min, n = 15 fields; T3
+
 at 14DIV: 3.73 ± 0.39, n = 
13 fields, p < 0.001, t-test; 3-4 cultures, 3 preparations per experimental set and time 
point). But already in 7-day-old T3-treated cultures the mean soma size of L-GABAergic 
neurons was larger compared to age matched T3-deprived cultures (Fig. 9 B; 153.71 ± 2.39 
μm2 versus 139.18 ± 2.39 μm2 respectively; mean ± SEM, n = 160 neurons per set, p < 
0.001, t-test). As expected, T3-treated sister cultures (cultures derived from the same 
preparations; 7-8 cultures, 3 preparations for each condition) allowed to grow until 14 DIV 
showed a much larger increase in soma size (291.73 ± 7.81 μm2 in T3+ compared with 
181.29 ± 6.23 μm2 in T3–; mean ± SEM, p = 170 neurons per set, p < 0.001, MW-RST). 
Thus, the difference of L-GABAergic soma size between treated and untreated cultures 
increased significantly from 10% after one week treatment to more than 61% after two 
weeks treatment (p < 0.001, MW-RST; Fig. 9 B). Apparently this increase in soma size 
precedes any increase in burst frequency.  
 
 
Figure 9: Sequence of T3-mediated neuronal growth and burst frequency modulation. 
A. T3 treatment during the first week in vitro did not change the frequency of spontaneous 
activity, in contrast with the significant increase in burst frequency after two weeks of treatment. 
B. Measures of L-GABAergic neurons sizes in 7-day-old cultures reveal a small but significant 
increase in T3-treated cultures. After two weeks in vitro, L-GABA neurons in T3-treated cultures 
were considerably larger than in T3-deprived cultures. Asterisks show significance compared with 
T3-deprived cultures. 
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4.2.6 Activity-dependence of L-GABAergic neurons growth 
To test if the morphological alterations of L-GABAergic and non-GABAergic 
neurons are independent from the T3-mediated increase of network activity, it was probed 
whether antagonists to receptors and channels mediating network activity interfere with the 
morphological effects of T3 treatment. Sodium channel blocker TTX or glutamate receptor 
(GluR) blockers APV and CNQX were added to the culture medium during the second 
week in vitro to silence neuronal activity (7-14DIV; Fig. 10, Table 3) (Opitz et al., 2002; 
de Lima et al., 2004).  
 
 
Figure 10: Neuronal activity modulation of T3-mediated growth of L-GABAergic neurons. 
A. The blockade of network activity with Na+ channel blocker TTX or glutamate receptor blockers 
APV and CNQX during the second week in vitro diminished the soma size of L-GABAergic neurons. 
However, T3-mediated enlargement of L-GABA soma size occurs also under a chronic activity 
blockade. L-GABAergic neurons in T3-treated cultures were larger than those in T3-deprived. B. 
Similarly, non-GABAergic neurons were also larger in T3-treated cultures than in T3-deprived 
cultures when network activity was blocked by TTX or APV/CNQX. In contrast to L-GABAergic 
neurons, which showed decreased cell size under activity blockade with APV/CNQX in T3-treated 
and T3-untreated cultures, non-GABAergic neurons’ size was not affected by activity blockade. 
Statistics shown in grey indicate comparison of experimental groups with untreated control 
cultures of the same hormone group. 
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The blockade of network activity with TTX or with APV/CNQX significantly 
diminished the soma size of L-GABAergic neurons in T3-supplemented cultures (Table 3, 
Fig. 10 A). In T3-deprived cultures, the blockade of network activity with GluR 
antagonists, but not with TTX, resulted in a significant decrease of L-GABAergic neurons 
size (Table 3, Fig. 10 A, white bars). These results indicate that neuronal activity 
modulates the growth of L-GABAergic neurons. However, when network activity was 
blocked, T3-treated L-GABAergic neurons were also significantly larger than in T3-
untreated cultures, suggesting that at least some T3-induced growth occur independently of 
the activity mediated modulation (Table 3, Fig. 10 A).  L-GABAergic neurons developed 
maximally when both factors, neuronal activity and T3, were present. 
Because also non-GABAergic cells showed a small T3-induced increase in soma 
area (see Fig. 4 F), additionally the soma size of non-GABAergic neurons was measured in 
cultures treated with TTX or APV/CNQX (Table 3, Fig. 10 B). Similar to L-GABAergic 
cells, when network activity was blocked by TTX or APV/CNQX, non-GABAergic 
neurons were larger in T3-treated than in T3-untreated cultures. In contrast to L-
GABAergic neurons, the soma size of non-GABAergic neurons was not affected by the 
activity blockade itself, neither in T3-supplemented nor in T3-deprived cultures (Table 3, 
Fig. 10 B).  
 
Table 3: Morphometry of L-GABAergic and non-GABAergic neurons in activity blockade 
experiments 
 Hormone deprived (T3-)  Hormone-treated (T3+)  
 Soma area (µm²) N P  Soma area (µm²) N P P* 
 Mean ± SEM    Mean ± SEM    
L-GABA neurons        
Drug control 203±6 212   314±7 210  <0.001 
TTX 172±2 213 0.218  199±4 211 <0.001 <0.001 
APV/CNQX 145±3 190 <0.001  215±6 181 <0.001 <0.001 
Non-GABA neurons        
Drug control 122±3 282   135±4 215  0.009 
TTX 113±2 303 0.193  135±3 276 0.633 <0.001 
APV/CNQX 113±3 187 0.291  138±4 172 0.282 <0.001 
N indicates the number of analysed L-GABA neurons (from 7-10 cultures, 4 preparations) and 
number of Non-GABA neurons (from 3-4 cultures, 2 preparations). P refers to the comparison 
between antagonists treated and untreated neurons; P* indicates comparison between T3-
treated neurons and T3-deprived neurons (MW-RST). 
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These experiments show first that independent of spontaneous activity, hormones 
acted as neurotrophic factors for the subpopulations of L-GABAergic and non-GABAergic 
neurons, and second that the activity blockade dramatically and specifically decreased the 
T3-mediated L-GABAergic neuronal growth. 
 
 
4.3 Focus on L-GABAergic interneurons 
L-GABAergic interneurons showed enlarged soma size in T3-treated cultures (see 
Fig. 4 D). The results above suggest that T3 modulation of interneuronal growth is, at least 
partly, independent from and precedes the increase in spontaneous network activity (see 
Figs. 9, 10). The morphological properties of L-GABAergic neurons suggest that these 
cells could synchronize neuronal activity in the network by collecting randomly generated 
activity and distributing it throughout the network of developing neurons (de Lima and 
Voigt, 1997; Voigt et al., 2001). Already at a time point when synchronous activity can be 
first observed in cultured cortical networks (7-8DIV), L-GABAergic neurons show 
extended axonal arborization that covers a surface of 0.5 mm
2
 (Voigt et al., 2001; Opitz et 
al., 2002). 
For further exploration of the hormonal modulation of L-GABAergic growth, low 
density cultures were generated (Figs. 11 - 14), which contain non-GABAergic and L-
GABAergic cells (Fig. 11  A, C), but are virtually free of S-GABAergic interneurons (Fig. 
11 B; 1.56 ± 0.73 cells/mm² in T3
–
 and 1.30 ± 0.73 cells/mm² in T3
+
). Thus, in these 
cultures nearly all GABAergic structures visualized by GABA immunocytochemistry 
originate from L-GABAergic cells (Figs. 12 - 14). Nevertheless, these cultures possess all 
typical alterations seen after hormone treatment in normal cultures. The density of non-
GABAergic neurons was also reduced in T3-treated two-week-old (15DIV) low density 
cultures (161.71.20 ± 13.43 cells/mm² in T3
+
 compared with 205. 77 ± 17.69 cells/mm² in 
T3
–
, p = 0.008, t-test, mean ± SEM, Fig. 11 C), and the number of L-GABAergic cells 
remained unchanged (4.94 ± 0.88 cells/mm² in T3
+
 compared with 7.02 ± 1.41 cells/mm² 
in T3
–
, p = 0.12, MW-RST, mean ± SEM, Fig. 11 A). Additionally, as expected, L-
GABAergic cells chronically treated with T3 showed increased soma size compared with 
T3-deprived cultures (Fig. 14 A: 320.33 ± 7.68 µm² in T3
+
 compared with 277.04 ± 8.77 
µm² in T3
–
; p < 0.001, MW-RST, mean ± SEM, n = 80 cells from four cultures, 2 
preparations). 
  Results 
 
49 
 
 
 
Figure 11: Neuronal population analysis of low-density cultures. 
A-C. Low-density cultures contain reduced numbers of non-GABAergic (C) and L-GABAergic cells 
(A) and are virtually free of S-GABAergic interneurons (B). The density of non-GABAergic neurons 
was reduced in two-week-old (15DIV) T3-treated low-density cultures (C) compared with T3-
untreated cultures, whereas the number of L-GABAergic cells remained unchanged (A). 
 
4.3.1 Dendritic development of L-GABAergic neurons in low density cultures  
 
 
Figure 12: Dendritic growth of L-GABAergic neurons is independent of T3-treatment. 
A-B. Representative individual drawings show the dendritic profiles of L-GABAergic neurons from 
T3-deprived (A) and T3-treated (B) 15-day-old low-density cultures. Scale bar: 200 µm. C-E. 
Neither the total dendritic length of L-GABAergic neurons (C), nor the number of primary 
dendrites per cell (D) or dendritic branches (E) were changed after T3 treatment.  
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Besides the quantification of soma area, we measured total dendritic length, the 
number of primary dendrites, the number of dendritic branches (Fig. 12) and, as an 
indicator for axonal innervation, the number of GABAergic boutons opposed to unstained 
non-GABAergic cells (Figs. 13, 14). Neither the total dendritic length (1570.76 ± 117.24 
µm in T3
+
 compared with 1667.01 ± 69.85 µm in T3
–
, p = 0.628, t-test, mean ± SEM) nor 
the number of primary dendrites per cell (6.0 ± 0.27 in T3
+
 compared with 5.80 ± 0.46 in 
T3
–
,  p = 0.617, MW-RST, mean ± SEM) nor dendritic branches (5.05 ± 0.58 per cell in 
T3
+
 compared with 5.85 ± 0.38 in T3
–
,  p = 0.318, t-test, mean ± SEM) of L-GABAergic 
neurons (n = 20 analyzed cells from 4 cultures, 2 preparations) were changed after T3 
stimulation (Fig. 14). Changes were observed however in the fine ramifications of L-
GABA axons and in the number of GABAergic boutons in the vicinity of non-GABAergic 
neurons (Fig. 13). 
 
4.3.2 Axonal development of L-GABAergic neurons in low density cultures  
L-GABAergic cells typically form long, highly branched axons forming 
conspicuous baskets and numerous boutons in the vicinity of neuronal cell bodies (de Lima 
and Voigt, 1997; Voigt et al., 2001). Along their long, richly ramified axons L-GABAergic 
neurons develop fine axonal arborizations that form putative synaptic boutons at the cell 
bodies and proximal dendritic regions of non-GABAergic neurons. Electronmicroscopic 
analysis had previously shown that these varicosities are synaptic contact sites (Voigt et 
al., 2001). The generation of prominent GABAergic boutons is characteristic for selected 
subtypes of GABAergic interneurons and proceeds in vivo (Karube et al., 2004) as well as 
in organotypic culture (Klostermann and Wahle, 1999; Di Cristo et al., 2004; 
Chattopadhyaya et al., 2004) implying that the occurrence of this characteristic axonal 
feature is intrinsic to neurons and genetically determined. 
While in T3-enriched cultures the axons formed richly arborized nests, including 
many boutons around small groups of cell somata (Fig. 13 B, D, F), these nests failed to 
develop in T3-deprived cultures (Fig. 13 A, C, E). This difference was confirmed by the 
quantification of GABAergic boutons density. The number of GABAergic boutons 
opposed to non-GABAergic neurons is significantly increased in T3-treated cultures (Fig. 
14 B: 14.63 ± 0.52 boutons/cell in T3
+
 compared with 9.45 ± 0.43 boutons/cell in T3
–
, p < 
0.001, MW-RST, mean ± SEM, n = 80 fields from 4 cultures, 2 preparations). These 
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results show that the increased L-GABAergic cell body size mirrors the increased axonal 
arborization and the increased density in GABAergic boutons in T3-treated cultures. 
 
 
Figure 13: Growth of GABAergic neuropile in T3-treated networks. 
Images show GABA immunostained 15-day-old low-density cultures grown in the absence (A, C, E) 
or presence (B, D, F) of T3. Because these low-density cultures contain virtually no S-GABAergic 
interneurons, all GABAergic structures visualized by GABA immunocytochemistry originate from L-
GABAergic cells. In T3-treated cultures L-GABAergic neurons (B, D, F) form clear visible nests of 
axonal arborizations with many boutons around small groups of cells, whereas in T3-deprived 
cultures these nests are less prominent or absent (A, C, E). Scale bar = 100 μm in A and B, 50 µm 
in C and D, and 20 µm in E and F. 
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Figure 14: Formation of GABAergic boutons by L-GABAergic neurons. 
A. As expected L-GABAergic cells treated with T3 show hypertrophy compared with untreated T3-
deprived cultures. B. In parallel, the number of GABAergic boutons in the vicinity of non-
GABAergic neurons is significantly increased in T3-treated cultures.  
 
4.3.3 T3 modulates the development of L-GABAergic axons and boutons 
Next the formation of GABAergic boutons and the distribution of L-GABAergic 
axonal arbors was analysed in more detail in GABA-immunostained 14-day-old cultures 
grown in the absence (T3
−
) or in the presence of triiodothyronine (T3
+
; Tables 4 - 5; Fig. 
15 - 16). Therefore regular cultures (plating density of 300 - 500 neurons/mm²) were used. 
The total length of GABAergic axons, the number of GABAergic boutons and the number 
of axonal branches were measured in randomly chosen fields (120 µm x 90µm). 
Independent of hormonal treatment the axons of L-GABAergic neurons formed a 
continuous interconnected network. The overall axonal length was reduced by T3 (Fig. 15 
C), whereas the number of GABAergic boutons (Fig. 15 D) and the number of axonal 
branches were increased (Fig. 15 E). In parallel, L-GABAergic neurons showed a 
prominent enlargement of neuronal soma size in the presence of T3 (Fig. 15 F: 308.45 ± 
6.63 µm² in T3
−
 and 351.07 ± 8.00 µm² in T3
+
; n = 120 cells; p < 0.001; MW-RST). The 
overall density of L-GABAergic neurons was not changed by hormone treatment (4.42 ± 
0.38 cells/mm² in T3
−
 and 4.38 ± 0.35 cells/mm² in T3
+
; n = 60 fields; p = 0.939; MW-
RST), thus the reduction in axonal length did not result from a loss of GABAergic neurons. 
Under both conditions, non-GABAergic neurons clustered into small groups and 
form cell rich and cell poor areas, whereas GABAergic neurons usually distributed 
between these clusters. In T3-treated cultures, GABAergic axonal arborizations and 
GABAergic boutons tended to concentrate around these groups of non-GABAergic 
neurons (Fig. 15 B1 - B3), whereas L-GABAergic axons in T3-untreated cultures were 
distributed more homogenously throughout the neuronal network (Fig. 15 A1 - A3).  
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Figure 15: T3 modulation of L-GABAergic neurons´ axonal growth and soma size. 
A-B. Images show GABA immunostained 14-day-old cultures grown in the absence (A1) or 
presence (B1) of T3. Each image shows a L-GABAergic neuron (arrow) with its conspicuous axonal 
arborizations (arrow heads) surrounded by smaller S-GABAergic neurons and unstained non-
GABAergic neurons. In T3-stimulated cultures L-GABAergic neurons selectively target groups of 
neuronal cell bodies with their axons (B3) but sparsely innervate cell free regions (B2). In contrast, 
in T3-deprived cultures both cell-free (A2) and cell-rich (A3) regions are equally covered with L-
GABAergic axons. Scale bar: (B1) 100 μm in A1 and B1; (B2) 25 μm in A2, A3 and B2, B3. C-F. 
Quantification of L-GABAergic neurons in T3-treated and T3-deprived cultures. Total axonal length 
per field (C), mean bouton (D) and branch density (E) and L-GABAergic soma size (F) per field. See 
also Table 4 (controls). 
 
To test the hypothesis that axonal parameters vary according to the distribution of 
neuronal cell bodies, the total length of GABAergic axons, the number of GABAergic 
boutons and the number of axonal branches were correlated to the number of non-
GABAergic cells. In cultures chronically treated with T3 the axonal length (Fig. 16 A; p < 
0.001; r
2
 = 0.180, LR), the number of boutons (Fig. 16 B; p < 0.001; r
2
 = 0.396, LR) and 
the number of axonal branches (Fig. 16 C; p < 0.001; r
2
 = 0.437, LR) were well correlated 
with the local cell density. In contrast, in cultures grown in the absence of T3 none of the 
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parameters were correlated with the local cell density (axonal length: p = 0.998, r
2
 < 
0.0001, LR; GABAergic boutons: p = 0.110, r
2
 = 0.0434, LR; axonal branches: p = 0.079, 
r
2
 = 0.0524, LR).  
 
 
 
Figure 16: Different distribution of L-GABAergic axons in T3-treated and T3-deprived cultures. 
A-C. Scatter plots indicate that the axonal length (A), the number of GABAergic boutons (B) and 
the number of axonal branches (C) are dependent on the number of non-GABAergic neurons in 
T3-stimulated (T3+) but not in T3-deprived cultures (T3-). Each dot represents one randomly 
chosen field (120 µm x 90 µm). Lines indicate best linear fit. D. The mean cell density of all 
measured fields was used as criteria to analyze data in subgroups with low and high cell densities 
(E-I). G shows total axonal length per field. E and F show boutons and branches density per axon 
segment length, and H and I show boutons and branches density per field. Asterisks show 
statistical significance between fields with low and high cell density as indicated by lines. Grey 
asterisks display significant differences between T3− and T3+ cultures. See also Tables 4, 5 
(controls). 
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For further quantitative analysis the data were grouped into fields with low cell 
density (≤ 4 cells/field) and fields with high cell density (> 4 cells/field) according to the 
mean density of non-GABAergic cells (4.85 ± 0.48 cells/field in T3
−
 and 4.60 ± 0.47 
cells/field in T3
+
; Fig. 16 D - I; Tables 4 - 5).  
Axonal Length. There was no difference in the mean total length of GABAergic 
axons between fields with low and high cell density in T3
−
 raised cultures (Fig. 16 G, 
Table 4). High cell density fields in T3-treated cultures showed a total GABAergic axonal 
length per field similar to the fields in T3-untreated cultures. In contrast, the GABAergic 
axonal length in low density fields in T3-treated cultures was significantly reduced. Thus, 
the decreased mean axonal length in T3-treated cultures (Fig. 15 C) resulted from axonal 
pruning in low density fields (Fig. 16 G).  
GABAergic boutons. T3-treated cultures showed an increased number of 
GABAergic boutons along axons in both high and low cell density areas, compared with 
those fields in T3-untreated cultures (Fig. 16 E; Table 5). However, no difference was 
found in the number of boutons per axonal length between high and low density fields in 
each of the treatment groups. Considering the number of boutons per field (Fig. 16 H; 
Table 4), no difference was detected between high and low density fields of T3-untreated 
cultures. In contrast, the number of GABAergic boutons per field was selectively enriched 
in fields with high cell density in T3
+
 cultures.  
Axonal branches. The number of axonal branches per axonal length was 
significantly increased by T3-treatement irrespective of cell density (Fig. 16 F; Table 5), 
indicating a general increase in axonal branching by T3. In contrast to GABAergic 
boutons, the local cell density promotes branching of GABAergic axons in T3
−
 and T3
+
 
cultures. The increase in axonal branching in high density fields was very pronounced in 
the presence of T3 (Fig. 16 I, Table 4). 
These results suggest a twofold effect of T3 treatment on the axon growth of L-
GABAergic neurons: on the one hand T3 favored the formation of GABAergic boutons 
and axonal branches; on the other hand T3 induced a selective reduction in axonal length 
in fields with low cell density. As a result, in T3-treated cultures GABAergic boutons and 
axonal branches were significantly increased in the vicinity of non-GABAergic neurons. 
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Table 4: Interactions of T3 and BDNF on the axonal growth of L-GABAergic neurons. 
 
 T3-  T3+  
 mean±sem (n) P# P§  mean±sem (n) P# P§ P* 
Axon length (µm per field) 
total 
control 951 ± 40 (60)    715 ± 42 (60)   <0.001 
K252a 1020 ± 50 (60) 0.277   943 ± 38 (60) <0.001  0.216 
BDNF 994 ± 42 (60) 0.406   762 ± 47 (60) 0.453  <0.001 
Low density 
Control 938 ± 54 (33)    577 ± 53 (36)   <0.001 
K252a 871 ± 120 (15) 0.561   923 ± 126 (7) 0.012  0.796 
BDNF 935 ± 52 (38) 0.967   561 ± 46 (37) 0.817  <0.001 
High density 
Control 966 ± 59 (27)  0.722  921 ± 43 (24)  <0.001 0.539 
K252a 1070 ± 52 (45) 0.208 0.086  945 ± 40 (53) 0.708 0.852 0.056 
BDNF 1094 ± 69 (22) 0.165 0.070  1084 ± 45 (23) 0.011 <0.001 0.909 
GABA boutons (per field) 
Total 
Control 47.1 ± 2.6 (60)    63.8 ± 4.8 (60)   0.009 
K252a 57.8 ± 2.7 (60) 0.005   82.9 ± 3.3 (60) 0.001  <0.001 
BDNF 66.8 ± 3.1 (60) <0.001   74.0 ± 5.9 (60) 0.181  0.836 
Low density 
Control 43.9 ± 3.7 (33)    47.9 ± 5.6 (36)   0.569 
K252a 46.5 ± 6.4 (15) 0.660   78.1 ± 9.4 (7) 0.029  0.016 
BDNF 59.6 ± 3.8 (38) 0.005   43.3 ± 3.7 (37) 0.498  0.003 
High density 
Control 50.9 ± 3.3 (27)  0.180  87.7 ± 5.8 (24)  <0.001 <0.001 
K252a 61.6 ± 2.8 (45) 0.024 0.032  83.5 ± 3.5 (53) 0.524 0.602 <0.001 
BDNF 79.4 ± 4.2 (22) <0.001 <0.001  123.4 ± 5.1 (23) <0.001 <0.001 <0.001 
Axon branches (per field) 
Total 
Control 4.48±0.30 (60)    6.23±0.55 (60)   0.040 
K252a 2.83±0.26 (60) <0.001   3.63±0.31 (60) <0.001  0.076 
BDNF 4.22±0.30 (60) 0.500   4.82±0.46 (60) 0.073  0.565 
Low density 
Control 3.91±0.39 (33)    4.61±0.65 (36)   0.885 
K252a 2.13±0.50 (15) 0.006   2.71±0.61 (7) 0.213  0.306 
BDNF 3.61±0.34 (38) 0.588   2.92±0.32 (37) 0.092  0.263 
High density 
Control 5.19±0.46 (27)  0.042  8.67±0.76 (24)  <0.001 <0.001 
K252a 3.07±0.30 (45) <0.001 0.074  3.75±0.33 (53) <0.001 0.205 0.241 
BDNF 5.27±0.49 (22) 0.833 0.004  7.87±0.71 (23) 0.447 <0.001 0.005 
         
P# indicates p-value of drug treatment groups vs. untreated controls of the same hormone and 
density category. P§ refers to p-value high density vs. low density of the same hormone and drug 
category. P* shows p-value T3-treated vs. T3-untreated of the same drug and density category. (n) 
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number in brackets indicates the number of fields analysed per condition. All data represent 
mean ± SEM. Statistics were made with t-test or MW-RST. 
 
Table 5: Normalized density of GABAergic boutons and axonal branches per axonal length. 
 
 T3-  T3+  
 mean±sem (n) P# P§  mean±sem (n) P# P§ P* 
GABA boutons (per mm axon) 
Total 
Control 51.8 ± 2.8 (60)    88.4 ± 5.0 (60)   <0.001 
K252a 58.8 ± 2.2 (60) 0.053   89.9 ± 2.4 (60) 0.433  <0.001 
BDNF 68.3 ± 2.4 (60) <0.001   92.7 ± 4.1 (60) 0.505  <0.001 
Low density 
Control 48.1 ± 3.5 (33)    81.1 ± 5.1 (36)   <0.001 
K252a 54.9 ± 2.7 (15) 0.264   87.8 ± 7.8 (7) 0.583  0.001 
BDNF 64.5 ± 4.1 (38) <0.001   78.3 ± 4.6 (37) 0.685  0.014 
High density 
Control 56.4 ± 4.5 (27)  0.142  99.5 ± 9.4 (24)  0.224 <0.001 
K252a 60.2 ± 2.6 (45) 0.436 0.311  90.1 ± 2.5 (53) 0.961 0.763 <0.001 
BDNF 74.9 ± 3.1 (22) 0.002 0.032  116.0 ± 4.9 (23) 0.001 <0.001 <0.001 
Axon branches (per mm axon) 
Total 
Control 4.75±0.32 (60)    8.34±0.61 (60)   <0.001 
K252a 2.67±0.21 (60) <0.001   3.87±0.28 (60) <0.001  <0.001 
BDNF 4.35±0.30 (60) 0.451   6.05±0.45 (60) 0.003  0.003 
Low density 
Control 4.04±0.36 (33)    7.27±0.63 (36)   <0.001 
K252a 2.36±0.23 (15) 0.008   3.20±0.80 (7) 0.009  0.304 
BDNF 3.99±0.52 (38) 0.926   5.29±0.61 (37) 0.027  0.075 
High density 
Control 5.64±0.50 (27)  0.009  9.94±1.16 (24)  0.032 <0.001 
K252a 2.78±0.24 (45) <0.001 0.392  3.96±0.30 (53) <0.001 0.394 0.004 
BDNF 4.97±0.43 (22) 0.335 0.112  7.26±0.56 (23) 0.046 0.032 0.003 
         
P# indicates p-value of drug treatment groups vs. untreated controls of the same hormone and 
density category. P§ refers to p-value high density vs. low density of the same hormone and drug 
category. P* shows p-value T3-treated vs. T3-untreated of the same drug and density category. (n) 
number in brackets indicates the number of fields analysed per condition. All data represent 
mean ± SEM. Statistics were made with t-test or MW-RST. 
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4.3.4 Contribution of BDNF to T3-mediated  L-GABAergic axon growth 
Previous results showed complementary effects of T3 and neuronal activity in the 
regulation of L-GABAergic neurons development (chapter 4.2.6). The neurotrophin BDNF 
is well known as a mediator of activity-dependent effects and has been shown to be an 
important regulator of interneuron development (Palizvan et al., 2004; Patz et al., 2004; 
Woo and Lu, 2006). Additionally, BDNF expression has been suggested to be regulated by 
T3 (Koibuchi et al., 1999; Sui et al., 2010). Thus, BDNF might act as a mediator of T3 
actions on early GABAergic neurons during neocortical network development. 
To investigate the interplay between BDNF signalling and T3-mediated growth of 
L-GABAergic neurons either exogenous BDNF (50 ng/ml) or the tyrosine kinase inhibitor 
K252a (100nM) were added to the cultures, alone or in combination with T3 (Figs. 17 - 18; 
Tables 4 - 5). K252a is a high-affinity inhibitor of the BDNF receptor TrkB (tropomyosin-
related kinase B; Tapley et al., 1992) and has been shown to inhibit BDNF-mediated 
plasticity of GABAergic neurons (Rutherford et al., 1997; Jin et al., 2003; Palizvan et al., 
2004; Patz et al., 2004; Peng et al., 2010). In the present experiments, TrkB signalling was 
inhibited during the second week in vitro. During this time synapse formation of L-
GABAergic axons takes place and early synchronous network activity is present (de Lima 
and Voigt, 1997; Voigt et al., 2001; Opitz et al., 2002). 
First, GABA-immunostainings revealed that K252a inhibited the characteristic 
axonal distribution pattern induced by T3-stimulation (Fig. 17). While GABAergic cells 
formed highly branched axon terminals with numerous boutons around non-GABAergic 
cell bodies sparing cell-free regions in T3-treated control cultures (Fig. 17 B), this typical 
pattern was completely inhibited by K252a (Fig. 17 D). In T3-untreated cultures the 
incubation with K252a did not affect axonal distribution (Fig. 17 A, C). To test whether 
differences between T3-treated and untreated cultures were induced by T3-mediated 
changes in BDNF levels, sister cultures were stimulation with exogenous BDNF (50ng/ml) 
during the same time period. Interestingly, BDNF application apparently did not change 
axonal distribution in T3-deprived cultures (Fig. 17 E), but further promoted bouton 
formation and axonal branching in the presence of T3 (Fig. 17 F).  
To quantify the axonal parameters under these conditions we again measured the 
total axonal length, the number of GABAergic boutons and the number of axonal branches 
in randomly chosen fields after the addition of K252a or BDNF (Fig. 17 - 18; Tables 4 – 5; 
control cultures are the same as in Fig. 16).  
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Figure 17: Effects of T3 and BDNF on the distribution of L-GABAergic axons and boutons. 
A-F. Images show GABAergic innervation patterns of areas with low or high cell density in T3-
untreated and T3-treated 14-day-old cultures, comparing controls (A-B) with cultures treated with 
K252a (C-D) or BDNF (E-F). G-J shows the quantification of the effect of K252a and BDNF 
treatment considering the mean of all fields: axonal length (G), relative number of GABAergic 
boutons along axons (H), relative number of axonal branches (I), and L-GABAergic neurons cell 
body size (J) for both T3− and T3+ cultures. Scale bar = 20 μm. 
 
Axonal Length. In T3-treated cultures K252a prevented the reduction of axonal 
length in fields with low cell density (Fig. 18 C, right side) and thereby the overall 
reduction of mean axonal length per field (Fig. 17 G), whereas BDNF application did not 
change overall axonal length. Interestingly, the addition of exogenous BDNF to T3-
deficient cultures also did not change the total axonal length per field (Fig. 17 G; Table 4). 
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Accordingly, treatment with K252a inhibited the positive correlation of axonal length with 
the local cell density in T3-supplemented cultures (p = 0.057; r
2
 = 0.0612, LR; Fig. 18 B, 
C right side; Table 4) but had no effect in T3-deprived cultures (p = 0.321; r
2
 = 0.0170, 
LR; Fig. 18 A, C left side; Table 4). BDNF application apparently did not change axonal 
distribution in T3-deprived cultures (Fig. 17 E, G), failing to establish a significant positive 
correlation of axonal length and cell density in T3
−
 cultures (p = 0.062; r
2
 = 0.0588, LR; 
Fig. 18 A, C left side; Table 4). In the presence of T3, the stimulation with exogenous 
BDNF promoted the correlation of axonal length with the cell density (p < 0.001; r
2
 = 
0.468, LR; Fig. 17 F; 18 B, C right side; Table 4).  
Boutons. The blockade of TrkB receptors did not change the relative density of 
boutons along axons (Fig. 17 H; Table 5). The application of exogenous BDNF increased 
the relative density of GABAergic boutons along axons in T3-deficient cultures, but this 
increased bouton density was still smaller than bouton density in T3-treated cultures. The 
T3-induced positive correlation of GABAergic boutons per field with the local cell density 
was inhibited by K252a (p = 0.191; r
2
 = 0.0292, LR, Fig. 18 E, F right side; Table 4), and, 
as expected, there was no correlation in T3-untreated cultures after K252a treatment (p = 
0.088; r
2
 = 0.0493; Fig. 18 D), although a small difference in boutons density was 
detected, when fields with high or low cell density were compared (Fig. 18 F, left side; 
Table 4). Exogenous BDNF application increased the bouton density in fields with high 
cell density independent of T3 presence (T3
−
: p < 0.001; r
2
 = 0.255, LR; T3
+
: p < 0.001; r
2
 
= 0.706, LR; Fig. 18 D, E, F; Table 4). However, the increase was much more pronounced 
in the presence of T3. 
Axonal Branches. Finally, the number of axonal branches per axonal length 
decreased significantly in the presence of TrkB receptor antagonist in both T3-untreated 
and T3-treated cultures. Moreover, the increased axonal branching due to T3-treatment 
was prevented by K252a (Fig. 17 I, Table 5). Different from the distribution of axonal 
length and GABAergic boutons, after incubation with K252a the number of axonal 
branches per field was still positively correlated with cell density in T3-treated and T3-
untreated cultures (T3
+
: p = 0.005; r
2
 = 0.131, LR; T3
−
: p = 0.022; r
2
 = 0.0866, LR; Figs. 
18 G, H; Table 4), even though the correlation indexes were quite small. After BDNF 
stimulation the branch numbers were well correlated to the neuron density in both T3
+
 and 
T3
−
 cultures (T3
+
:
  
p < 0.001; r
2
 = 0.483, LR; T3
−
: p < 0.001; r
2
 = 0.186, LR; Fig. 18 G, H; 
Table 4). However, the correlation index was higher in T3-treated cultures. The 
comparison of fields with low and high cell density (Fig. 18 I) again illustrates that the 
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number of branches is enhanced in high-density areas by T3 in the presence of BDNF 
signalling. 
 
 
 
Figure 18: L-GABA axon growth and bouton formation in the presence of T3 and BDNF. 
Scatter plots show distribution of axonal length (A, B), GABAergic boutons (D, E) and axonal 
branches (G, H) of T3− (open dots) and T3+ cultures (filled dots) when treated with K252a (red) or 
exogenous BDNF (blue). Lines indicate best linear fit. Black dots and lines display data and best 
linear fit of untreated control cultures as shown in Fig. 20 A-C. C, F, I. As in Fig. 20 E-I, quantitative 
data were grouped into fields with low (≤ 4 cells/field) and fields with high cell density (> 4 
cells/field). C shows total axonal length per field. F shows boutons density per field, and I shows 
branches density per field. Asterisks show statistical significance between fields with low and high 
cell density as indicated by lines. Black asterisks directly above bars display significant differences 
between T3− and T3+ cultures of the same treatment and density category. Gray asterisks 
compare K252a or BDNF treated cultures with untreated controls of the same hormone and 
density category. For more details see also Table 4. 
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Soma size. Previous results suggested that the increased number of GABAergic 
boutons correlates with a simultaneous growth of neuronal soma (see Fig. 14). Therefore 
the soma size of L-GABAergic neurons was additionally measured in this set of 
experiments after application of K252a or BDNF (Fig. 17 J; n = 120 neurons, 6 cultures). 
The mean soma size of L-GABAergic neurons in control cultures was 308.4 ± 6.6 µm² in 
T3
−
 and 351.1 ± 8.1 µm² in T3
+ 
(cf. Fig. 15 F: p < 0.001, MW-RST). The TrkB inhibitor 
K252a reduced the soma size to 245.6 ± 4.4 µm² in T3
−
 (p < 0.001, MW-RST compared 
with T3
−
 control) and 263.6 ± 4.6 µm² in T3
+ 
(p < 0.001, MW-RST compared with T3
+ 
control). Thus T3-treated neurons were still larger than T3-deprived neurons even when 
BDNF signalling was blocked (p < 0.001, t-test), revealing a direct neurotrophic effect of 
T3 on L-GABA soma growth. In contrast the application of exogenous BDNF did not 
further promote somatic growth in T3-deprived cultures (307.8 ± 6.1 µm², p = 0.754, MW-
RST compared with T3
−
 control) or in T3-treated cultures (347.9 ± 6.4 µm², p = 0.565, 
MW-RST compared with T3
+
 control; p < 0.001, t-test compared with BDNF-treated T3
−
). 
In conclusion, the results suggest that T3 promotes the somatic growth and the 
concomitant increase in relative bouton numbers along axons independently of BDNF 
signalling. In T3-untreated cultures BDNF stimulation can only partially rescue deficits in 
bouton density. In contrast, the pruning of GABAergic axons from low cell density areas 
and the branching of axons, and thereby the characteristic accumulation of boutons around 
non-GABAergic cells, were prevented by TrkB receptor antagonist K252a. Since the 
BDNF-dependent pruning of GABAergic axons occurred only in T3-treated cultures and 
could not be induced by BDNF stimulation in T3-deprived cultures, this process seems to 
be synergistically regulated by T3 and BDNF. 
 
 
4.4 T3 modulation of GABA signalling maturation 
The proper function of GABAergic signalling is not only controlled by the density 
and distribution of GABAergic synapses. Its polarity and strength also depends on the 
intracellular chloride concentration in the postsynaptic cell, which is regulated by the 
cation chloride cotransporters NKCC1 and KCC2 (Kahle et al., 2008; Blaesse et al., 2009; 
see also chapter 2.1.4). The aim of the next experiments was to study the influence of T3 
on the functional maturation of the GABAergic system by estimating the developmental 
  Results 
 
63 
 
expression of KCC2 and NKCC1 and its implication in the shift from depolarizing to 
hyperpolarizing GABAergic signalling. 
 
4.4.1 Expression of KCC2 and NKCC1 
In cultured networks the developmental GABA shift occurs between 9 and 20DIV 
(Baltz et al., 2010). Therefore the expression of NKCC1 and KCC2 was determined in 
Western blot experiments (Fig. 19) in 7 to 21-day-old cultures. GAPDH protein level was 
used as a loading control, and NKCC and KCC2 data were normalized to the mean 
expression of 7DIV old T3-untreated cultures to calculate the developmental expression 
profile. 
The results showed that NKCC1 became downregulated between 14 and 21 DIV in 
T3
−
 as well as in T3
+
 cultures (Fig. 19 A, B; n = 5 blots; two preparations). The NKCC1 
level in T3
−
 cultures increased slightly from initially 100 ± 23.8 % at 7DIV to 130 ± 28.7 
% at 14DIV (p = 0.442, t-test compared with 7DIV) and then dropped to 27 ± 4.8 % at 
21DIV (p = 0.017, t-test compared with 7DIV). Similarly, the NKCC1 protein level of T3
+
 
cultures increased slightly from 102 ± 13.1 % at 7DIV to 152 ± 51.8 % at 14DIV (p = 
0.374, t-test compared with 7DIV) and decreased to finally 42 ± 10.9 % at 21DIV (p = 
0.008, t-test compared with 7DIV). The protein levels were not different between T3
−
 and 
T3
+
 cultures at any age (p = 0.933, t-test at 7DIV; p = 0.714, t-test at 14DIV; p = 0.242, t-
test at 21DIV). 
In contrast, the expression of KCC2 was regulated in a hormone-dependent manner 
(Fig. 19 B, C). In T3
−
 cultures KCC2 decreased from initially 100 ± 14.0 % at 7DIV to 41 
± 9.6 % at 14DIV (p = 0.006, t-test compared with 7DIV) and finally to 65 ± 16.0% at 
21DIV (p = 0.127, t-test compared with 7DIV). In T3
+
 cultures the expression of KCC2 
increased from 215 ± 56.2 % at 7DIV to 419 ± 63.5 % at 14DIV (p = 0.027, t-test 
compared with 7DIV) and then slightly decreased to 315 ± 71.8 % at 21DIV (p = 0.301, t-
test compared with 7DIV). The expression of KCC2 was increased in T3
+
 cultures 
compared to T3
−
 cultures at 14 and 21DIV (p = 0.132, MW-RST at 7DIV; p = 0.002, MW-
RST at 14DIV; p = 0.007, t-test at 21DIV). 
The results indicate that T3 affects the expression of NKCC1 and KCC2 in a 
transporter specific manner. KCC2 expression is highly dependent on the presence of T3 
suggesting a prominent role for thyroid hormone in chloride homeostasis and therefore also 
in GABAergic signalling. 
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Figure 19: KCC2 and NKCC1 expression in T3-stimulated and T3-deprived cultures. 
A. Representative Western Blots of 7 to 21-day-old cultures stained for NKCC1 or KCC2 as 
indicated. GAPDH levels were used as a loading control, and NKCC and KCC2 data were 
normalized to the mean expression of 7DIV old T3-untreated cultures to calculate the 
developmental expression profile. B. Developmental downregulation of NKCC1 protein levels was 
independent of T3 treatment. C. Expression of KCC2 was increased in T3-treated cultured 
compared with T3-untreated cultured at 14 and 21DIV. Asterisks show statistical significance 
between T3− and T3+ cultures as indicated by lines. Grey asterisks display significant differences of 
14-day-old or 21-day-old cultures compared with 7-day-old cultures of the same hormone group. 
 
4.4.2 GABA signalling shift 
The developmental downregulation of NKCC1 and concomitant upregulation of 
KCC2 lowers the intracellular chloride concentration and shifts GABAergic signalling 
from depolarizing to hyperpolarizing (Ben-Ari et al., 2007; Blaesse et al., 2009). Following 
the T3-dependent differences in KCC2 expression the developmental shift in GABA 
signalling should also be affected. The developmental changes in GABAA receptor-
mediated synaptic transmission were tested in calcium imaging experiments by the local 
application of the GABAA receptor agonist muscimol (Fig. 20: 10 to 15 fields, 3 
independent experiments).  
Following the high intracellular chloride concentration muscimol evoked strong 
calcium transients in young neurons (Fig. 20 A). At 6 DIV virtually all neurons were 
depolarized by muscimol application (99.1 ± 0.4 % in T3
−
; 98.0 ± 0.9 % in T3
+
, n = 10 
fields, p = 0.622, MW-RST). Starting on 9DIV differences in muscimol responsiveness 
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between the subpopulations of L-GABAergic, S-GABAergic and non-GABAergic neurons 
became evident (Table 6, Fig. 20). Interestingly, there was no developmental decrease in 
muscimol responses in the subpopulation of S-GABAergic neurons throughout 
development. Virtually all S-GABA were activated by muscimol even at 27DIV, the oldest 
age that has been analysed, and there were no differences between T3
−
 and T3
+
 cultures at 
any time.  
 
 
Figure 20: Modulation of GABA signalling shift by T3. 
A. Normalized fluorescence of an individual 9-day-old non-GABAergic neuron demonstrates 
intracellular calcium transients in response to local application of KCl (60mM) and GABAA receptor 
agonist muscimol (200µM) during calcium imaging as indicated. B. Representative calcium 
transients of non-GABAergic neurons grown either in T3− and T3+ in response to muscimol 
application. C. The developmental shift from depolarizing to hyperpolarizing actions of GABA is 
indicated by the fraction of neurons with a significant increase in fluorescence after muscimol 
stimulation (n = 10-15 fields each). At 6DIV virtually all neurons (black and white rectangles) show 
calcium transients after muscimol application. Whereas only few L-GABAergic neurons (grey 
rectangles) can be activated by muscimol application after day 9, virtually all S-GABAergic neurons 
(gray circles) respond to muscimol during the whole culture period until day 27. However, none of 
the GABAergic subpopulations was affected by T3 treatment. In contrast, T3 treatment 
accelerates the developmental downregulation of depolarizing actions of muscimol in non-
GABAergic neurons (black triangles). See also Table 6. 
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In contrast, the subpopulation of L-GABAergic neurons showed a fast and early 
onset of decrease in responses to muscimol application already after 9DIV. At 15DIV only 
fewest L-GABAergic neurons showed a calcium influx upon muscimol stimulation. As 
with S-GABAergic neurons there was no difference between T3
−
 and T3
+
 cultured 
neurons. However it is noteworthy that due to the low overall density in neuronal cultures 
and the high magnification of recording fields during imaging the number L-GABAergic 
neurons recorded in the randomly chosen fields was low (in total 125 neurons over all 
cultures and ages). Since many fields contained only one or two L-GABAergic neurons 
statistical analysis on this data was not possible. 
 
Table 6: GABA shift experiments 
           
 Non-GABA (% active)  S-GABA (% active)  L-GABA (%) 
 T3− T3+ P  T3− T3+ P  T3− T3+ 
DIV           
           
9 92.9 ± 3.2 89.8 ± 4.0 0.427  98.7 ± 0.9 100 ± 0 0.266  88.9 71.4 
12 79.5 ± 4.7 84.1 ± 4.0 0.461  97.8 ± 1.2 100 ± 0 0.356  21.4 17.4 
15 56.1 ± 7.1 27.0 ± 5.8 0.004  91.5 ± 4.9 99.4 ± 0.6 0.225  6.7 0 
18 37.2 ± 4.8 14.6 ± 4.3 0.002  98.7 ± 0.9 99.3 ± 0.5 0.950  0 0 
21 13.5 ± 4.1 16.3 ± 3.9 0.740  92.4 ± 3.7 99.1 ± 0.7 0.439  0 0 
27 16.4 ± 4.2 10.9 ± 2.7 0.282  99.2 ± 0.8 100 ± 0 0.728  n.c. n.c. 
           
Data show the fraction of muscimol responding cells in percentage of the total number of cells. N 
= 10-15 fields per time point, 3 cultures from 3 preparations; P refers to the comparison between 
T3-treated and T3-untreated neurons with t-test or MW-RST; because of the low cell density no 
statistics were made for L-GABAergic neurons, n.c., not calculated, because of very low cell 
density. All data represent mean ± SEM. 
 
Most non-GABAergic neurons were responding to muscimol application at 12DIV 
without a difference between T3-treated and untreated cultures. After that a remarkable 
drop in the fraction of responding cells was measured in T3-treated cultures. In contrast, 
the developmental downregulation was slowed in T3-untreated cultures. Interestingly, the 
difference between the both treatment groups disappeared at. At 27DIV still a small 
fraction of non-GABAergic cells was responding to muscimol application. 
The results show that the developmental switch of GABAergic signalling 
proceeded in both treatment groups but was accelerated in the presence of T3. This 
indicates that the developmental transition in GABAergic signalling in neuronal cultures 
might be largely driven by the downregulation of NKCC1 protein, since the transition also 
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takes place in T3-deprived cultures with a low basal level of KCC2 expression. Otherwise, 
the remarkable decrease in muscimol responding cells around 15DIV in T3
+
 cultures is 
timely well correlated to the increase in KCC2 protein expression (cf. Fig. 19 C) 
confirming a prominent modulatory role for KCC2 in the GABA shift. Interestingly a 
small population of non-GABAergic neurons and the whole population of S-GABAergic 
were still responding to muscimol application at the end of the fourth week in vitro. 
 
4.4.3 Contribution of GABA signalling to network activity 
During early postnatal development synchronous network activity is driven by 
synergistic actions of GABAergic and glutamatergic neurotransmission, resulting in strong 
stereotyped synchronous depolarizations (Voigt et al., 2001; Opitz et al., 2002; Ben-Ari et 
al., 2007). After GABA signalling switched from depolarizing to hyperpolarizing, neuronal 
activity becomes regulated by a precisely balanced interaction of depolarizing 
glutamatergic and hyperpolarizing GABAergic signalling (Baltz et al., 2010). Following 
the differences in KCC2 expression between T3
−
 and T3
+
 cultures the contribution of 
hyperpolarizing GABAergic signalling to network activity might also be affected by 
thyroid hormones. To analyse the impact of hyperpolarizing GABAergic transmission on 
network activity, cultures raised in the absence or presence of T3 were treated during the 
third week in vitro, the time when GABA is mainly hyperpolarizing, with GABAA receptor 
antagonists BMI and PTX. Spontaneous network activity was measured with calcium 
imaging technique at 21DIV in the presence of receptor antagonists (Fig. 21 A, Table 7).  
T3-treated control cultures showed an increase in burst frequencies compared to 
T3-untreated control cultures (Fig. 21 B, Table 7) as reported previously for 14-day-old 
cultures (chapter 4.1.1; Fig. 1). Receptor blockade with BMI and PTX reduced the burst 
frequency in both T3-untreated as well as T3-treated cultures. However, burst frequency 
was still increased in T3
+
 cultures compared to T3
−
 cultures when GABAA receptors were 
blocked. In addition to burst frequencies also the duration of calcium transients was 
measured since GABA has been shown to play a modulatory role in burst kinetics (Baltz et 
al., 2010). The mean burst duration in T3
−
 cultures was not altered by GABAA receptor 
blockade with BMI and PTX (Fig. 21 C, Table 7). Interestingly, receptor blockade 
significantly increased the duration of calcium transients in T3
+
.  
In addition to blockade of GABAergic neurotransmission we used the recently developed 
specific KCC2 inhibitor VU0240551 (Delpire et al., 2009) to increase the intracellular 
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chloride concentration and to reduce the hyperpolarizing potential of GABAA receptor 
signalling. Corresponding to receptor blockade experiments VU0240551 was added to the 
culture medium during the third week in vitro and was also present during fluorescence 
recording sessions (n = 15 fields, 3 cultures). The inhibition of KCC2 increased the burst 
frequency in T3
−
 cultures (Fig. 21 B, Table 7). The mean frequency of spontaneous 
network events was also increased in T3
+
 cultures, but the difference was not significant 
because of high variability between different cultures. In contrast to burst frequency the 
inhibition of KCC2 had no effect on the burst duration (Fig. 21 C, Table 7) in both T3
−
 and 
in T3
+
 cultures.  
 
Figure 21: Contribution of inhibitory GABA signalling to network activity. 
A. Traces show the change in intracellular calcium signal of individual neurons in 21-day-old 
cultures. Fluorescence data are expressed as dF/F (background-corrected fluorescence divided by 
resting fluorescence). Neurons were grown either in the absence or presence of T3 and treated 
with GABA receptor antagonists BMI + PTX or KCC2 inhibitor VU0240551 from 14-21DIV. Calcium 
imaging was performed in the presence of the drugs. B. Burst frequencies in both T3-treated and 
T3-untreated cultures were reduced by BMI + PTX but enhanced by VU0240551 C. BMI + PTX 
treatment prolonged calcium transients selectively in T3-treated cultures, whereas VU0240551 
did not affect burst duration. Asterisks show significant differences as indicated by lines. Grey 
asterisks indicate statistical differences between T3+ and T3− cultures of the same drug category. 
See also Table 7. 
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Table 7: Contribution of GABA signalling to network activity 
       
 T3−   T3+   
  P control   P control P T3 
       
frequency 
(bursts / min) 
      
control 3.33 ± 0.41   9.37 ± 0.39  < 0.001 
BMI/PTX 1.87 ± 0.12 0.004  5.07 ± 0.36 < 0.001 < 0.001 
VU 5.53 ± 0.67 0.011  15.47 ± 2.39 0.125 0.014 
       
duration 
(seconds) 
      
control 10.34 ± 0.72   4.76 ± 0.18  < 0.001 
BMI/PTX 9.07 ± 0.72 0.319  6.53 ± 0.23 < 0.001 < 0.001 
VU 8.26 ± 0.26 0.064  4.36 ± 0.46 0.409 < 0.001 
       
N = 15 fields from 3 cultures, 2 preparations; P control refers to the comparison between blocked 
and control cultures with t-test or MW-RST; P T3 refers to the comparison between T3-treated and 
T3-untreated neurons with t-test or MW-RST; All data represent mean ± SEM. 
 
The experiments confirm that GABAergic signalling has a direct influence on the 
frequency and duration of network wide spontaneous calcium transients. Similar 
observations have been made with multi electrode recordings from cultured cortical 
neurons where acute and chronic blockade of GABAergic signalling reduced burst 
frequency and prolonged burst duration (Baltz et al., 2010). Furthermore these experiments 
showed that the burst duration, which is reduced in T3-treated cultures, was only 
prolonged by GABAA receptor blockade in T3-treated but not in T3-deprived cultures. 
This suggests that GABAergic signalling has a larger impact on network activity in T3-
treated than in T3-untreated networks, which might result, at least partly, from the 
enhanced expression of KCC2 in T3
+
 cultures. In contrast to the complete blockade of 
GABAA signalling, reducing the hyperpolarizing drive of GABA signalling by inhibition 
of KCC2 increased burst frequency, but had no influence on burst duration as recently 
reported for spontaneous activity in spinal cord networks (Stil et al., 2011). In addition the 
results suggest that the number or properties of glutamatergic synapses were probably also 
affected by thyroid hormone application since the burst frequency and duration were 
different between T3
−
 and T3
+
 cultures in the presence of GABAA receptor antagonists.  
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4.5 Network changes after early T3 deficiency 
A critical period for thyroid hormone signalling has been proposed since lack of T3 
during the first two postnatal weeks causes severe and irreversible mental retardation and 
locomotor deficiencies following cortical, hippocampal and cerebellar malformation 
(Oppenheimer and Schwartz, 1997; Koibuchi and Chin, 2000; Bernal et al., 2003; Venero 
et al., 2005). However, defects can be rescued by early postnatal administration of high 
doses of thyroid hormones (Legrand, 1984; Venero et al., 2005; Gilbert et al., 2007). 
The previous results show that T3 modulated the development of cortical 
GABAergic neurons, increased synapse and bouton densities, and enhanced burst 
frequency during the second week in vitro. As the processes of synaptogenesis (Muramoto 
et al., 1993; Papa et al., 1995; de Lima et al., 1997), axonal growth (Voigt et al., 2005) and 
burst frequency development (Baltz et al., 2010) proceed during the third week in vitro, the 
next question was whether deficits in neuronal development induced by T3 deprivation 
during the first two weeks may normalize during the third week in vitro or can be rescued 
by later T3 application. 
To address this question four experimental groups were set: a) chronically deprived 
cultures (T3
−
), b) chronically T3-supplemented cultures (T3
+
), c) cultures supplemented 
with T3 only during the third week in vitro (T3
−/+
), d) and cultures supplemented with T3 
only during the first two weeks (T3
+/−
). The neuronal populations and GABAergic 
morphological development was examined in cultures of the different sets after GABA 
immunocytochemistry. Additionally, the patterns of spontaneous network activity were 
examined with calcium imaging. 
 
4.5.1 Development of neuronal populations 
The development of GABAergic and non-GABAergic neurons was estimated with 
a focus on the two subpopulations of GABAergic interneurons, L-GABAergic and S-
GABAergic neurons. First, the development of neuronal densities was analysed between 
14 and 21DIV (Fig. 22, Table 8; n = 60 fields, 6 cultures, 2 preparations). As previously 
shown, T3 affects the density of GABAergic and non-GABAergic neurons at 14DIV in a 
population specific manner (cf. Fig. 4), including a reduction of non-GABAergic neuron 
number after T3-stimulation.  
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Table 8: Development of neuronal populations 
       
 cells/mm² P − P ANOVA   P 14DIV 
       
L-GABA       
14 DIV       
T3− 7.32 ± 0.52      
T3+ 6.15 ± 0.56 0.076     
21DIV       
T3− 4.59 ± 0.43  |   < 0.001 
T3−/+ 4.37 ± 0.37  |   < 0.001 
T3+/− 3.81 ± 0.31  0.196   0.002 
T3+ 3.55 ± 0.38  |   < 0.001 
       
Non-GABA       
14DIV       
T3− 666.96 ± 35.25      
T3+ 464.41 ± 26.52 < 0.001     
21DIV       
T3− 410.01 ± 18.22  |   < 0.001 
T3−/+ 370.37 ± 16.12  |   < 0.001 
T3+/− 369.50 ± 18.61  0.305   0.011 
T3+ 384.84 ± 15.46  |   0.103 
       
       
  P − P −/+ P +/−  P 14DIV 
       
S-GABA cells/mm²      
14DIV       
T3− 53.90 ± 2.61      
T3+ 62.44 ± 4.75 0.294     
21DIV       
T3− 52.13 ± 2.70     0.741 
T3−/+ 57.76 ± 3.16 0.178    0.384 
T3+/− 86.18 ± 4.38 < 0.001 < 0.001   < 0.001 
T3+ 89.00 ± 5.07 < 0.001 < 0.001 0.675  < 0.001 
       
% GABA % of total      
14DIV       
T3− 16.79 ± 0.83      
T3+ 21.27 ± 1.48 0.028     
21DIV       
T3− 18.80 ± 1.03     0.277 
T3−/+ 21.67 ± 1.28 0.107    0.002 
T3+/− 30.11 ± 1.71 < 0.001 < 0.001   < 0.001 
T3+ 28.29 ± 1.71 < 0.001 0.003 0.435  0.002 
       
P −, p-value of T3 treated groups vs. T3 untreated controls; P −/+, p-value of T3 treated groups vs. 
the P −/+ group; P +/−, p-value of T3 treated group vs. the P +/− group; P 14DIV, p-value of 21DIV 
cultures vs. 14DIV cultures (T3− and T3−/+ vs. T3− at 14DIV; T3+ and T3+/− vs. T3+ at 14DIV); Statistics 
were made with t-test or MW-RST. P ANOVA, p-value of 21DIV cultures tested with ANOVA. N = 60 
fields each, 6 cultures, 2 preparations. All data represent mean ± SEM.  
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Indeed, a decrease in non-GABAergic neuron density was observed at 14DIV when 
cultures were treated with T3 (Fig. 22 B; Table 8). Measurement of neuron density at 
21DIV indicated that the neuron number later became similar between T3
−
 and T3
+
 due to 
a delayed decrease in neuronal density in T3
−
 cultures. The overall reduction in non-
GABA density may follow activity-dependent intrinsic cell death programs and is in line 
with a generally accelerated maturation by T3. Also the L-GABA density was independent 
from T3 treatment at 21DIV, and already at 14DIV (Fig. 22 A; Table 8).  
S-GABAergic interneurons develop later and still proliferate in embryonic cultures 
usually resulting in a higher density than L-GABAergic neurons. Interestingly there was a 
remarkably difference in S-GABAergic density at 21DIV (Fig. 22 C; Table 8). The density 
of S-GABA cultured in presence of T3 during the first two weeks (T3
+/−
) was .not different 
from chronically T3-treated cultures, but significantly increased to T3-untreated control 
cultures. In contrast T3-stimulation only during the third week in vitro (T3
−/+
) did not 
increase S-GABA density compared with control cultures. Thus in contrast to L-
GABAergic neurons the density of S-GABAergic neurons was dependent on T3. 
Following the increase in S-GABA density also the total fraction of GABAergic neurons 
was increased in cultures treated with T3 at least during the first two weeks in vitro (Fig. 
22 D; Table 8). 
Noteworthy, the density of S-GABAergic neurons was only by trend and not 
significantly increased at 14DIV, in contrast to the initial experiments where already at 
14DIV a mark T3-mediated increase in S-GABA number was measured (cf. Fig. 4). 
Nevertheless, at 21DIV a large difference between T3-treated and untreated cultures was 
established suggesting that the development of S-GABAergic neurons might be somehow 
slowed in this set of experiments. The reason for this is not entirely clear, but one 
explanation might be the addition of glia cells to cultures that grow older than two weeks, 
since glia cells have been suggested to inhibit neuronal development (de Lima and Voigt, 
1999). 
In summary, these results suggest that the final number of S-GABAergic neurons 
was established during the first two weeks in vitro. T3 promoted the integration of S-
GABAergic neurons into the network but only during an early critical period. T3 
stimulation after the second week in vitro was not sufficient to promote S-GABA survival. 
This is in line with previous reports that the survival of small GABAergic neurons depends 
on glutamatergic activity and neurotrophins during a restricted period of early network 
development (de Lima et al., 2004; de Lima et al., 2007).  
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Figure 22: T3-stimulation increases the density of S-GABAergic neurons at 21DIV. 
A-C. Neuronal cell densities in 14- and 21-day-old cultures were regulated by T3 in a 
subpopulation dependent manner. Whereas the densities of L-GABAergic (A) and non-GABAergic 
neurons (B) were not different at 21DIV, S-GABAergic neurons (C) show a prominent increase in 
cell number when cultured in T3-containing medium during the first two weeks in vitro. T3 
treatment after 14DIV does not rescue S-GABAergic neuron density at 21DIV. D. According to the 
change in S-GABAergic neuron density, also the overall fraction of GABAergic neurons is increased 
at 21DIV in cultures treated with T3 during the first two weeks in vitro. Asterisks indicate 
differences between T3-treated and untreated cultures as indicated. Grey asterisks display 
differences between 14- and 21-day-old cultures. See also Table 8. 
 
Interestingly the T3-sensitive period for S-GABA establishment seems to be timely 
correlated with the depolarizing period of GABAergic signalling (cf. Fig. 20). 
Depolarizing GABA signalling has neurotrophic effects potentially by inducing the 
expression and release of BDNF (Owens and Kriegstein, 2002; Ben-Ari et al., 2007). To 
demonstrate that the survival of S-GABA density might depend on the release of 
neurotrophins during spontaneous network activity S-GABA densities were calculated in 
14-day-old cultures treated with the TrkB inhibitor K252a during the second week (Fig. 23 
A: n = 60 fields, 6 cultures, 2 preparations). The S-GABA density was dramatically 
reduced by K252a from 100.87 ± 6.01 cells/mm² in T3
−
 controls and 112.38 ± 6.39 
cells/mm² in T3
+
 controls to 2.38 ± 0.39 cells/mm² in T3
−
 (p < 0.001, MW-RST) and 3.97 
± 0.67 cells/mm² in T3
+
 (p < 0.001, MW-RST). The data confirm that S-GABAergic 
neurons are strongly dependent on neurotrophin support during the second week in vitro.  
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For complementation also the densities of L-GABAergic and non-GABAergic 
neurons were assessed. BDNF signalling blockade by K252a during the second week did 
neither affect the density of L-GABAergic neurons (Fig. 23 B: 4.42 ± 0.38 cells/mm² in 
T3
−
 controls; 4.38 ± 0.35 cells/mm² in T3
+
 controls, p = 0.939, MW-RST compared with 
T3
−
 controls; 5.11 ± 0.49 cells/mm² in T3
−
 + K252a, p = 0.616, MW-RST compared with 
T3
−
 controls; 5.11 ± 0.45 cells/mm² in T3
+
 + K252a, p = 0.353, MW-RST compared with 
T3
+
 controls; p = 0.747, MW-RST compared with T3
−
 + K252a), nor the density of non-
GABAergic neurons (Fig. 23 C: 707.75 ± 46.07 cells/mm² in T3
−
 controls; 521.41 ± 28.54 
cells/mm² in T3
+
 controls, p < 0.001, t-test compared with T3
−
 controls; 763.31 ± 52.65 
cells/mm² T3
−
 + K252a, p = 0.605, MW-RST compared with T3
−
 controls; 552.95 ± 30.95 
cells/mm² in T3
+
 + K252a, p = 0.455, t-test compared with T3
+
 controls; p = 0.004, MW-
RST compared with T3
−
 + K252a). Thus, the results demonstrate that exclusively the 
survival of S-GABAergic neurons was dependent on BDNF signalling during the second 
week in culture, whereas the numbers of L-GABAergic and non-GABAergic neurons were 
not sensitive to BDNF deprivation. 
 
 
Figure 23: Survival of S-GABAergic neurons is dependent on BDNF signalling. 
A-C. Treatment with K252a during the second week in vitro dramatically reduced the density of S-
GABAergic neurons at 14DIV (A), but not of L-GABAergic (B) and non-GABAergic (C) neurons. 
Asterisks show significant differences as indicated. Asterisks indicate differences between T3-
treated and untreated cultures as indicated. Grey asterisks display differences between K252a 
treated and control cultures. 
 
4.5.2 Development of neuronal soma sizes 
In addition to neuronal densities we measured the development of neuronal soma 
sizes between 14 and 21DIV as a general indicator of neuronal growth (Fig. 24, Table 9; n 
= 120 neurons, 6 cultures from 2 preparations). As already shown (see Figs. 4, 14, 15) L-
GABAergic neurons showed a prominent T3-mediated enlargement of soma sizes at 
14DIV (Fig. 24 B). However, in 21-day-old cultures the difference in soma sizes of L-
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GABA vanished (Fig. 24 A, B) due to a progressive prominent growth between 14 and 
21DIV. Also S-GABAergic (Fig. 24 C) and non-GABAergic (Fig. 24 D) neurons showed a 
prominent growth between 14 and 21 days in vitro, but no difference in soma sizes 
between the experimental groups was observed at 21DIV (Table 9). 
These experiments indicate that T3 accelerates the somatic growth of L-
GABAergic neurons and to a lesser extent that of S-GABAergic neurons, but cell sizes in 
all experimental groups reaches the same final size at 21DIV.  
 
 
 
Figure 24: T3-treatment did not affect neuronal soma size at 21DIV. 
A. Images show GABA immunostained 21-day-old cultures grown in the absence (top) or presence 
(bottom) of T3. Both images show a central L-GABAergic neuron surrounded by smaller S-
GABAergic neurons and unstained non-GABAergic neurons. Scale bar = 50 μm.  B-D. Soma sizes of 
neuronal subpopulations increase with culture time. All subpopulations show a significant soma 
enlargement between 14 and 21DIV. However, there were no differences between T3-treated 
and untreated cultures at 21DIV. Asterisks show significant differences as indicated. Grey asterisks 
display differences between 14- and 21-day-old cultures of the same hormone category. See also 
Table 9. 
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Table 9: Development of neuronal soma sizes 
     
 soma size (µm²) P*  P 14DIV 
     
L-GABA     
14 DIV     
T3− 303.64 ± 5.10    
T3+ 358.87 ± 6.27 < 0.001   
21DIV     
T3− 485.11 ± 9.99 |  < 0.001 
T3−/+ 471.36 ± 11.28 |  < 0.001 
T3+/− 472.62 ± 9.94 0.401  < 0.001 
T3+ 462.98 ± 10.14 |  < 0.001 
     
S-GABA     
14DIV     
T3− 35.31 ± 0.46    
T3+ 37.28 ± 0.54 0.006   
21DIV     
T3− 51.99 ± 0.73 |  < 0.001 
T3−/+ 50.84 ± 0.79 |  < 0.001 
T3+/− 52.34 ± 0.63 0.201  < 0.001 
T3+ 51.14 ± 0.88 |  < 0.001 
     
Non-GABA     
14DIV     
T3− 117.80 ± 3.83    
T3+ 116.56 ± 3.65 0.797   
21DIV     
T3− 153.84 ± 4.15 |  < 0.001 
T3−/+ 164.17 ± 4.90 |  < 0.001 
T3+/− 163.51 ± 5.26 0.230  < 0.001 
T3+ 164.28 ± 4.78 |  < 0.001 
     
P*, p-value of T3 treated groups vs. T3 untreated controls tested with t-test or MW-RST at 14DIV 
and ANOVA at 21DIV; P 14DIV, p-value of 21DIV cultures vs. 14DIV cultures (T3− and T3−/+ vs. T3− at 
14DIV; T3+ and T3+/− vs. T3+ at 14DIV). N = 120 neurons each, 6 cultures, 2 preparations. All data 
represent mean ± SEM.  
 
4.5.3 Development of L-GABAergic axons and boutons 
Next we asked whether the initially described T3-mediated changes in axonal 
development might be also transient effects. We first calculated the mean density of 
GABAergic boutons in 21-day-old cultures. Because of the highly increased density of the 
GABAergic neuropil at 21DIV it was not possible to reliably estimate the length and 
branch numbers of GABAergic axons. At 14DIV (Fig. 25 A) the mean number of boutons 
was increased in T3-treated cultures (47.05 ± 2.55 boutons/field in T3
−
; 63.80 ± 4.79 
boutons/field in T3
+
; n = 60 fields, p = 0.009, MW-RST). Like the soma size also the 
overall number of GABAergic boutons formed by L-GABAergic neurons did not differ 
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between T3-treated and T3-untreated cultures at 21DIV (Fig. 25 B: 90.86 ± 6.37 
boutons/field in T3
−
; 83.63 ± 7.42 boutons/field in T3
−/+
; 75.55 ± 8.22 boutons/field in 
T3
+/−
; 76.48 ± 10.06 boutons/field in T3
+
; n = 40 fields; p = 0.512, ANOVA). 
In 14-day-old cultures GABAergic axons showed a characteristic concentration in 
cell rich areas in the presence of T3 (cf. Figs. 15, 16). Correlating the number of 
GABAergic boutons to the local cell density at 21DIV (Fig. 25 C) suggested that this 
characteristic distribution was gradually also established in older T3-deprived cultures 
(T3
−
; p < 0.001; r
2
 = 0.308; T3
−/+
; p < 0.001; r
2
 = 0.374; T3
+/−
; p < 0.001; r
2
 = 0.548; T3
+
; 
p < 0.001; r
2
 = 0.574). However, there were still differences in the correlation indexes and 
in the slopes of the regression lines between the different experimental groups.  
According to the mean cell number (Fig. 25 D; 3.40 ± 0.40 cells/field in T3
−
; 3.55 ± 
0.38 cells/field in T3
−/+
; 3.93 ± 0.46 cells/field in T3
+/−
; 3.65 ± 0.43 cells/field in T3
+
; n = 
40 fields each) the data were again grouped into fields with low (≤ 3 cells/field) and high 
cell density (> 3 cells/field). The results confirm that independent of hormonal treatment 
axons were concentrated in regions with more than 3 cells/field (Fig. 25 E; in 
boutons/field, brackets indicate number of fields: 69.88 ± 8.99 (17) in T3
−
 low-cell-density 
and 106.39 ± 7.49 (23) in T3
−
 high-cell-density, p = 0.003, t-test; 57.63 ± 7.31 (19) in T3
−/+
 
low-cell-density and 107.14 ± 10.13 (21) in T3
−/+
 high-cell-density, p < 0.001, t-test; 48.64 
± 8.79 (22) in T3
+/−
 low-cell-density and 108.44 ± 10.60 (18) in T3
+/−
 high-cell-density, p 
< 0.001, t-test; 37.73 ± 10.12 (22) in T3
+
 low-cell-density and 123.83 ± 11.04 (18) in T3
+
 
high-cell-density, p < 0.001, t-test). 
However, the increase in bouton number in fields with high cell density compared 
with that in fields with low cell density revealed that T3 stimulation during at least the first 
two weeks in vitro had long-lasting effects on axonal distribution (Fig. 25 F). The increase 
in chronically deprived cultures was 152.24 ± 10.72% (n = 23 fields) and was not further 
promoted if T3-stimulation was applied only during the third week of culturing (185.91 ± 
17.57%, n = 21 fields, p = 0.103, t-test compared with T3
−
). T3 presence during the first 
two weeks (222.97 ± 21.80%, n = 18 fields, p = 0.003, t-test compared with T3
−
) as well as 
chronic T3 treatment (328.23 ± 29.26%, n = 18 fields, p < 0.001, MW-RST compared with 
T3
−
) significantly increased the difference between fields with high and low cell density. 
The increase in chronically treated cultures was significantly larger than in cultures from 
reversal experiments (p = 0.007, t-test compared with T3
+/−
; p < 0.001, t-test compared 
with T3
−/+
) indicating that continuous T3 presence was essential for the optimal axonal 
adjustment. 
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Figure 25: Development of L-GABA axons and boutons at 21DIV. 
A. T3 enhances the overall density of GABAergic boutons in 14-day-old cultures. B. In 21-day-old 
cultures the overall number of GABAergic boutons is not different between culture conditions. C. 
In all experimental groups the number of GABAergic boutons was dependent on the local density 
of non-GABAergic neurons, but the slope of the regression line was highest in chronically T3-
treated cultures. D. According to the mean neuron number at 21DIV data were grouped into fields 
with low (≤ 3 cells/field) and high (> 3 cells/field) cell densities. E. In all culture conditions the 
number of GABAergic boutons was significant higher in fields with high cell density compared 
with fields with low cell density. F. The normalized difference in bouton numbers (boutons in 
fields with high cell density in percent of boutons in fields with low cell density of the same 
experimental group) was significantly increased compared with T3-untreated cultures when 
neurons were treated with T3 during the first two weeks in vitro. Asterisks show significant 
differences as indicated. Grey asterisks display statistical difference compared to T3− (E). 
 
These results demonstrate that the general growth of L-GABAergic neurons, 
reflected by the soma size and the overall number of GABAergic boutons, is transiently 
promoted by T3. A concentration of GABAergic boutons around cell bodies of non-
GABAergic neurons could be observed in all cultures, but this concentration was more 
pronounced in cultures that received T3 during the first two weeks of development. Thus, 
the maturation of L-GABAergic axonal arborizations is most sensitive to T3 during initial 
phases of network formation. However, optimal axonal growth is dependent on continuous 
T3 presence. 
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4.5.4 Spontaneous network activity 
Finally we estimated the functional development of neuronal networks 
supplemented with T3 during different time windows using the calcium imaging technique 
(Fig. 26: n = 20 fields, 4 cultures from 2 preparations). In general all 14 to 21-day-old 
cultures showed prominent synchronous network events (Fig. 26 A - C).  
 
 
Figure 26: Network activity at 21DIV and reversibility. 
A. Traces show the change in intracellular calcium signal of individual neurons from 14- or 21-day-
old cultures grown either in the absence or presence of T3 as indicated. Fluorescence data are 
expressed as dF/F (background-corrected fluorescence divided by resting fluorescence). B. 
Analysis of calcium transients. Top panel: raw fluorescence data from ten individual cells and 
three background regions. Middle panel: fluorescence data were background corrected and 
normalized (dF/F) according to the minimal fluorescence level during the sequence. Bottom 
panel: mean dF/F averaged from the ten individual cells presented above. The mean dF/F trace of 
each recorded field was used to calculate burst duration. C. T3 increases the burst frequency at 
14DIV. D. The maximal burst frequency at 21DIV was measured in cultures chronically treated 
with T3. E. Burst duration at 21DIV was reduced in reversal experiments compared with T3-
untreated cultures and minimal burst duration was observed in T3-treated cultures (n = 20 fields). 
F. Cumulative representation of burst durations including all single transients analyzed in mean 
dF/F data (n = 451 bursts in T3−: 622 bursts in T3−/+; 588 bursts in T3+/−; 925 bursts in T3+). 
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However, chronic supplementation of neuronal cultures with T3 clearly enhanced 
the burst frequencies at 14DIV (Fig. 26 A, B; T3
−
: 5.67 ± 0.31 bursts/min, T3
+
: 8.70 ± 0.45 
burst/min, p < 0.001, t-test) as well as at 21DIV (Fig. 26 A, C; T3
−
: 7.56 ± 0.77 bursts/min, 
T3
+
: 13.30 ± 0.45 bursts/min, p < 0.001, MW-RST) compared to T3-deprived cultures. 
Furthermore, T3 treatment only during the third week in vitro did not enhance burst 
frequencies compared with untreated control cultures (T3
−/+
: 8.41 ± 0.53 bursts/min; p = 
0.273, MW-RST compared with T3
−
 at 21DIV). Additionally, depletion of the hormone 
from the culture medium at 14DIV normalized burst frequencies compared with untreated 
cultures (T3
+/−
: 8.31 ± 0.43 bursts/min, p = 0.589, MW-RST compared with T3
−
 at 
21DIV). Thus the high burst frequency of chronically T3-treated cultures (T3
+
) could not 
be achieved by T3 supplementation neither during only the first two weeks in vitro (T3
+/−
: 
p < 0.001, t-test compared to T3
+
 with 21DIV) nor during only the third week of culturing 
(T3
−/+
: p < 0.001, t-test compared with T3
+
 at 21DIV). 
The duration of calcium transients in 21-day-old cultures was estimated as a general 
indicator of burst kinetics (Fig. 26 D, E; n = 20 fields, 4 cultures from 2 preparations). The 
mean length of calcium transients in T3-deprived cultures was 7.95 ± 0.45 sec (Fig. 26 D). 
The duration was significantly decreased already by transient T3 presence during the first 
two weeks (T3
+/−
: 5.91 ± 0.16 sec; p = 0.003, MW-RST compared with T3
−
) or during the 
third week of development (T3
−/+
: 6.26 ± 0.17; p = 0.013, MW-RST compared with T3
−
). 
Chronic T3-treatment during the entire cultivation period reduced the burst duration to 
3.97 ± 0.09 sec (p < 0.001, MW-RST compared with T3
−
; p < 0.001, t-test compared with 
T3
+/−
; p < 0.001, t-test compared to T3
−/+
). These results indicate that a constant supply of 
T3 is correlated with an increased burst frequency and a decrease of bursting duration. 
However, the addition of the hormone after the initial period of development (i.e., only 
during the third week in vitro [T3
−/+
]) is not sufficient to rescue the network from deficits 
associated with the absence of T3.  
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5. Discussion 
5.1 Hormonal modulation of network activity and synaptic maturation 
5.1.1 Network activity 
Converging evidence suggests that during early neocortical development 
synchronous network activity emerge when neurons become interconnected. Synchronous 
events with very low frequency develop to reach maximal cellular participation, which 
includes nearly all neurons (Garaschuk et al., 2000; Opitz et al., 2002; Corlew et al., 2004). 
As development proceeds, synchronous events with lower cellular participation and higher 
burst frequency become interposed to events with higher participation, and eventually 
these slow highly synchronous events disappear (Corlew et al., 2004; Allene et al., 2008; 
Baltz et al., 2010). 
Two-weeks-old cultures treated chronically with triiodothyronine (T3) showed 
increased frequency of spontaneous bursts of activity and decreased neuronal participation 
per event, when compared with T3-deprived cultures (Fig. 1). These results strongly 
suggest that networks treated with T3 show more mature properties than untreated 
networks, and that T3 actions contribute to the generation of synchronous events with 
higher frequency and lower neuronal participation. Additionally, at the end of the third 
week in vitro (Fig. 26) chronically T3-treated cultures showed higher burst frequencies but 
shorter burst durations than untreated cultures. 
Synchronous network activity is found transiently in a wide range of brain 
structures and plays an important role in the establishment of neuronal connections 
(Garaschuk et al., 2000; Voigt et al., 2005; Allene et al., 2008). It is suggested that early 
spontaneous activity patterns guide the initial wiring of cortical structures and disappears 
upon maturation of sensory systems, when experience-dependent mechanisms further 
refine network connectivity (Katz and Shatz, 1996; Hensch, 2004). Considering the 
importance of activity-dependent processes in neuronal maturation, early network activity 
may be an attractive candidate to mediate several indirect effects of T3. Enhanced 
maturation of network activity may induce additional development of the GABAergic 
neurons and other activity-dependent processes regarding survival and maturation of 
neuronal connectivity. For example, by regulating network activity through local increases 
in synaptogenesis and neuronal growth, T3 may indirectly modulate the formation of long 
range axonal connections (Voigt et al., 2005). Indeed, T3 has been shown to influence the 
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establishment of cortical and hippocampal projections potentially by means of activity-
dependent mechanisms (Schwegler et al., 1991; Li et al., 1995; Lucio et al., 1997). On the 
other side, it could not be excluded that a premature increase in spontaneous activity due to 
an early excess of T3 might convey negative effects like an abnormal stabilization of 
developing synapses, prevention of normal refinement and specific synaptic elimination, 
leading to altered circuitry. 
 
5.1.2 Synaptic maturation 
The present results show additionally that T3-mediated increase in synchronous 
activity is paralleled by increases in co-expression of synaptic proteins in pre- and 
postsynaptic compartments (Fig. 2). The increase in density of glutamatergic and 
GABAergic synapses following T3 treatment concurs with the idea of network activity 
maturation.  
Thyroid hormones have already been shown to enhances the expression of several 
presynaptic proteins involved in neurotransmitter release, e.g. Synapsin (Hosoda et al., 
2003), SNAP-25 (Zhang et al., 2008), Synaptophysin (Gong et al., 2010) and 
Synaptotagmin-1 (Wang et al., 2011). Accordingly, Hosoda et al. (2003) showed that 
exposure to triiodothyronine or thyroxine caused an increase in the frequency of 
spontaneous synchronous oscillatory changes in intracellular calcium concentration, which 
correlated with the number of synapses formed. Consequently, deficits in thyroid hormone 
signalling have been related to impaired long term potentiation (Sui and Gilbert, 2003; 
Gerges and Alkadhi, 2004; Dong et al., 2005), which potentially might arise from deficits 
in synaptic proteins. 
 
5.1.3 Axonal arrangement and pruning 
The present experiments further show that the number of GABAergic boutons 
formed by large GABAergic neurons is increased in 14-day-old cultures, suggesting an 
increase in GABAergic synapses and GABA release (Figs. 13, 14). But not only the 
number of GABAergic boutons is enhanced in T3-stimulated cultures, GABAergic axons 
also form conspicuous nests of axonal protrusions around groups of non-GABAergic cells 
(Figs. 13, 15, 16). These characteristic nests arise from the enhanced formation of 
GABAergic boutons in the vicinity of non-GABAergic neurons but apparently also from 
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the pruning of GABAergic axons from cell free regions (Fig. 15, 16). The results suggest 
that T3 is involved in both the formation of new contacts and the pruning of other ones. 
The reorganization of synaptic contacts and pruning of axonal projections is an 
important process in the establishment and refinement of neuronal networks. Following the 
initial formation of synaptic connections, many developing circuits undergo a period of 
regression and refinement, through which some connections are eliminated while others 
are strengthened (Purves and Lichtman, 1980; Lohof et al., 1996; Zhang and Poo, 2001). It 
is typical for the initial wiring of neuronal networks that an exuberant number of 
connections are formed, which are then refined by a selective, often activity-dependent 
pruning of overwhelming connections (Innocenti and Price, 2005). Interestingly, thyroid 
hormones have been suggested to play a role in the refinement of exuberant axons 
(Innocenti and Price, 2005). T3 has been shown to regulate the disappearance of transient 
callosal projections (Li et al., 1995; Lucio et al., 1997). In animals made hypothyroid 
during early development, callosal projection which are normally transient, could also be 
found in adult animals. These T3-mediated processes might be activity-dependent, since 
the refinement of callosal projection is also regulated by neuronal activity (Wang et al., 
2007). 
 
5.2 Hormonal modulation of GABAergic neurons development 
The analysis of neuron development was done on three neuronal subpopulations, 
the L-GABAergic neurons, S-GABAergic neurons and non-GABAergic neurons, which 
can be easily identified in neuronal cell cultures. Special attention was given to the 
subpopulations of GABAergic neurons, which develop in close interrelationship with the 
network activity. The results suggest population specific changes in soma sizes and cell 
density at 14DIV following thyroid hormone treatment (Fig. 4).  
 
5.2.1 Large GABAergic interneurons 
Irrespective of growing conditions, L-GABA neurons have a large cell body, 
stellate dendritic tree and thick axons forming long range connections. In mature cultures, 
L-GABAergic neurons show morphological and physiological properties similar to cortical 
parvalbumin neurons in situ (Voigt et al., 2001; de Lima et al., 2004; Klueva et al., 2008; 
see chapter 2.2.5).  
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The present results demonstrate that the morphological maturation of large 
GABAergic interneurons is highly sensitive to T3 during early postnatal development. T3 
stimulation accelerates the formation of GABAergic boutons and has profound long-lasting 
effects on the distribution of axonal arborisations among non-GABAergic neurons. In the 
presence of T3 L-GABA axons sprout around cell bodies and are pruned in cell free areas 
(Figs. 15, 16) resulting in conspicuous nests of axonal protrusions around groups of non-
GABAergic cells (Figs. 13, 15, 16). Also the soma size of L-GABAergic neurons was 
transiently increased in hormone-treated cultures (Figs. 4, 15, 24), suggesting that T3 
accelerates the maturation of this interneuron type. But the acceleration of soma size 
development and bouton formation observed in hormone-treated cultures is presumably not 
caused by an enhanced overall cell growth, because number and length of dendrites are not 
changed (Fig. 12). 
Accumulating evidence already suggests that parvalbumin expressing interneurons 
in vivo are modulated by thyroid hormone signalling (Berbel et al., 1996; Gilbert et al., 
2007; Wallis et al., 2008). Disrupting thyroid hormone signalling by rendering rats 
hypothyroid or using mice expressing a dominant-negative point mutation in the TRalpha1 
gene reduces the number of parvalbumin-immunoreactive neurons as well as the density of 
parvalbumin-positive terminals and processes in hippocampus and neocortex (Berbel et al., 
1996; Gilbert et al., 2007; Wallis et al., 2008). Since parvalbumin neurons have been 
identified to express thyroid hormone receptors (Guadaño-Ferraz et al., 2003), it is likely 
that these neurons are a direct target of T3. The present results extend available evidence 
by showing that already during early cortical network development, when parvalbumin is 
not present yet, a deficit of thyroid hormone slows the development of this subpopulation 
of GABAergic neurons. 
 
5.2.2 Small GABAergic interneurons 
S-GABAergic neurons are a second and numerically larger subpopulation of 
GABAergic neurons. These neurons are born later, have smaller fusiform to bipolar or 
multipolar cell bodies and very thin axons (de Lima and Voigt, 1997; de Lima et al., 2004). 
They typically express the calcium binding protein calretinin and might therefore be 
correlates of calretinin/VIP interneurons of the upper cortical layers in situ (Gonchar and 
Burkhalter, 1997). 
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In contrast to large GABAergic neurons, the small GABAergic cells showed only 
minor changes in soma size following T3 treatment (Fig. 4), but a large increase in S-
GABA density could be measured already in 14-days-old cultures (Fig. 4). This difference 
did not normalize in older cultures and could not be rescued by later T3 application (Fig. 
22), suggesting that S-GABAergic neurons are irreversibly established until the end of the 
second week in vitro. As these neurons are a numerically large group, also the relative 
proportion of all GABAergic neurons was increased in T3-treated cultures (Fig. 4, 22). 
In contrast to parvalbumin neurons, which have already been identified to be 
sensitive to thyroid hormones, little is known about the effects of thyroid hormones on 
other GABAergic neuron populations. This might be due to the fact, that these smaller, late 
born interneurons compose a quite heterogeneous group. In culture these neurons are 
characterized by their small, fusiform cell bodies and their late appearance. Due to their 
late birth, S-GABAergic neurons are generated in vitro from precursors and increase 
numerically until the end of the second week in vitro (de Lima and Voigt, 1997; de Lima et 
al., 2004). Interestingly, it has been shown that these neurons are specifically vulnerable to 
irreversible elimination from the network during a critical time window (DIV12-14) (de 
Lima et al., 2004). During this time they strongly depend on glutamatergic activity 
mediated by NMDA receptors (de Lima et al., 2004) and the presence of neurotrophins 
(Fig. 23). The present results suggest that thyroid hormones promote the establishment of 
S-GABAergic neurons during this special time window, potentially indirect by the increase 
in neuronal activity. 
 
5.2.3 Non-GABAergic neurons 
The present study was focussed in the developmental aspects of GABAergic 
neurons, because GABAergic neurons were recently identified as an important target of 
thyroid hormone actions and because of the intricate interrelationship of GABAergic 
neurons and network activity development during early network formation. Nevertheless, 
the results suggest that also the number of glutamatergic synapses (Fig. 2) and the size of 
non-GABAergic neurons (Fig. 4) is increased by T3 at 14DIV. Additionally, T3 treatment 
enhanced the burst frequency even in the presence of blocked GABAergic 
neurotransmission (Fig. 21), suggesting the modulation of glutamatergic mechanisms. 
Thus, although the present study did not investigated the long-term changes in 
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glutamatergic neurons in detail, also non-GABAergic neuron are likely a target of thyroid 
hormone actions. 
This is in line with reports showing that thyroid hormones regulate the development 
of axonal projections (Li et al., 1995; Lucio et al., 1997), the number of dendritic spines 
(Ruiz-Marcos et al., 1980, 1982; Nimchinsky et al., 2002), the differentiation of dendrites 
(Ipiña et al., 1987; Sala-Roca et al., 2008), NMDA receptor expression (Kobayashi et al., 
2006; Lee et al., 2003) and the excitability of glutamatergic neurons (Potthoff and Dietzel, 
1997; Hoffman and Dietzel, 2004; Niederkinkhaus et al., 2009). Since the differentiation 
and synaptogenesis of glutamatergic cells is also modulated by activity- and neurotrophin-
dependent mechanism (Lessmann et al., 2003; Gottmann et al., 2009), it would be 
interesting, whether T3-mediated modulation of glutamatergic and GABAergic neurons 
follow the same mechanisms. 
 
5.2.4 Relevance of GABAergic neurons modulation 
GABAergic signalling plays important roles both during development and for adult 
brain function. During development immature GABAergic signalling regulates 
neurogenesis (LoTurco et al., 1995; Haydar et al., 2000), cell migration (Behar et al., 2000; 
Lujan et al., 2005) and neuritogenesis (Groc et al., 2002; Ben-Ari et al., 2007). Many 
neurotrophic actions of GABA have been related to the depolarizing actions of immature 
GABAergic signalling (Owens and Kriegstein, 2002; Cancedda et al., 2007; Pfeffer et al., 
2009). Depolarizing GABAergic neurotransmission is required for the initiation and 
propagation of early synchronous network activity. In this process the function of L-
GABAergic neurons is of special interest. The presence and the size of L-GABAergic 
neurons impact the initial development of neocortical networks (Voigt et al., 2001; Baltz et 
al., 2010) especially promoting the early synchronization of spontaneous activity and the 
maturation of glutamatergic synapses (Voigt et al., 2001, 2005). Because L-GABAergic 
cells are key elements in the emergence of early oscillatory network activity, the action of 
thyroid hormone on their growth contributes to the timely appearance of synchronized 
network activity. The increased growth and synaptogenesis of early GABAergic neurons 
lead to the enhanced maturation of network activity, which in turn may induce additional 
development of the GABAergic neurons and other activity-dependent processes like 
survival and trimming of neuronal connectivity (de Lima et al., 2004; Ben-Ari et al., 2007).  
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Moreover, the correct development of the GABAergic system is essential for the 
balance between excitation and inhibition in adult cortical networks (Buzsáki, 2006). 
Consequently, dysfunctions of GABAergic signalling have been associated with several 
pathological conditions that are potentially generated when the balance between excitation 
and inhibition is impaired, such as autism, mental retardation, epilepsies and schizophrenia 
(DeFelipe, 1999; Levitt et al., 2004; Lewis et al., 2005; Wonders and Anderson, 2006, 
Ben-Ari et al., 2007; Woo and Lu, 2006). By modulating the growth and synaptic 
maturation of GABAergic neurons, T3 might modulate critical aspects of neuronal network 
formation and maturation, and in turn T3 deprivation might cause multiple and irreversible 
developmental deviations. Indeed, deficits in the maturation of the GABAergic system 
reported in mice harbouring a mutant thyroid hormone receptor have been directly 
correlated to a reduction on gamma oscillation power and locomotor dysfunctions and 
anxiety (Venero et al., 2005; Wallis et al., 2008).  
 
5.3 T3-mediated expression of KCC2 and GABA switch 
The depolarizing actions of GABA during early postnatal development originate 
from a high intracellular concentration of chloride regulated by the two cation chloride 
cotransporters NKCC1 and KCC2 (Ben-Ari, 2007; Blaesse et al., 2009). The 
developmental downregulation of NKCC1 and concomitant upregulation of KCC2 
represent the onset of mature hyperpolarizing GABAergic signalling by lowering the 
intracellular chloride concentration. Recently, thyroid hormone signalling has been linked 
to the expression and function of NKCC1 and KCC2 in hippocampus and auditory system 
respectively (Friauf et al., 2008; Hadjab-Lallemend et al., 2010). 
To examine the influence of T3 on the GABA shift, the developmental expression 
patterns of NKCC1 and KCC2 protein in T3 treated and untreated cultures were 
determined. Our results reveal that KCC2 is critically dependent on thyroid hormone 
signalling since no developmental upregulation of KCC2 protein could be observed in the 
absence of T3 (Fig. 19). Moreover, the failure of KCC2 upregulation in T3-deprived 
neurons was correlated to a delayed switch from depolarizing to hyperpolarizing 
GABAergic signalling in non-GABAergic neurons (Fig. 21), corroborating the idea of a 
correlation between KCC2 expression and the developmental GABA shift (Rivera et al., 
1999; Zhu et al., 2005; Lee et al., 2005). In contrast to KCC2, the developmental 
downregulation of NKCC1 after the second week in vitro was independent of thyroid 
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hormone presence (Fig. 19). Interestingly, in T3-deprived cultures the developmental 
GABA shift was correlated with the downregulation of NKCC1, suggesting an important 
role of NKCC1 downregulation in the regulation of the GABA shift. The results extend 
recent studies which suggest that thyroid hormone signalling regulates GABAergic 
function in hippocampus and auditory system, respectively (Friauf et al., 2008; Hadjab-
Lallemend et al., 2010). 
Deficit in KCC2 has been correlated to epilepsy and spasticity (Munoz et al., 2007; 
Kahle et al., 2008; Boulenguez et al., 2010) and thus might potentially be related to 
locomotor dysfunctions reported in mice harbouring a mutant thyroid hormone receptor 
(Venero et al., 2005; Wallis et al., 2008). Moreover, plasticity of GABAergic signalling 
can be rapidly induced by the regulation of intracellular chloride through the immediate 
modulation of KCC2 expression and function by neuronal activity, referred to as ‘ionic 
plasticity’ (Wardle and Poo, 2003; Rivera et al., 2004; Blaesse et al., 2009). Following the 
failure of developmental KCC2 upregulation in T3-deprived neurons this form of plasticity 
should be limited in the absence of thyroid hormone. Additionally, KCC2 might also be 
involved in maturation of excitatory synapses since KCC2 located at excitatory synapses 
(Gulyas et al., 2001) has been suggested to regulate dendritic spine formation by a 
transport independent mechanism (Li et al., 2007). 
Interestingly, thyroid hormones have also been suggested to modulate the Na
+
-K
+
-
ATPase (Bajpai et al., 2001; Pacheco-Rosado et al., 2005; Cheng et al., 2010). This is of 
relevance, because NKCC1 and KCC2 do not use adenosine triphosphate (ATP) but 
operate using the electrochemical gradients for Na
+
 and K
+
 produced by the Na
+
-K
+
-
ATPase. Since also the Ca
2+
-ATPase is affected by thyroid hormones (Cheng et al., 2010), 
thyroid hormones are an important regulator of the neurochemical composition and thus 
the intrinsic properties of neurons. 
 
5.4 Mechanisms of thyroid hormone mediated actions 
To analyse the underlying mechanisms of T3 actions in more detail the work was 
focused on the development of L-GABAergic neurons because of two reasons: first, these 
neurons show large changes in soma size in initial experiments (Figs. 4), and thus they 
might be particularly sensitive to thyroid hormone treatment. Secondly, the development of 
L-GABAergic cells is of special interest, because they are key players in the generation 
and propagation of network activity (Voigt et al., 2001). 
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5.4.1 Direct or indirect T3 modulation of GABAergic neurons? 
Although a large number of thyroid hormone regulated proteins has been identified 
(Yen et al., 2006; Takahashi et al., 2008), the question whether changes in protein 
expression are the direct or indirect result of thyroid hormone action remains unanswered. 
Only few genes have already been shown to be under direct control of T3 (Bernal et al., 
2003). The present data suggest that synchronous network activity enhancement parallels 
the increased growth of L-GABAergic neurons by thyroid hormone. On the one hand, it is 
an attractive hypothesis that T3 promotes the maturation and synaptogenesis of L-
GABAergic cells, which then, due to the excitatory action of GABA during early 
development, enhances the network activity. On the other hand, the maturation of 
GABAergic neurons depends on neuronal activity (Patz et al., 2004; Jin et al., 2003; 
Chattopadhyaya et al., 2004; de Lima et al., 2004). So it is also feasible that GABAergic 
maturation is not the cause but rather the consequence of activity enhancement by T3 
stimulation.  
In favor of the first hypothesis the results show that T3 influences L-GABAergic 
neurons growth also in the absence of activity (Fig. 10). Moreover, a significant 
modulation of L-GABAergic interneurons development by thyroid hormones occurs before 
any measurable alteration of spontaneous activity (Fig. 9). Also the GABAergic boutons 
density along axons increases in presence of T3 irrespective of local cell density and 
independently of BDNF activity, although stimulation with exogenous BDNF partially 
rescued GABAergic bouton formation in absence of T3 (Figs. 16, 17, 18). Thus, growth 
and bouton formation of L-GABAergic neurons is, at least partly, directly induced by T3 
actions. In line with this, thyroid hormone receptors have been found in parvalbumin-
positive GABAergic neurons of the hippocampus and neocortex (Guadano-Ferraz et al., 
2003). 
 
5.4.2 Genomic or non-genomic actions? 
In the classical view the actions of T3 are mediated by nuclear thyroid hormone 
receptors (TRs). These ligand-modulated transcription factors can directly bind to the DNA 
and influence gene expression (Yen, 2001; Bernal, 2007), and TRs are expressed in 
virtually all neurons (Wallis at al., 2010) including parvalbumin interneurons (Guadano-
Ferraz et al., 2003). This is in line with the present results showing that thyroid hormone 
receptor antagonist 1-850 (Schapira et al., 2003) reduces T3 mediated increase in burst 
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frequency as well as in L-GABA soma size (Fig. 8). Additionally, T3 effects can be 
induced by very low concentrations (Fig. 6) and burst frequency is not dependent on the 
acute presence of T3 (Fig. 7), which is also more likely for regulation by genomic actions.  
This suggestion is supported by recent studies using mutant mice. Thyroid 
hormones had already been shown to modulate the development and function of 
parvalbumin-positive interneurons (Berbel et al., 1996; Gilbert et al., 2007). Similar results 
were obtained from experiments using mutant mice devoid of all TRs or carrying a 
mutated form of the TRalpha receptor (Guadano-Ferraz et al., 2003; Venero et al., 2005; 
Wallis et al., 2008) suggesting a prominent role of nuclear receptors in GABAergic 
neurons development. 
In conclusion, the detailed mechanisms of T3-mediated growth of GABAergic 
neurons are still unclear, but the results suggest, in line with the literature, that T3 acts 
primary via nuclear thyroid hormone receptors. However, the contribution of non-genomic 
hormone actions or the involvement of other growth factors cannot be completely 
excluded. 
 
5.4.3 Dependence on neuronal activity 
The present experiments suggest that independent of spontaneous activity, thyroid 
hormones act as neurotrophic factors for the subpopulations of L-GABAergic and non-
GABAergic neurons. T3-treated neurons were significantly larger in T3-treated then in T3-
untreated cultures even when network activity was blocked (Fig. 10, cf. chapter 5.4.1). 
However, antagonists to ionotropic glutamate receptors and TTX blocked most of T3 
effect on L-GABAergic growth and in turn GABAergic neurons developed maximally 
when both neuronal activity and T3 were present (Fig. 10). Additionally, also in T3-
deprived cultures the blockade of network activity decreased the size of L-GABAergic 
neurons (Fig. 10), suggesting that neuronal activity modulates the growth of L-GABAergic 
neurons. Indeed, it is well established that the morphological and functional maturation of 
GABAergic interneurons is dependent on neuronal activity (Huang et al., 2007; Huang, 
2009; Cossart, 2010). The results suggest that an intricate hormone-activity 
interrelationship influences GABAergic neurons development. Thus, either both T3 
modulation and network activity function synergistically promoting GABAergic neuron 
growth or T3-mediated effects are partly activity-dependent.  
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5.4.4 Contribution of BDNF signalling 
A mediator for the hormonal- and activity-dependent modulation of L-GABAergic 
neurons might be brain derived neurotrophic factor (BDNF), whose expression is said to be 
regulated by both thyroid hormones (Koibuchi et al., 1999, 2001; Sui et al., 2010) or by 
neuronal activity (Zafra et al., 1990; Thoenen et al., 1991; Gorba et al., 1999). The 
neurotrophin BDNF is well known as a mediator of activity-dependent effects and BDNF 
strongly promotes interneuron development (Marty et al., 1996, 1997; Rutherford et al 
1997; Huang et al., 1999; Yamada et al., 2002; de Lima et al., 2004; Palizvan et al., 2004; 
Patz et al., 2003, 2004; Woo and Lu, 2006). 
Indeed, some aspects of GABAergic neurons development are dependent on BDNF 
signalling. Both the L-GABA soma size and the axonal branching were sensitive to the 
TrkB receptor inhibitor K252a irrespective of T3 presence (Fig. 18). Furthermore, K252a 
abolished the positive correlation between axonal parameters and the local cell density in 
T3-treated cultures and also inhibited the pruning of GABAergic axons from fields with 
low cell density (Figs. 17, 18). 
Thus the neurotrophin BDNF might act as a mediator of thyroid hormone actions 
since T3 has been suggested to regulate BDNF expression (Koibuchi et al. 1999; Koibuchi 
and Chin, 2000; Sui et al., 2010). In addition, T3 promotes the maturation of spontaneous 
network activity (Figs. 1, 4, 26) and BDNF secretion by projection neurons in the cerebral 
cortex is regulated by neuronal activity (Zafra et al., 1990; Lessmann et al., 2003). Thus, 
BDNF mediation might explain the intricate interrelationship between T3, L-GABAergic 
interneurons and network activity development. 
Moreover, the present results suggest a synergistic action of T3 and BDNF. The 
reduction of GABAergic axonal length in low neuronal density fields and thereby the 
correlation of axonal length and GABAergic boutons with the local cell density occurs 
only when both T3 and BDNF are present (Figs. 17, 18). In the absence of T3, even 
stimulation with exogenous BDNF had no influence on the axonal length and only partially 
enhanced the bouton formation and the correlation of GABAergic boutons with the local 
cell density (Fig. 18). 
Interestingly, it has been demonstrated that an overexpressed unliganded TR 
prevent nerve growth factor (NGF) induced neurite outgrowth in PC12 cells and raised the 
hypothesis that unliganded TRs might block neurotrophin-dependent neuronal maturation 
(Munoz et al., 1993; Bernal, 2007). Similarly, a combination of both NGF and T3 was 
Discussion 
92 
 
necessary to induce the expression of cytoplasmic dynein, a protein that is involved in 
retrograde axonal transport, in dorsal root ganglion explant cultures (Barakat-Walter and 
Riederer, 1996). In favour of this hypothesis the present data suggest that unliganded TRs 
might repress aspects of BNDF-induced maturation of large GABAergic interneurons. 
The contribution of BDNF signalling to thyroid hormone actions has also been 
discussed in context of cerebellar Purkinje cell development (Heuer and Mason, 2003). But 
in contrast to the present results no interactions of T3 and BDNF could be observed. T3 
induced growth of Purkinje cell dendrites also in the absence of BDNF signalling, but 
TrkB antagonists influenced the patterning of dendrites. 
 
5.4.5 Open questions: Other factors? 
As discussed previously, the results suggest that T3 acts primary via nuclear thyroid 
hormone receptors on the development of GABAergic neurons and network activity. 
However, the contribution of non-genomic hormone actions or the involvement of other 
growth factors cannot be completely excluded. 
Thyroid hormones have been suggested to induce non-genomic effects by binding 
to a membrane receptor formed by the integrin alphaVbeta3 and activating the mitogen-
activated protein kinase signalling cascade (Bergh et al., 2005; Davis et al., 2005). 
Additionally, thyroid hormones rapidly modulate protein phosphorylation (Sarkar et al., 
2006) and cytoskeletal proteins (Zamoner et al., 2006). Recently, fast and direct non-
genomic modulation of glutamatergic and GABAergic signalling by thyroid hormones has 
been suggested (Losi et al., 2008; Piua and Losi, 2011). In contrast, T3 application in the 
present experiments had no direct influence on the frequency of network events (Fig. 7). 
This contrast might be explained by the different methods of investigation and very high 
doses of thyroid hormones used by Piua and coworkers (Losi et al., 2008; Piua and Losi, 
2011). Additionally, non-genomic actions mediated by the integrin alphaVbeta3 are more 
likely for T4 than for T3 (Cheng et al., 2010). 
Furthermore, the contribution of non-neuronal cells to T3-mediated effects is an 
unsolved issue. On the one hand, thyroid hormones are known to regulate astrocyte 
maturation (Paul et al., 1996; Anderson, 2001; Mendes-de-Aguiar et al., 2010), which 
might further modulate neuronal development. On the other side, thyroid hormone actions 
might depend on the release of trophic factors from glial cells. It has been suggested that 
the release of basic fibroblast growth factor from glial cells is essential for the T3-mediated 
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increase in excitability of hippocampal neurons (Niederkinkhaus et al., 2009). 
Additionally, T3 loses its ability to enhance neurite outgrowth in dorsal root ganglion 
explant cultures when non-neuronal cells are eliminated from the cultures (Barakat-Walter, 
1996). Thus selected stimulating effects of T3 are probably mediated through non-neuronal 
cells. 
 
5.5 Temporal aspects 
5.5.1 Transient effects 
Morphological analyses revealed that T3-dependent acceleration of the somatic 
growth of L-GABAergic neurons (Fig. 24) and the increased formation of GABAergic 
boutons (Fig. 25) disappeared around 21DIV. This is in line with reports showing that lack 
of T3 during the first two to three weeks of postnatal development results in a delayed 
upregulation of specific proteins (Oppenheimer and Schwartz, 1997; Royland et al., 2008; 
Morte et al., 2010), the later appearance of parvalbumin interneurons in the cortex (Wallis 
et al., 2008) and a general delay in network development (Venero at al., 2005; Wallis et al., 
2008). However, all these parameters normalize during later postnatal development. Thus, 
several aspects of neuronal development might become independent from T3 signalling 
after an initial T3-dependent period (Oppenheimer and Schwartz, 1997). Additionally, 
some homeostatic mechanisms may compensate specific developmental parameters in 
order to approximate a behaviourally plausible network performance (Turrigiano and 
Nelson, 2004; Marder and Goaillard, 2006; Grashow et al., 2010).  
 
5.5.2 Long-lasting effects 
The characteristic GABAergic innervation of non-GABAergic cell bodies with a 
sparing of cell free regions (Fig. 25), and the density of late-born S-GABAergic neurons 
(Fig. 22) were still reduced in 21-day-old T3-deprived cultures. Additionally, the burst 
frequency was significantly reduced in three week old T3-untreated cultures compared to 
T3-treated ones (Fig. 26). None of these features could be rescued by T3 application 
starting after the second week in vitro. Thus T3 is essential for selected aspects of cortical 
interneuron and network activity development during a restricted period of early network 
formation and T3 deprivation during this time might cause a permanent or at least long-
lasting deficit in the network architecture development. 
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The most severe consequences of thyroid hormone deficits in vivo are induced 
during a developmental period up to the end of second postnatal weeks in rodents. 
Irreversible mental retardation and locomotor deficiencies follow cortical, hippocampal 
and cerebellar malformations (Oppenheimer and Schwartz, 1997; Koibuchi and Chin, 
2000; Anderson, 2001; Bernal et al., 2003). Alterations in the formation of the network 
structure, especially those alterations concerning excitatory-inhibitory balance and the 
structure of the synaptic connections may explain the consequences of malfunction in 
mature networks. However, data about long-lasting consequences of hypothyroidism on 
GABAergic neurons are controversial. Gilbert et al., (2007) reported chronic decrease in 
the number of parvalbumin-positive interneurons after thyroid hormone deprivation during 
early development. In contrast, reduction in parvalbumin expression in mice bearing a 
mutated TRalpha was transient (Wallis et al., 2008) or could be reversed by high doses of 
T3 in adulthood (Venero et al., 2005).  
 
5.5.3 Critical period of GABAergic neurons development 
Thyroid hormones control several developmental processes, many of them 
restricted to innate critical periods (Oppenheimer and Schwartz, 1997; Koibuchi and Chin, 
2000; Bernal et al., 2003). In line with this, the results of the present work show that 
deficits in GABAergic neuron density, axonal patterning, and burst frequency following 
early T3 deprivation could not be rescued by T3 application after the second week in vitro. 
However, the mechanisms generating such sensitive periods are still unclear. In general, 
two principal possibilities are feasible: limitations in the T3 signalling pathways itself or 
changes in the plasticity of GABAergic neurons. 
First, changes in the T3 signalling pathways might create periods with enhanced 
sensitivity. Indeed, the spatio-temporal pattern of T3 availability appears dynamic and 
heterogeneous during development (Quignodon et al., 2004). But postnatal T3 levels in 
serum and brain are homeostatically controlled and quite stable, and are therefore unlikely 
to close a critical period (Quignodon et al., 2004). The differential expression of thyroid 
hormone receptors TRalpha and TRbeta is another possible explanation for the time 
sensitive actions of T3. Especially the TRbeta is expressed more postantally with more 
restricted spatio-temoral expression pattern, and therefore might act more specifically. 
However, the thyroid hormone receptors are expressed early in embryonic development 
and increase with further development without prominent changes during early postnatal 
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development (Bradley et al., 1992; Oppenheimer and Schwartz, 1997). Finally, TRs bind 
several coregulators, which represent an important regulation mechanism for thyroid 
hormone actions. Although the exact expression patterns of these coregulators have not 
been clarified, the developmental expression patterns of coregulators might be the most 
interesting candidates to explain developmental changes in thyroid hormone sensitivity 
(Yen, 2001; Bernal, 2009). Thus in summary, the specific developmental events in T3 
signalling remain poorly understood. 
Secondly, the change in T3 sensitivity might arise from general alterations in 
neuronal plasticity. In general, neurons undergo a developmental transition from immature 
to mature stages (Moody and Bosma, 2005) accompanied by prominent changes in gene 
expression (Mody et al., 2001; Stead et al., 2006; Semeralul et al., 2006) and neuronal 
properties (Klueva et al., 2008; Doischer et al., 2008; Okaty et al., 2009). Also the 
developmental switch in GABAergic signalling results from changes in intrinsic neuronal 
features (Ben-Ari et al., 2007; Blankenship and Feller, 2010). Thus it is feasible, that 
neurons might lose some kind of plasticity during this transition. Indeed, age-dependent 
changes in GABAergic synapse plasticity have been reported (Gubellini et al., 2001; 
Chattopadhaya et al., 2004). Additionally, the activity-dependent survival of a 
subpopulation of GABAergic neurons is restricted to a critical period of early development 
(de Lima et al., 2004). More generally, it is known that the plasticity of adult neurons, in 
contrast to immature neurons, is limited by several factors on the cellular and molecular 
level e.g. myelination, perineuronal nets and the excitatory-inhibitory balance (Bavelier et 
al., 2010). 
 
5.5.4 Role of depolarizing GABA? 
The present results suggest that specific aspects of GABAergic neurons 
development, the establishment of axonal distribution (Fig. 25) as well as the survival of S-
GABAergic neurons (Fig. 22), are correlated to a critical phase of early network 
development (until the end of the second week in vitro). Imaging experiments revealed that 
this time is well correlated to depolarizing actions of GABAergic signalling (Fig. 20), 
suggesting that these processes might be limited by the transition from depolarizing to 
hyperpolarizing GABAergic signalling. 
The developmental switch in GABAergic signalling represents a hallmark in 
network maturation (Ben-Ari et al., 2007; Blankenship and Feller, 2010). Interestingly, the 
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excitatory actions of GABAergic signalling have been implicated in the early 
morphological and functional maturation of neurons (Owens and Kriegstein, 2002). Thus, 
the T3-mediated acceleration of GABAergic neurons growth and synaptogenesis during 
early development, and thereby a presumably increased GABAergic neurotransmission, 
might strengthen the neurotrophic actions of depolarizing GABAergic signalling. 
Moreover, both long-lasting effects the establishment of axonal distribution (Fig. 
25) as well as the survival of S-GABAergic neurons (Fig. 22) were dependent on BDNF 
signalling (Figs. 17, 18, 23). Thus it is likely that some activity-dependent mechanisms 
may be involved. Interestingly, depolarizing GABA increases BDNF expression in 
postsynaptic neurons (Berninger et al., 1995; Obrietan et al., 2002), which might provide 
an optimal environment for initial interneuron development. GABA itself can stimulate the 
expression of BDNF, which then in turn facilitates the maturation of GABAergic neurons 
creating a positive feedback loop. But GABA switches to repressing BDNF expression 
during the GABA shift (Berninger et al., 1995), what might close the window for the initial 
GABA-triggered and BDNF-mediated interneuron maturation. Thus there might be a 
critical phase of BDNF dependence in the development of GABAergic neurons, which 
ends with the switch in GABAergic signalling. So, if developmental processes like the 
axonal pruning are synergistically regulated by BDNF and T3, lack of thyroid hormone 
during the time of depolarizing GABA, the time when depolarizing GABA can stimulate 
BDNF expression, should hamper the positive effects of this feedback loop and might 
explain the presence of a critical period. 
 
5.5.5 Relevance of T3 modulation for the in vivo cortical network development 
The effects of T3 not only depend on the site of action but also on the 
developmental timing. T3 deficiency during fetal brain development results in different 
behavioral and neuroanatomical malformations than during perinatal development. In 
rodents T3 affects proliferation and migration during prenatal development and 
differentiation of neurons and synapse formation during perinatal and postnatal 
development. Multiple genes mediate T3 actions (Alvarez-Dolado et al., 1999; Alvarez-
Dolado et al., 2000; Royland et al., 2008; Morte et al., 2010) and it is possible that 
different mechanisms are involved in successive phases of development (Zoeller and 
Rovet, 2004; Morreale de Escobar et al., 2004). The present results show that the initial 
steps of the functional network formation are regulated by thyroid hormone. This specially 
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concerns the perinatal and the early postnatal period in rodents that correspond to the first 
half of the third trimester in humans (Zoeller and Rovet, 2004; Khazipov and Luhmann, 
2006).  
Since most effects of T3 actions have been observed during early development 
thyroid hormones have been suggested to accelerate and synchronize neuronal maturation 
(Oppenheimer and Schwartz, 1997; Koibuchi and Chin, 2000; Bernal et al., 2003). If 
developmental processes occur out of phase, windows of opportunity may be missed and 
irreversible maladaptive changes may occur. The present data show that T3 promotes the 
expression of KCC2 and the development of GABAergic synaptic network, partially 
mediated by BDNF signalling. Developmental impact of T3 on GABAergic network 
formation is most relevant in the limited period of early network activity characterized by 
the depolarizing actions of GABA. As the BDNF-mediated upregulation of KCC2 is 
apparently limited to early development (Aguado et al., 2003; Rivera et al., 2004; Ludwig 
et al., 2011), it might be coordinated with T3-mediated interneuron growth. Taken 
together, the results of the present study corroborate the idea that T3 accelerates neuronal 
maturation, and by doing that, contribute to the timely synchronization of critical aspects 
of network activity and GABAergic system development during the early neocortical 
development. This highlights the importance of thyroid hormone signalling during early 
network development. 
 
5.6 Conclusions 
Taken together, the results show that T3 contributes to the morphological and 
functional maturation of early cortical networks by regulating the development of the 
cortical GABAergic system. 
T3-deprivation during the first two weeks induced long-lasting deficits in the 
axonal patterning of L-GABAergic neurons and the density of small late born GABAergic 
neurons. Additionally, the expression of the potassium chloride cotransporter KCC2 was 
retarded in T3-untreated networks. These alterations in the formation of the network 
structure, especially those alterations concerning excitatory-inhibitory balance and the 
structure of the synaptic connections, may explain the consequences of malfunction in 
mature networks following deficits in T3 signalling. 
The results also demonstrate that cultures chronically treated with T3 showed 
increased frequency of spontaneous bursts of activity and more mature properties than 
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untreated networks. Network activity in turn plays an important role in the maturation of 
developing neuronal structures (see chapter 2.1.3). Thus it is feasible that disturbances of 
early network activity provoke abnormalities that might explain at least some 
developmental effects of T3. This hypothesis could provide a framework to understand and 
further investigate the physiological and structural changes both due to deficits or excess of 
thyroid hormones. 
Recovery experiments highlighted the importance of thyroid hormone signalling 
during early network development. They suggest that the development of GABAergic 
neurons and network activity is especially sensitive to thyroid hormone modulation during 
the first two weeks in cultures, and that developmental deficits following early T3 
deprivation might not be rescued after this initial T3 sensitive period. These results 
corroborate the idea that T3 accelerates neuronal maturation and thereby contributes to the 
timely synchronization of critical developmental processes. 
 
5.7 Perspectives 
“There is excitement ahead for thyroid research in neuroendocrinology!” 
Graham R. Williams (2008) 
 
5.7.1 Role of T3 in synaptic plasticity 
The present results highlighted the function of thyroid hormones in synaptic 
plasticity, especially in the formation of GABAergic boutons and axons. Although thyroid 
hormones have already been shown to modulate the expression of several synaptic proteins 
and the structure of neuronal axons, dendrites and dendritic spines (see chapter 2.3.4), their 
distinct role in synaptic plasticity is still unknown. An unresolved issue is whether thyroid 
hormones act in an instructive or a permissive fashion. Do they directly enhance synaptic 
maturation or are they simply permissive factors, setting the framework for activity-
dependent maturation, e.g. by modulating the threshold for synaptic plasticity? 
Interestingly, T3 and also T3 binding sites have been shown to be located at synaptic sites 
(Dratman et al., 1976, 1982, 1987; Mashio et al., 1982) and thyroid hormones rapidly 
modulate protein phosphorylation in cerebrocortical synaptosomes (Sarkar et al., 2006), 
rising the still unanswered question whether T3 might even function as a neurotransmitter 
(Dratman and Gordon, 1996). A contribution of T3 to synaptic plasticity further raises the 
question, where and when T3 is released in the brain. A large amount of T3 is generated 
locally in the brain by deiodination of T4 in astrocytes (Guadano-Ferraz et al., 1997; 
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Williams, 2008). It will be of interest whether the release of this T3 occurs in a 
consecutive, paracrine fashion (Gereben et al., 2008; Freitas et al., 2010) or is triggered by 
specific events, e.g. neuronal activity. Thus there are several unresolved questions which 
have to be addressed to establish the exact role of thyroid hormones in activity-dependent 
synaptic arrangement, especially during early development. 
 
5.7.2 Signalling pathway 
The present work highlights the interactions of thyroid hormone signalling and 
actions mediated by neuronal activity, especially those induced by BDNF. The present data 
suggest that T3 interacts with BDNF signalling pathways and thus suggest an important 
role for T3 in activity-dependent plasticity. However the exact interaction sites of these 
pathways are still unclear, but their identification might considerably improve our 
understanding of thyroid hormone function on synaptic plasticity and neuronal maturation. 
Control of BDNF expression. Thyroid hormones have been suggested to regulate 
the expression of BDNF (Koibuchi et al., 1999, 2001; Shulga et al., 2009; Sui et al., 2010). 
Because the upregulation of BDNF expression occurs in a fast (Sui et al., 2010) and 
promoter specific fashion (Koibuchi et al., 1999), a direct mechanism of T3-mediated 
BDNF expression is feasible. However, the identification of a thyroid hormone response 
element in the BDNF promoters is still missing. But only the identification of this specific 
binding site can prove the direct regulation of BDNF expression by T3. 
Interaction of T3 and BDNF. In addition to the direct regulation of BDNF, the 
signalling pathways of thyroid hormones and BDNF offer several interaction sites, which 
have to be taken into account when investigating the mechanism of thyroid hormone 
actions. 
(1) The actions of thyroid hormones are thought to be mainly mediated by nuclear 
receptors, which are ligand-dependent transcription factors. Unliganded receptors can 
function as potent repressors of gene expression by binding corepressors with histone 
deacetylase activity (Yen, 2001; Bernal, 2007; Williams, 2008). Thus, the deacetylation 
and thereby inaccessibility of DNA might hinder BDNF-mediated transcription of genes. 
Indeed, such a mechanism has already been suggested to regulate neurotrophin-dependent 
maturation of PC12 cells (Munoz et al., 1993; Bernal, 2007).  
(2) It has recently been shown that TRs can also be localized in the cytosol (Storey 
et al., 2006) and bind to a subunit of the phosphoinositide-3-kinase (PI3K; Moeller et al., 
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2006). The PI3-kinase is an important downstream factor of BDNF signalling (Gottmann 
et al., 2009; Minichiello, 2009) and is essential for axonal development and synaptic 
plasticity (Cosker and Eickholt, 2007; Hoeffer and Klann, 2009). T3 binding modulates the 
PI3K and mammalien-target-of-Rapamycin (mTOR) pathway in non-neuronal (Moeller et 
al., 2006) and neuronal cells (Cao et al., 2009; Sui et al., 2008) and might thereby regulate 
BDNF-mediated induction of the same pathway.  
(3) T3 directly regulates the expression of a set of proteins, e.g. the 
Ca
2+
/calmodulin-dependent protein kinase IV (CamKIV), the calmodulin binding protein 
RC-3/neurogranin, and the growth associated protein GAP-43 (reviewed in Bernal et al., 
2003; Bernal, 2009), which take important places in synaptic plasticity and therefore might 
modulate BDNF-dependent plasticity (Benowitz and Routtenberg, 1997; Minichiello, 
2009). At least, thyroid hormones have been suggested to control the expression of 
neurotrophin receptors (Roskoden et al., 1999). 
These pathways have been identified very recently and have not been analysed in 
detail. Thus the detailed mechanisms and their contribution to thyroid hormone actions are 
still unclear and have to be investigated. 
 
5.7.3 Clinical relevance 
The objects of the present work have been related to different psychiatric disorders. 
Thus, deeper understanding of the mechanisms of the intricate interrelationship of 
GABAergic neurons, thyroid hormones and network activity, especially during early 
development, might be helpful to better understand the causes of psychiatric disorders and 
might give rise to improved prevention and therapeutic strategies.  
Thyroid hormones. Lack of thyroid hormones has been correlated to a set of 
developmental disorders with cretinism as its most severe form (World Health 
Organization, 2004). Furthermore T3 deficiency has also been linked to depression, 
anxiety and ADHD (Kirkegaard and Faber, 1998; Morreale de Escobar et al., 2004; 
Vermiglio et al., 2004; Carvalho et al., 2009; Pilhatsch et al., 2010). Mild hypothyroidism 
caused by iodine deficiency led to reduced intellectual ability (Delange, 2000; de Benoist 
et al., 2008) and is the world’s greatest single cause of preventable brain damage. 
Consequently, the maintenance of adequate iodine levels is a great public health challenge 
(World Health Organization, 2004). In addition, thyroid hormone application might be a 
treatment strategy in neurological disorders. Indeed, T3 is commonly used to accelerate or 
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augment standard antidepressant trials (Carvalho et al., 2009). Thyroid hormones might 
also be a potential therapeutic approach for human peripheral nerve injuries (Barakat-
Walter, 1999). T3 treatment accelerated and improved the regeneration of sciatic nerves 
and the recovery of sensory and motor functions after peripheral nerve transection in rats 
(Barakat-Walter, 1999). 
GABAergic neurons. Dysfunctions of GABAergic signalling can result in several 
pathological conditions, such as autism, mental retardation, epilepsies and schizophrenia 
(DeFelipe, 1999; Levitt et al., 2004; Lewis et al., 2005; Wonders and Anderson, 2006; 
Ben-Ari et al., 2007; Woo and Lu, 2006). In addition, deregulated excitatory GABAergic 
signalling has been implicated in the genesis of neuropathic pain, neonatal seizures, 
temporal lobe epilepsy and seizures that occur after ischemic–hypoxic insult (Kahle et al., 
2008). Thus, the understanding of GABAergic neurons plasticity will be helpful in the 
prevention and treatment of psychiatric disorders related to GABAergic signalling. 
Furthermore, maturation of the GABAergic system has been correlated to the 
closure of the ‘critical period’ of cortical plasticity and inhibitory GABAergic signalling is 
suggested to function as a ‘brake on plasticity’ (Huang et al., 1999; Bavelier et al., 2010). 
Resetting the inhibitory-excitatory balance might provide a strategy to reactivate neuronal 
plasticity (Hensch, 2005; Bavelier et al., 2010). 
Early spontaneous network activity. Early spontaneous network activity is thought 
to have an important role in the development of circuits. Disruption of normal firing 
patterns during development, for example by fetal alcohol exposure, prevents the normal 
development of primary sensory systems (Stromland et al., 2004; Medina et al., 2005). An 
understanding of the mechanisms that mediate spontaneous activity could have profound 
implications for the clinical treatments of pregnant women and will help to prevent 
neuropathologies associated with fetal exposure to neuroactive pharmacological agents 
(Blankenship and Feller, 2009). 
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7. Appendix 
7.1 Solutions and media 
7.1.1 General buffer 
Phosphate buffered saline (PBS) 
137 mM NaCl 
  2.6 mM KCl 
  8.1 mM Na2HPO4 
  1.4 mM KH2PO4 
  Aqua dest. (pH 7.4) 
 
artificial cerebrospinal fluid (aCSF)  
     140 mM NaCl 
     5 mM KCl 
     1.5 mM CaCl2 
     0.75 mM MgCl2 
     1.25 mM NaH2PO4 
     20 mM d-glucose 
     15 mM HEPES/NaOH 
     Aqua dest. (pH 7.4) 
 
 
7.1.2 Solutions and media for cell culture 
Hank’s medium  Hank´s balanced salt solution (HBSS, Ca
2+
 and Mg
2+
    free; Gibco by Invitrogen, Carlsbad, CA, USA) 
     20 mM HEPES (Carl Roth, Karlsruhe, Germany) 
     pH 7.4 
 
Dissociation buffer   0.5% trypsin/EDTA (Gibco) in Hank’s medium 
 
Astrocyte culture medium Dulbecco’s modified Eagle medium (DMEM, Gibco) 
      10% fetal calf serum (FCS; Gibco) 
 
N2 neuron culture medium 75% DMEM (Gibco) 
     25% Ham’s F12 (Gibco) 
     N2 supplements (Gibco) 
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7.1.3 Solutions for immunocytochemistry 
Tris/metabisulfite solution Aqua dest.  
0.05 M Tris (pH 7.5) 
0.85% sodium metabisulfite  
 
Preincubation  Tris/metabisulfite solution  
3% bovine serum albumin  
10% normal goat serum  
0.6% Triton X-100 
 
Primary antibody   Tris/metabisulfite solution 
3% bovine serum albumin 
10% normal goat serum 
0.6% Triton X-100 
 
PBS washing buffer   0.1 M PBS (pH 7.4) 
 
Secondary antibody  0.1 M PBS (pH 7.4) 
10% normal goat serum 
2% bovine serum albumine 
5% sucrose  
0.3% Triton X-100 
 
Peroxidase reaction  50 mM Tris-HCl in Aqua dest. 
0.01% 3, 3' diaminobenzidine tetrahydrochloride 
0.004% H2O2 
1% Nickel ammonium sulfate 
50 mM Imidazole 
 
 
Modifications for synapse stainings: 
 
PBS washing buffer   0.01 M PBS (pH 7.4) 
 
Preincubation   0.01 M PBS (pH 7.4) 
10% normal goat serum 
5% sucrose 
2% bovine serum albumine 
0.25% Triton X-100 
 
Antibody solution   0.01 M PBS (pH 7.4) 
10% normal goat serum 
5% sucrose 
2% bovine serum albumine 
0.25% Triton X-100 
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7.1.4 Solutions for proteinbiochemistry 
RIPA (Radio Immuno Precipitation Assay) lysis buffer 
stock solution  150 mM NaCl 
1% Igepal 
0.5% Sodium deoxycholate (Doc) 
0.1% sodium dodecyl sulfate (SDS) 
10% Glycerol 
in 50 mM Tris-HCl (pH 8.0) 
 
working solution RIPA stock solution 
4% Protease inhibitor (Complete) 
0.5% phenylmethanesulfonyl fluoride (PMSF)                
 
8% SDS-Page (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) 
6.6 ml Aqua dest. 
3 ml 1.5 M Tris-HCl, pH 8.8 
     60µl 20% (w/v) SDS 
     2.4 ml 40% Acrylamide/bisacrylamide  
                60 µl 10% (w/v) Ammonium persulfate (APS) 
12 µl Tetramethylethylenediamine (TEMED) 
 
SDS-Page sample buffer  6.7 ml Aqua dest. 
stock solution  300 µl 2M Tris-HCl, pH6.8   
     1,0 ml Glycerol 
     1,0 ml 20% SDS 
     500 µl of 0,1% Bromphenol blue solution 
 
working solution  stock solution 
5% ß-Mercaptoethanol 
 
Running-puffer (10x stock) Aqua dest. 
       192 mM Glycine   
     25 mM Tris-base     
                 0.1% SDS 
   pH 8.6 
 
working solution Aqua dest. 
10% stock solution 
 
Transfer buffer (stock) Aqua dest. 
48 mM Trizma-base  
39 mM Glycine 
0.0375% SDS 
pH 8.6  
 
working solution  Transfer buffer 
20% Methanol 
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Immunoblot 
 
Blocking solution   0.1 M PBS  
5% milk 
1% GNS 
0.1% Tween20 
 
Washing buffer (PBST) 0.1 M PBS (pH 7.4) 
0.1% Tween20  
 
Antibody solution  0.1 M PBS 
1% milk 
1% GNS 
0.1% Tween20 
 
 
 
7.2 Drugs / Pharmacological reagents 
Drug Abbrev. Concentr. Manufacturer 
triiodothyronine T3 15 nM Sigma-Aldrich, St. Louis, MO, 
USA 
Corticosterone Cort 0.1 μg/ml Sigma-Aldrich, St. Louis, MO, 
USA 
tetrodotoxin TTX 1 µM Alomone Labs, Jerusalem, Israel 
D-(-)-2-amino-5-
phosphonopentanoic acid 
APV, 
D-AP5 
12.5-50 µM Tocris Cookson, Ellisville, MO, 
USA 
6-cyano-7-nitroquinoxaline-
2,3-dione disodium 
CNQX 2.5-10 µM Tocris Cookson, Ellisville, MO, 
USA 
Potassium chloride KCl 60 mM Merck KGaA, Darmstadt, 
Germany 
Muscimol  200 μM Sigma-Aldrich, St. Louis, MO 
Brain derived neurotrophic 
factor 
BDNF 50 ng/mL Pepro Tech, Rocky Hill, NJ, USA 
K252a - 100 nM Calbiochem by Merck KGaA, 
Darmstadt, Germany 
1-850 - 1 µM Merck KGaA Darmstadt, 
Germany 
(-)-bicuculline methiodide BMI 20 µM Sigma-Aldrich, St. Louis, MO, 
USA 
Picrotoxin PTX 10 µM Tocris Cookson, Ellisville, MO, 
USA 
VU0240551 VU 4 µM Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA 
 
  Appendix 
 
123 
 
7.3 Primary antibodies 
Antibody Host Dilution 
ICC 
Dilution 
WB 
Cat. No./ 
clone 
Manufacturer 
GABA mouse 1:200 - clone 5A9 Chemicon, Temecula, CA 
Pan-Shank mouse 1:100 - clone 
N23B/49 
UC Davis/NIH NeuroMab 
Facility, Davis, CA 
GluR2 mouse 1:100 - clone 
L21/32 
UC Davis/NIH NeuroMab 
Facility, Davis, CA 
Gephyrin mouse 1:1000 - No.  
147 011 
Synaptic Systems, 
Göttingen, Germany 
Synapsin 
1,2 
rabbit 1:500 - No.  
106 002 
Synaptic Systems, 
Göttingen, Germany 
KCC2 rabbit - 4 µg/ml Cat. 
KCC21-A 
Alpha Diagnostic 
International Inc, San 
Antonio, TX 
KCC2 mouse - 1-10 
µg/ml 
clone 
N1/12 
UC Davis/NIH NeuroMab 
Facility, Davis, CA 
NKCC mouse - 330ng/ml clone T4 Hybridoma Bank, Iowa 
City, IA 
GAPDH mouse - 1:1000 clone 1D4 Covance, Princeton, NJ 
 
 
7.4 Secondary antibodies and peroxidases 
Antibody Host Dilution 
ICC 
Dilution 
WB 
Cat. No. Manufacturer 
anti-mouse goat 1:200 - SMI-
5010C 
Convance Inc, Princenton, NJ 
Peroxidase-
anti 
peroxidase 
mouse 1:200 - 405 Sternberger, Baltimore, MD; 
now Convance Inc, 
Princenton, NJ 
anti-mouse 
Cy2 
goat 1:400 - 115-225-
003 
Dianova, Hamburg, Germany 
anti-rabbit 
Cy3 
goat 1:400 - 115-165-
003 
Dianova, Hamburg, Germany 
anti-mouse 
HRP 
goat - 1:10000 P0447 Dako, Glostrup, Denmark 
anti-rabbit 
HRP 
goat - 1:2000 P0448 Dako, Glostrup, Denmark 
StrepTactin 
HRP  
- - 1:10000 161-
0380 
Bio-Rad Laboratories Inc., 
Hercules, CA 
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7.5 Lab instruments and equipment 
Instrument Application Manufacturer 
Axiophot 2 Microscope Zeiss, Oberkochen, Germany 
Spot slider CCD camera Diagnostic instruments, Sterling Heights, 
MI, USA 
Axiovert S100 TV Microscope Zeiss, Oberkochen, Germany 
CoolSNAP ES CCD camera Roper Scientific, Ottobrunn, Germany 
UniBlitz Shutter Visitron Systems, Puchheim, Germany 
STG 2008 Stimulus generator Multi Channel Systems, Reutlingen, 
Germany 
Axioskop Standard WL Microscope Zeiss, Oberkochen, Germany 
Camera Lucida  Zeiss, Oberkochen, Germany 
Hp Officejet pro L7580 Scanner Hewlett-Packard Company, Palo Alto, 
CA, USA 
EBU-4000 Semi-dry-blotter C.B.S. Scientific, Del Mar, CA, USA 
Mini-Protean Tetra Cell Electrophoresis Cell Bio-Rad Laboratories Inc., Hercules, CA 
GeneGnome5 ECL detection Syngene by Synoptics Ldt, Cambridge, 
UK 
BB 6220 CU Incubator Heraeus, Hanau, Germany 
Hera cell 240 Incubator Thermo Electron Corp., now Thermo 
Fischer Scientific Inc., Waltham, MA  
 
 
7.6 Software 
Software Version Supplier 
Metamorph 7.0 Molecular Devices, Sunnyvale, CA, 
USA 
Matlab 7.5 MathWorks, Natick, MA, USA 
MiniAnalysis 6.0.3 Synaptosoft, Decatur, GA, USA 
HP SolutionCenter Officejet L7500 
series 
Hewlett-Packard Company, Palo Alto, 
CA, USA 
SigmaStat 2.03 SPSS Inc., Chicago, IL, USA 
SigmaPlot 8.0 SPSS Inc., Chicago, IL, USA 
QuantityOne 4.5.0 Bio-Rad Laboratories Inc., Hercules, 
CA, USA 
Excel 2003, SP3 Microsoft Corp., Richmond, WA, USA 
CorelDraw 15 Corel Corp., Ottawa, ON, Canada 
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